ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000380.1|Leupyrrin_2 # 589 # 2577 # 1 # ID=1_2;partial=00;start_type=TTG;rbs_motif=GGG;rbs_spacer=15bp;gc_cont=0.784	BGC0000380.1|Leupyrrin_2 	589	2577	+	Loose	350	25.7942	dfrI	34.04	3004645	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	TTGGCCCATCCGTGGCCGATCTGGCATGGCCGCCCGGTGAGCTCCGGAGAGAAACGCTGCTGGCTCGATCGGTCGCTCGCCTTCCTCTCGGCCGCGCTGCCGTTCGGGCTCTCGCTGGCCCGCGCCGCCTCCTCCGGGCAGTGGCGGGAAGACCTCACCGCCGTCCGGGACCTCGGCCTCGTCGCGGTCGGGGTGGGCGGCGGCCTCTCGACGGCGCTCTCGCAGGCGCTGAGCCTGCTCCCGCTCGGCCCCCGCACCTTCCGCACCGCCCTCGGCTCGGCGCTCGCGCTCGCGCTCGCGTCGCGCGTGCTCTACGAGATGGTCCGCCGGCTCCTCCTGGAGGCCGCGCGGCCGGCGCCCCTGCCCGGGCTCTCGCTCCTTCGGCGGCTCCGCGGCGGCGCGGCGGAGCCGGCGCGCCCCGCGCCGGGCTCGCCGGACGGCGCCGTGAGCCCGCGCCTCGCCGCCGTGCTCGCGGCGATCGCCGTGCTCACGGCGGCGCTGTCGCCGACCTGGCAGCGGGAGGCGACGGTCGGCGGCGGCGCCATGCTCGCCACCTGCTGCGCGCTCGTGACGGTCGCGCTCGCGTCGGCCTGCGCCGAGCAGGCGCGGCACGCGGGGCGCGCGTGGATCGGGCTCGGCGCGCTCCTCGGGGCCACGTTCGCCGAGAGCCCCCCCGCCGGCCTCGCCGCGCTCGCGGCGGCGTACGCCATGTTCCTCGCCCGCCGGGGCCTCGCCGACCGCCCCGCGGACGCCTCGGCCGCCGCCGGCCCGCCCCGCCGCATGCTGGGGGCCGCCGCCGGCGCCGGCGCGCTCACGGCCGCGCTCCTGCTCGCGCCGCTCGTGCTCCGGCCGCTCGCGCCGCGCGCGTGGGCGGACATCGGCCGCTCGCTCACGACCGGGAGCCTCGCCGCGCTCGACGTCGCGAGCGCGCGCACCACGGCGCTCGCCGCGTGGAGCCGCGAGATCGGCGTCGCCTCCCTGCTCATCGCCGCGGCCGGGCTCTCGCTCGCGCTCCTGCGCCCGCGCGCGCGGTGGCTCATCGCGCCCTTCCTCGTGCTGCTCGCGCTCGACACCGTCCTGCCCGCGCGGGCCGCCGGCGTGCTCTCCGCGGATCCGCTCACCCCGCTGCGCTCGCTCGCGGTCGCGGCGATCGCCGCCGGCTCGGCGCTCGGGGCGCACGCGGCGGTCCGGGCGCTGCTCGACACGCGCGTGCCGTTCTCGCGGAGCGGCGCGGTGCTGCTCGTCGTCTTCCAGCTGACGCTGGTCGCGCTGACGAGCGAGGAGGCCGGCTTCGCCGCCGACCGGAGCGAGCAGACGGCCGCCGAGGTGTGGACCGACGAGGCGTACGGGAGCCTCGACCCGAAGTCGGCGATCCTCGTGCGATCGCCGGCGATCGCGTGGCGGGTCTGGGCGGCGCGGATCACGCGCGGCGAGCGGCCGGACGTCCTCGTGGTCCCGATCCCGCTGCTCGATCGCGGCCAGGTCGCGGCGAGCCTGCTCGCCGAGGAGCGCAAGCTCGCGCCGCTGCTGCGCGACTTCGCGCTCGCGGGCGAGCCGAGCGAGTTCGCGCTCTCCACGCTGGCCGACGTCCGGCCCCTCTACGTGGAGCTCGATCCGCGCTGGTCGAAGAAGCTGCTCGGCCACCTGAACGTCGCCGGGATCTGGCTCGAGTACGCCCCGCAGCCGCTCGGCGCGTCGGACCGCAAGCTGGCGACCGCGCAGTCGATCGCGCCGATCCGGCGCGTGCTGGAGGCGCTCTCGGTGGCCGCGGTGCCGGACACGTCGACGGCGGCCGTCCTCGCGTCCACGATGCGGGGCCAGTCGAACGTCGTCAGCCTGCTGGGCGAGCGCGTCGTGGCGCAGTCGTTCCTGGACCGGCTGGGCGAGCTCGCCCTCGAGGACCCGTTCGTCTCCGGCGGCCCGAGCCGCCGCGCCGTCGCCGGCATCCGCCAGGCGTTCATCGCGAGGCGCCCCGTGCGGCGCCGCTGA	MAHPWPIWHGRPVSSGEKRCWLDRSLAFLSAALPFGLSLARAASSGQWREDLTAVRDLGLVAVGVGGGLSTALSQALSLLPLGPRTFRTALGSALALALASRVLYEMVRRLLLEAARPAPLPGLSLLRRLRGGAAEPARPAPGSPDGAVSPRLAAVLAAIAVLTAALSPTWQREATVGGGAMLATCCALVTVALASACAEQARHAGRAWIGLGALLGATFAESPPAGLAALAAAYAMFLARRGLADRPADASAAAGPPRRMLGAAAGAGALTAALLLAPLVLRPLAPRAWADIGRSLTTGSLAALDVASARTTALAAWSREIGVASLLIAAAGLSLALLRPRARWLIAPFLVLLALDTVLPARAAGVLSADPLTPLRSLAVAAIAAGSALGAHAAVRALLDTRVPFSRSGAVLLVVFQLTLVALTSEEAGFAADRSEQTAAEVWTDEAYGSLDPKSAILVRSPAIAWRVWAARITRGERPDVLVVPIPLLDRGQVAASLLAEERKLAPLLRDFALAGEPSEFALSTLADVRPLYVELDPRWSKKLLGHLNVAGIWLEYAPQPLGASDRKLATAQSIAPIRRVLEALSVAAVPDTSTAAVLASTMRGQSNVVSLLGERVVAQSFLDRLGELALEDPFVSGGPSRRAVAGIRQAFIARRPVRRR	MNQNRDDHNRAADREKTAEKRGENQCIISLILAMADNGTIGDKNALPWHLPNDLQFLKKSTMGKPIVMGRKTYQSIGRPLPGRTNVVISRSLEKEALPGCLIYSDLSVAIAALKKEPEVEEIMIMGGAQIYRAALPMMDRLYLTHVHANIEGDTQMPPFDFSHATLIFEEKHFKDEKNRYDYTFEIWDFKK	346.60	gnl|BL_ORD_ID|2124|hsp_num:0	3344			231	372	trimethoprim
BGC0000380.1|Leupyrrin_4 # 4173 # 4742 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=10bp;gc_cont=0.619	BGC0000380.1|Leupyrrin_4 	4173	4742	+	Loose	700	27.7202	ADC-217	47.22	3006386	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	ADC beta-lactamases pending classification for carbapenemase activity	ATGATCCTCACGAGAGTTAAGCAGGCTGTTCAGGACGTGCAGAGGGCGATGCACGAGCAACACCACCGTTACCAGGAGCAGGACTCGACCCAGACCCTGCGCGAGGGGCTCGAGGAGTATCACCAGAACGCATTGCTCTACAAACCGACCGCGATGACGCCGAGCTCCAAGCGGTTCTTCAAGGCGCACGACGCGTGCCACGTGGTGTTCGGCTGCAGCACCACGCCGGAGCAAGAGGCGCTCATCGACGTCTGGACGATGTTCGGCACGACCTGGCAATGGAGCGAGTACCTCGGCGAGGTGGAGAGGCCGGACCAGAAGCAGCGGATCCTCGGAGAGATCATCCCGGGCGTCGGATACGGGCGCATGGCGTTCCTCGTGCTCGTCACGCTCCCCGGCTGCTTCACCGTGTACAAGCGCACGCAGGAGATGCACCAGAAATGGGGCATGTACGAGTACGAGCCGTACCTCGACACCACGCTCAAGGACATTCGCAAGAAGTACAATATCCGCGTGTACTCGTCCGAAAAGCTGCCCAGGACGGCGCCCGCCGTGGAGAGCCGGATATGA	MILTRVKQAVQDVQRAMHEQHHRYQEQDSTQTLREGLEEYHQNALLYKPTAMTPSSKRFFKAHDACHVVFGCSTTPEQEALIDVWTMFGTTWQWSEYLGEVERPDQKQRILGEIIPGVGYGRMAFLVLVTLPGCFTVYKRTQEMHQKWGMYEYEPYLDTTLKDIRKKYNIRVYSSEKLPRTAPAVESRI	MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNNKKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKELKNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQENTMYQALGWEEFSYPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK	49.35	gnl|BL_ORD_ID|3215|hsp_num:0	4282			810	912	
BGC0000380.1|Leupyrrin_5 # 4739 # 6160 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.687	BGC0000380.1|Leupyrrin_5 	4739	6160	+	Loose	600	33.8834	APH(9)-Ia	32.05	3002662	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(9)	ATGAGTGATTCAGGGACTCCCACCGGCAAGCTCTCCCGCATCCGCGTCGCGGGCGCAGCGGCGGCCCAGGCGAGCGTCAGCCAGCTGAGGTACGCCACGAAGCGGCTCACGGGCGACACCGACGACGACGAGCTGCGGCGACTGCGCGACGAATCCATCGGGAAGGCGGTGTTCCAGGCGCTCGGGCAGCTGCGCGGCGGAGCGCTGAAGATCTCGCAGATGCTCGCCGCTCACGAAGATCTGGTGCCGCCGGCCGTCCGTCAGGAGCTCGCCAAGGCGAGCTACCGGGCGCCGAGCCTGAACCGAGCCGTGGTCCGCAGGATGATCACGATGAGCCTCGGGCAAACCCCGGAGCAGCTATTCGCGTCCTTCGAGCCCGACGCGTTCGCCGCCGCGAGCCTGGGACAGGTGCACCGCGCGGTCGAGCGCGACACCGGCCGCCGGCTGGCGGTGAAGATACAGTATCCGGGCATCGGCGACGCGCTCCGCAACGACATCGCCATCCTCCGGGCGCTGTTCACCACGCTGGCCGTCGTGACCCCGGCGTCGGACGGGAGGGCGCCCAACATGAAGGCCGTCGAGCCGCTGCTCGCCGAGATCGAGGACACCCTGCTCGAGGAGGTCGACTACCGTCACGAGGCGCTGACGACCTCCTGGTTCCGCAAGTACCTGAGGCACGACCTCGTCGTGATCCCGCAGGTCGTCCCGAAGTTCAGCAGCTCCGTCATCCTCACGACCACGCTCCTCGAGGGCAAGCACCTCGAGGAGTGGCTGGCGACGAACCCCTCGAAGGAGGAGCGCGACCGCATCGGGCAGGCGCTTTGCGACGTGTTCTTCGAGTGCGTGTTCGAGCTCGGGATCGTGCACGCGGACCCGAACCCGGGCAATTACATCTTCACGGACGACGGCCGCCTCGGGCTCATCGATTTCGGGTGCGTTCAGCTCATCGAGCTCCGGAACGTCCAGCTCGTCGCGGCGACCCTGCTGGCGTACGCGAAAGGCGACCTGGAGCAGGCCATCACCGAGTACCAGCGCGTCGGCATGCTGAGCCCGACGCTGACCGCGGCGCAGCGAGCGGAGATCGTGGAGCTGATGCGGCCGTCGCAGGAGTGGGTCAGCCTGGTGCTCGGCGCGGACGAGATCGACTTCGCGGAGCATCCGGAGTTCATGACGAGCATGCGGCGCTCGGCCCTCACCCTCGGGCCTGCCTTCCAGAGGCCGAGGCGCGGGCTGCTCTACCTCTCGCGCGCGCTGTGGGGCCTCTTCTCGATGCTCACGCAGCTCGGCGCGAAGGTGACCATGGCAGGCCGGGTGCCCCCGCCGGAGCGGCTGCAGACGCTCCAGTCCATGGGCCAGGTGATCGATGAGGTGACCGGCGACGCCGAATCCGGCAGGATGAGCTACTCGTCGCTGAAGGCCTGA	MSDSGTPTGKLSRIRVAGAAAAQASVSQLRYATKRLTGDTDDDELRRLRDESIGKAVFQALGQLRGGALKISQMLAAHEDLVPPAVRQELAKASYRAPSLNRAVVRRMITMSLGQTPEQLFASFEPDAFAAASLGQVHRAVERDTGRRLAVKIQYPGIGDALRNDIAILRALFTTLAVVTPASDGRAPNMKAVEPLLAEIEDTLLEEVDYRHEALTTSWFRKYLRHDLVVIPQVVPKFSSSVILTTTLLEGKHLEEWLATNPSKEERDRIGQALCDVFFECVFELGIVHADPNPGNYIFTDDGRLGLIDFGCVQLIELRNVQLVAATLLAYAKGDLEQAITEYQRVGMLSPTLTAAQRAEIVELMRPSQEWVSLVLGADEIDFAEHPEFMTSMRRSALTLGPAFQRPRRGLLYLSRALWGLFSMLTQLGAKVTMAGRVPPPERLQTLQSMGQVIDEVTGDAESGRMSYSSLKA	MLKQPIQAQQLIELLKVHYGIDIHTAQFIQGGADTNAFAYQADSESKSYFIKLKYGYHDEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAPNGFTQNLTGKQWKQLGKVLRQIHETSVPISIQQQLRKEIYSPKWREIVRSFYNQIEFDNSDDKLTAAFKSFFNQNSAAIHRLVDTSEKLSKKIQPDLDKYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAPKERDLMFIGGGVGNVWNKPHEIQYFYEGYGEINVDKTILSYYRHERIVEDIAVYGQDLLSRNQNNQSRLESFKYFKEMFDPNNVVEIAFATEQ	142.90	gnl|BL_ORD_ID|227|hsp_num:0	252			384	600	spectinomycin
BGC0000380.1|Leupyrrin_7 # 7128 # 9428 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=7bp;gc_cont=0.704	BGC0000380.1|Leupyrrin_7 	7128	9428	+	Loose	600	28.4906	FRI-3	41.46	3004799	protein homolog model	n/a	n/a	penam	antibiotic inactivation	FRI beta-lactamase	ATGGCGCAGCCGGAGATCAAGCAGACCTTCTGCCGCATCTGCGAGGCGCTCTGCGGCCTGGAGGCGACGGTCGAGGGCGACACCCTCGTGAGCCTGCGGCCCGATCGGGAGCACCCGCTCTCGAAGGGGTTCGCCTGCGTGAAAGGGGTGCAGTACGCCGGGATCCACGAGGACCCGGACCGCCTCAATCACCCGATGAAGCGCACGCCTCGCGGCTTTGAGCGCATCTCCTGGGAGACCGCCCTCTCGGAGATAGGAGAGCGCCTCCGCGAGCAGCTCCGGCGACACGGGCCGCGCTCGATGGGCATGTACCTCGGCAACCCGACGTTCTTCAACTACAAGGCCCTCCTGTTCGCGCAGGATTTCATGCGGGCGGTCGGGTCGCCGAACCTCTTCGCCTCGCACTCGATCGACTGCAACAACAAGCTCAAGGTGGCCGAGCTGATGTACGGGCTGGCGATGGCGCACCCCGTGCCGGACCTGGTCCACACGCGCTTTTTCCTCTGCCTCGGCTCGAACCCCACCGTGAGCCAGATGAGCTTCGTCCACGCGCCGAACGCGCTGGGGCAGCTCAAGGAGATCGTGAAGCGCGGCGGCCGCGTGATCCTCGTCGACCCCCGGCGCACGGAGACGGCCGACCAGGTGGGCGAGCACCTGTTCATCCGCCCCGGCACCGACGCGTACCTGCTCCTCGCGATGGGCCAGGTCCTGTTCGCCGAAGGGCGCTGCGACGTGGAGAGGCTGAAGGCGATCGGCAACGGCGCGGAGGAGCTCCGCGCTGCGGTGCGGGCCTGGACGCCGGAGCGGGTCGAGCCGATCACCGGCATCCCGGCCGGCGAGCTCCGCGCGCTGGCCCGCGATTACGCGGAGGCGAACGGGGCCGCCATTCACATCTCCACCGGCGTCAACATGGGCCCGTTCGGCTCGATCGCCTACTGGATGGCGCAGGCGCTCAACCTGGCCACCGGCAATGTCGATCGACGCGGAGGGTTGCTGATGCCCAAAGGACCGTTCGACCTCCTCTCGCTGGGGAGCCGCTCGGGCTTCGGCAAGTCGCGCGCCCGCACGCGCGTCGGGGGCCACGAGGCCGTCTACGACGCGCTGCCGAGCGGGGCCCTCGCCGAGGAGATCACCCAGCCTGGCGAGGATCGGCTCCGGAGCCTCATCGTCTGCGCCGGCAATCCGGCGCACTCCATCCCCGGTGGGCGGCTCCGGGAGGCGCTGAAGCAGCTGGACACGCTGGTCTGTATCGACATCTATCGAAACGCGACCGCGGAGCACGCCCATTACCTGCTGCCCGCGACCGACATGCTGGAGCGCTCCGATATCCCCCTGGGCATGATCCTGTCGCAGGTGACGCCGTACGCTCAGTTCAGCGAGCGCGTCGTCGCGCCGAAGCACGAGCGCCGGGAGGAGTGGGAGATCTTCAGCGAGCTGCTCCTCGCCTGCGGGATCCGGCCGAAGCAAGGCAACCTGTGCTCGGCGCTCCCGCAGGTCAACCGCTTCCTGAAGTACTTGCCAGGGAAGCTCCGCGTCGAGCCGGACCACCTGCTCGAGCTCGCGCTGCGCGTCCTCGGCGACGTGAGCCTTTCGCGGTTGCGGGCCCAGCCGCGGGGCGCCTTCTTGCCGCCGACGCAGCCGGGCTCGTTCCTCGGCAAGCGGGTCTTCACCCCGGATGGACGCGTCGATCTCGCCCCGCGGGCGCTCGTGCAGGACCTGACTCGCCTCGCGGGCGAAGAAGCTCGCTTTCGGCGGCACGCGGCGCAGGGCGACAGCGGGCCGCGCGACGTGCTCGAGCTCTTCCTCGTCGGGCGGCGCGAGCGGCGCAGCCACAACTCCTGGATGCTGAACAACAGCCGGCTCCGGCAGCCGCCGACGAACGTATGCCTGCTGAGCCCAGAGGACGCAGCGCAGGCCGGGATCCGCGACAGGGACCTCGTCGCGATCCGCTCCGAAGGGCGCGAGATCGTGCTGCCCGTGGAGCTCAGCGACGCCGTGGGCCGCGGCGTCATCGTCGTACCCCACGGCTGGGGGCACGCGCAGAGCGGGATGTCGGTGGCGAGCCACCTCGGTGGAGCGAACGTGAATGACGTGATCCCCGGCGGCACGGCCAACCTGGAGCCCGTGAGCGGTCAGGCGATCATGACCGGGCACGTCGTGCAGGTGCGGCGCGCCCGGCCGGCGACCGCTCCGGCGAACGACAGTGGGTCCCGGGGCCCGCCCGCTGCTCTCCCCGGAGCTGGCCCGTCCCCGCGAGTGAACCGGTCCGCGCCCGTCGAACCCGAAGGCCATCCACGATGA	MAQPEIKQTFCRICEALCGLEATVEGDTLVSLRPDREHPLSKGFACVKGVQYAGIHEDPDRLNHPMKRTPRGFERISWETALSEIGERLREQLRRHGPRSMGMYLGNPTFFNYKALLFAQDFMRAVGSPNLFASHSIDCNNKLKVAELMYGLAMAHPVPDLVHTRFFLCLGSNPTVSQMSFVHAPNALGQLKEIVKRGGRVILVDPRRTETADQVGEHLFIRPGTDAYLLLAMGQVLFAEGRCDVERLKAIGNGAEELRAAVRAWTPERVEPITGIPAGELRALARDYAEANGAAIHISTGVNMGPFGSIAYWMAQALNLATGNVDRRGGLLMPKGPFDLLSLGSRSGFGKSRARTRVGGHEAVYDALPSGALAEEITQPGEDRLRSLIVCAGNPAHSIPGGRLREALKQLDTLVCIDIYRNATAEHAHYLLPATDMLERSDIPLGMILSQVTPYAQFSERVVAPKHERREEWEIFSELLLACGIRPKQGNLCSALPQVNRFLKYLPGKLRVEPDHLLELALRVLGDVSLSRLRAQPRGAFLPPTQPGSFLGKRVFTPDGRVDLAPRALVQDLTRLAGEEARFRRHAAQGDSGPRDVLELFLVGRRERRSHNSWMLNNSRLRQPPTNVCLLSPEDAAQAGIRDRDLVAIRSEGREIVLPVELSDAVGRGVIVVPHGWGHAQSGMSVASHLGGANVNDVIPGGTANLEPVSGQAIMTGHVVQVRRARPATAPANDSGSRGPPAALPGAGPSPRVNRSAPVEPEGHPR	MFFLKKAQVHLFFFLCLPLNSFASQESNSIEQMRELEAAFGGRIGVYILNTKNGKEFSYRQDERFPLCSSFKAFLAASVLKKTQDKSVSLDDMMEYSGRVMEKHSPVSEKYRKTGASVRTLAKAAIQYSDNGASNLLMERYIGGPEGLTAFMRSTGDTDFRLDRWELELNSAIPGDERDTSTPKAVAMSLKNIAFGSVLDAKNKSLLQEWLKGNTTGNARIRAAVPDKWDVGDKTGTCGFYGTANDVAILWPDANSPAVMAVYTTRPNQNDKHDEAVIKNSAKIAINAVYGSYK	260.54	gnl|BL_ORD_ID|2281|hsp_num:0	3594			24	132	
BGC0000380.1|Leupyrrin_8 # 9425 # 10780 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.687	BGC0000380.1|Leupyrrin_8 	9425	10780	+	Loose	750	26.5646	bmr	28.17	3003007	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; nucleoside antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAACCTGCTCGATCTCGGAATTTCGCAGCTGCTGGAGAAGAAGTCGCTCGTGCACTCCGGCATCCGTGGTGGTGATGTGCCGCTCACCATCTACGACATGGATTATGGGCTCTACATGAGCCAGCGCGTGCTGTTCTATCGACGTGCCGTCGACGTCGCGGCGCTGCGGCGCTCGTTCGAGCGCATGCTCCAGCGCGTGCCGCTGCTCGCGGGCCGCCTGGTCCGCACGGAGGACGGCGACCTGCTCATCCGCTGCTCCGACGGGGGCGCGGAGCTGTCCGTCGTCGAGCAGCGGGGCACGATCGAGGAGTACGGCATCGGTCGGTCGGCCACCTCGGAGCTCGCCCGCTTCACCGGTCTTCACAGCGGATTCCGCCTCGTGAACCACGACGCGCCGCTCTTGCGGGTCCGGGTCACCCTCATGCGCTCGGGCGGCATGGCGATCGGCGTGTCGGCCCCCCACATCGTCATGGATGCCGGTACGGTGACCAGGTTCTTGTCGTACTGGTCGAAGGAGCATCGAGGGCTGCCCTGGCCTGGCCTCGACCCGGAGCGCGCCGCGCTCCTGGCCTTCGAGGAGCAGGCGCGCCGGGAGGTCGCCTCGGTCCGAGCGAGGCGGCTCAGGACGGCGCTGCACGACGTCGCGTTCGTGGCCAAGATCATCCAGCACATCGGTCCGGTCGAGTCGCGCGTGATCCGCTTTCCGGCCGAGGAGGTGAGCCGCCTGGAGCAGAGGGCGCGCGAGAGCGCCGGCACCGAGGGAGCTCAGCTCTCCACCTACGACGCCCTGGGCGCGCACTTCTGGAAGGTGGTGACGGCGCTGCGCGGGTACGCCGGGCGCACGACGGACAAGCTGACGATGGTGATCGATGTGAGGAGCCGCATGGAGCCGCTGCTCTCGGCCCCGTACCTGGGCAACGGGGTGACGGACTTGACGTGCGACCTGCCCAGCACAGAGCTGAGCTCGGCGTCCGTGGGCGCGATCGCGGTCCAGATCCGGCGCGCCCGGAAGGCGTTCACCCCGGAAGCGGCGCGCGCGGCTCACGCGCAGCACTGCAAGGATTGGGAGTCGGGCCGACACAGGCGCCTCATGGATCGGGTGACCGCTCGGGCGCTCGACGGGAACATGTGTTTCAACAGCGAGGCGGGGGCGCCACTCTACGATGTAGATTTCGGTGAGGGCAGGCCATTCTGGTGCGAGCGGCCTTTCTACCCCATCCCGCGCTTCGTCGTCATCTCGCCCGCCCCCGCCGGCGACGGGTCCGTCGATCTTCGGCTCGCCCTCCCGCGAGATGACATGAGGAAGCTGGACTCGCCGGAGCTCCAGCGAAAGCTCCATCCTGTAGCGGCCTGA	MNLLDLGISQLLEKKSLVHSGIRGGDVPLTIYDMDYGLYMSQRVLFYRRAVDVAALRRSFERMLQRVPLLAGRLVRTEDGDLLIRCSDGGAELSVVEQRGTIEEYGIGRSATSELARFTGLHSGFRLVNHDAPLLRVRVTLMRSGGMAIGVSAPHIVMDAGTVTRFLSYWSKEHRGLPWPGLDPERAALLAFEEQARREVASVRARRLRTALHDVAFVAKIIQHIGPVESRVIRFPAEEVSRLEQRARESAGTEGAQLSTYDALGAHFWKVVTALRGYAGRTTDKLTMVIDVRSRMEPLLSAPYLGNGVTDLTCDLPSTELSSASVGAIAVQIRRARKAFTPEAARAAHAQHCKDWESGRHRRLMDRVTARALDGNMCFNSEAGAPLYDVDFGEGRPFWCERPFYPIPRFVVISPAPAGDGSVDLRLALPRDDMRKLDSPELQRKLHPVAA	MEKKNITLTILLTNLFIAFLGIGLVIPVTPTIMNELHLSGTAVGYMVACFAITQLIVSPIAGRWVDRFGRKIMIVIGLLFFSVSEFLFGIGKTVEMLFISRMLGGISAPFIMPGVTAFIADITTIKTRPKALGYMSAAISTGFIIGPGIGGFLAEVHSRLPFFFAAAFALLAAILSILTLREPERNPENQEIKGQKTGFKRIFAPMYFIAFLIILISSFGLASFESLFALFVDHKFGFTASDIAIMITGGAIVGAITQVVLFDRFTRWFGEIHLIRYSLILSTSLVFLLTTVHSYVAILLVTVTVFVGFDLMRPAVTTYLSKIAGNEQGFAGGMNSMFTSIGNVFGPIIGGMLFDIDVNYPFYFATVTLAIGIALTIAWKAPAHLKAST	115.94	gnl|BL_ORD_ID|1152|hsp_num:0	1256			222	417	acriflavine; puromycin; chloramphenicol
BGC0000380.1|Leupyrrin_9 # 10951 # 12363 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=8bp;gc_cont=0.686	BGC0000380.1|Leupyrrin_9 	10951	12363	+	Loose	650	30.4166	otr(C)	29.75	3002894	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGCTTCGTATGATGTGCTCTCGGCGCATGACGCGTCATTTCTGTACAACGAGACGCAGGCGGCTCACATGCACGTGGGGGCGCTCGCCATCCTGGAGCGCGTCCAGCTCTCCGAGGAGCAGGTACGAGCGCACGTGAACAGCCGGTTGCACCTCGTGCCCCGCCTGCGCAGGCGGGTGGCCTGGGTGCCCGGGAACATCGGCCGGCCGGCCCTGCTGGACGACCCGAGCTTCGACATCCGATCGCACGTCCGCTTCTGCGAGCTGCCCGCGCCGCGCGGCGTCGAGCAGGCGCGGCAGCTGATGGCAGAGCTGATGAGCGTGCCGCTCGATCGCGGGCGACCGCTCTGGGAGATCTGGTTCTTCGATCTGTCCGAGGAGCGGACCGGCTTCATCTTCAAGATACACCACTGCCTGGTCGACGGCGTGAGCGGCGTCAACGTGGCAACGGTGCTCCTCGACCCCGAGAAGGAGCCGGTGCGCATCGAGCCCCCGCCGTTCCGACCGGTAGGTCCGCCCTCGCGGGCGAAGCTCCTGGTCGACGCGGTCGTGGAAGCGTACACGCCGCCCATCGAGCTCATCCGATGGCTGCGCGGCAGCGAGGCCGAGGAGAGCCGCGGGATGCGCCGCGCCGCCGAGATCGCCAAGGGGACGCTATCGTGGGCCCGGTCCGTCCGTGAGCTGGCGCCGCGCACGTCCCTCTCGACGCCGATCGGCGCAGCGCGGCGCTTCGCGTCGGTGCGCGCAAGGCTGGACGACTTCAAAGAGATCAAGAAGCGCTACGCCTGCACGGTGAACGACGTCGTGCTCGCGGCGGTCGCCGGTGGGCTGGGCAAGCTCATGCGCGCTCGCGGCGAGGACACCGACGGGCTGACGATGAAGGCGATGGTGCCTGTCAGCCTCCGGGATCCATCGCAGCGCACGGGTCACGGCAACAAGGTCTCCATGATGGCGGCGGAGCTGCCGGTGGGCCTGCGAGGCGCAGGCGAGCGGGTCGAGTTCGTGCGCGATCGCGTGGCGGAGCTCAAGAAATCGAAGCAATCGCTCGGCAGCGAGCTCTTCATGAAGCTGAGCGAATATGCGCCGCCGGCGGTGCTGGCGCTCACGGGCCAAGCGTTGACGCAGCGGAGCCACGTGAACCTCGTGATCACGAACGTGCCCGGCCCGCAGTTCCCGCTGTATTTCCAGGGCGCGAAGCTGCTCGACGCGATCCCCTGTCTACCGCTCTTCGGCACCAACTCGGTCGGCGTCGCGGTCCTGTCGTACGACGGCTACATCCACTTCGGGTTGCTGGGCGACCGCGACGCGCTGCCGGATCTACACCTCTTCAGCCAGGGCATCGAGGAGGCCATCCGCGAGATGCTCTCCGCGGTCGGGCGCGGCGATCAGCCGCGGGTCGAGGCTGCCGAATAG	MASYDVLSAHDASFLYNETQAAHMHVGALAILERVQLSEEQVRAHVNSRLHLVPRLRRRVAWVPGNIGRPALLDDPSFDIRSHVRFCELPAPRGVEQARQLMAELMSVPLDRGRPLWEIWFFDLSEERTGFIFKIHHCLVDGVSGVNVATVLLDPEKEPVRIEPPPFRPVGPPSRAKLLVDAVVEAYTPPIELIRWLRGSEAEESRGMRRAAEIAKGTLSWARSVRELAPRTSLSTPIGAARRFASVRARLDDFKEIKKRYACTVNDVVLAAVAGGLGKLMRARGEDTDGLTMKAMVPVSLRDPSQRTGHGNKVSMMAAELPVGLRGAGERVEFVRDRVAELKKSKQSLGSELFMKLSEYAPPAVLALTGQALTQRSHVNLVITNVPGPQFPLYFQGAKLLDAIPCLPLFGTNSVGVAVLSYDGYIHFGLLGDRDALPDLHLFSQGIEEAIREMLSAVGRGDQPRVEAAE	MTRKTISNGARNAVEVRGLVKHFGEVKAVDGVDLDVREGTVLGVLGPXGAAXXRGALPAHVXGPDAGRRPWRFXTWCANRRALRRTIGXHRPVRXGRRESFSGRENLYMIGRXLDLSRKDARARADELLERFSLTEAAGRAAAKYSGGMRRRLDLAASMIGRPAVLYLDEPTTGLDPRTRNEVWDEVRSMVRDGATVLLTTQYMEEAEQLAHELTVIDRGRVIADGKVDELKTKVGGRTLQIRPAHAAELDRMVGAIAQAGLDGIAGATADHEDGVVNVPIVSDEQLSAVVGMLGERGFTISGHQHPSAQLXEVFLAITGQKTSEAADGGPQDGPQDQQGVQDKQYEEVPA	133.90	gnl|BL_ORD_ID|1952|hsp_num:0	1991			381	726	tetracycline
BGC0000380.1|Leupyrrin_10 # 12385 # 13953 # -1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.678	BGC0000380.1|Leupyrrin_10 	12385	13953	-	Loose	1000	152.525	almE	27.36	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGACGTACCTGTTGCATCAGCTGCTCAAGAACGCGGCCCGTCGCTTCCCCGACGGGCCGGCCGTCGTCGACGGCGGTCAAACCGTGACCTACCGGGAGCTCGACGAGCGCTCCAATCAGATCGCTCAGCTCCTCCGGGAAATGGGCATCGGCAAGGACCATCGGGTCGGCGTCTGCGTCGACAAGTCTGCTGCCATGGTCGCCGCCGTGTTCGGCGTCCTGAAGGCGGGCGCCGCCTACGTCCCGCTCGATCCGCTCGCCCCGGCGAAGCGCATCGGGTTCATCGTGCGCGACTGCGCGCTCTCCGCCGTCTGCGTCTCGGGCAACCGGCTGGCCCGGCTCAAGGAATGCGCGAAAGCCGGTGAAGAGATCGCGGCGATCGTGGTGGACGGCAGCGGCGCGGCCCCCGAGGGCGTCCGCCCGCTCCTCGCGGACGCGATCTCGCGCCAGCCCGGCAGCGCTCCGCCCGAGGCTGACATCACCGAGAACGACCTCGCCTACATCCTGTACACCTCCGGCTCCACGGGCACGCCGAAGGGCGTGATGGTCAGCCACCGCGCTTCGCTCACCTTCGTCGACTGGTCGCACGATTGCTTCGAGCTCTCCTCCCGGGACCGGGTCGCCGGCTACACGCCGCTCCACTTCGATCTGTCGATCCTCGACATCTTCTCCACCGTGAAGGCCGGAGGGACGATCGTCCTCGTCCCGCCGGAGCTGTCGCTCTTCCCGGCGGGGCTCGCCGACTTCATCGAAGCGCAATCGATCAGCGTCTGGTACTCCGTCCCGTCGATACTGACCCAGCTGGTGCTCCGCGGCGAGCTGTCGCGACACCCGTACGCGCAGCTGCGCGCGATCCTCTTCGCCGGAGAGGTGTTCCCGGTCAAGTACCTCCGCCAGCTCATGGAGCTCATCCCCCGCGCTCGTTATTACAACCTGTACGGGCCCACGGAGACGAACGTGTGCACCTATTACGAGGTCCCCGGGGGCTCGGCGGAGCTCGGCGAATTGCTGCCGATCGGGCGCGCCTGCGCCAACACCGAGGTCTTCGCGATCGACTCGAACGGCGCGCTGGTCCAGCCCGGGGGGACAGGGGAGCTCTTCGTCCGCGGGCCGTCCCTGACGAAGGGGTACTGGGGCCAGCGAACCTCCGAATACACCGGGCTGTGTCCGCACCCGCTGTCGCCGCTCGTGCCGGAGCAGGTCTATCGCACGGGGGACCTCGTCACCCTGCACCGGAACGGCGACTATACCTGGATGGGGCGCATCAGCGAGACCATCAAGAGCCGGGGCTATCGCATCGAGCCCGGCGAGGTGACCGCCCGGCTGCTCGAGCACCCTGCCGTCAAGGAGGCCTGCACGTTCGGCGTCCCGCATCCCATGCTCGGCAGCGAGATCAAATCCGTGGTGGTCAAGGAGGCGGACCGGGACGTGAAGGCTGACGAGCTCCGGGTGCACTGCGCTGAATTCCTGCCGGGTTACATGATCCCGAGCATCATCGAGTTCCGCAGCGAGCTGCCGCGCACGAGCACGGGCAAGATCGACAAGACCGCGCTTGAACGGGGCGAGTAG	MTYLLHQLLKNAARRFPDGPAVVDGGQTVTYRELDERSNQIAQLLREMGIGKDHRVGVCVDKSAAMVAAVFGVLKAGAAYVPLDPLAPAKRIGFIVRDCALSAVCVSGNRLARLKECAKAGEEIAAIVVDGSGAAPEGVRPLLADAISRQPGSAPPEADITENDLAYILYTSGSTGTPKGVMVSHRASLTFVDWSHDCFELSSRDRVAGYTPLHFDLSILDIFSTVKAGGTIVLVPPELSLFPAGLADFIEAQSISVWYSVPSILTQLVLRGELSRHPYAQLRAILFAGEVFPVKYLRQLMELIPRARYYNLYGPTETNVCTYYEVPGGSAELGELLPIGRACANTEVFAIDSNGALVQPGGTGELFVRGPSLTKGYWGQRTSEYTGLCPHPLSPLVPEQVYRTGDLVTLHRNGDYTWMGRISETIKSRGYRIEPGEVTARLLEHPAVKEACTFGVPHPMLGSEIKSVVVKEADRDVKADELRVHCAEFLPGYMIPSIIEFRSELPRTSTGKIDKTALERGE	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	93.88	gnl|BL_ORD_ID|4935|hsp_num:0	5928			135	1635	colistin A; colistin B
BGC0000380.1|Leupyrrin_11 # 14047 # 15162 # -1 # ID=1_11;partial=00;start_type=TTG;rbs_motif=GGG;rbs_spacer=5bp;gc_cont=0.678	BGC0000380.1|Leupyrrin_11 	14047	15162	-	Loose	900	26.1794	adeH	43.24	3000779	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	TTGGACCTGCTCGGGCGTGTCCGGAGCGCGGCCGAGGAACGGATGAACGGCGAGCTGGCAGAGCTCGACAGGACCGAGACCTTCAACCTGAAAGGCTGGCAAGCTTGCGCCGACCTCGGGGTGCTCGGGTACCGCGTTCCGCGCCGGTACGGAGGTCAGGAGCTCGATGTGCTCGACACCGTGGCAGCGCTCGAAGGGCTGGGCCAAGGCTGTCGCGACAACGGCCTCATGCTCGCCGTCGGGGCGCACATCTGGGCGTGCGAGGTCCCGATCCTGGCGTTCGGAACCGAGGAGCAGAAGCTCGAGTATCTGCCGAAGCTCGCCAGCGGCGAGCTCGTCGCGTGTCACGCGGTCAGCGAGCCCCAGGCAGGGTCGGACGTCTCCAGCGTGTCCACGACCGCGGTCCGACGCGGTGATCGGTACGTGCTGAACGGGCGCAAGCTGTACGTCACCAACGCGCCGATCGCGGGCCTGTGCATCGTGTTCGCCACCCTGGATCCGGCGGCCGGCCCCCGAGGGCTCACGGCCTTTCTCGTCGAGCCCGACTCCGCCGGCATGGCCGTCCGCAAGGTCTCGAAGATGGGCCTGCGCACCGCGCAGATGGGCGAGATCTCGCTGGTCGATTGCGAGGTGCCGCTGAAGAACCTGCTCGGCAAGGAGCGCGAGGGGCTCGATATCTTCAACCACTCGATGGAGTGGGAGCGCGGGTTCATCCTCGCGCCGGCGGTCGGGAGCATGGAGCGCGTCCTGCAGCGCTGCGTCCGCCATGCCAGGAGCCGCAAGCAGTTCGGCGCGCCCATCTCGTCGTTCCAGGCGATCTCCCACAAGCTCGTCGACATGAAGCTCCGCATCGAGACGTCGCGCTCCCTGCTGCACGGGGTAGCTCACCTCAAGCAGCAAGGCAGATCGGCGCTCGGCGCCGCTGCGATGGCGAAGCTCCACATCAGCGAGTCCTGGACCCAGGTGTGCCTGGACGCCCTGCAGATCCACGGGGCCCAGGGGTACCTCTGCGAGAACGAGCTCGAGCGAGAGGTTCGCGACGTGCTCGGCAGCAAGATCTTCTCGGGCACCAGCGAGATCCAGCGACGGATCATCGCGCAGCTCATGGGCCTTTGA	MDLLGRVRSAAEERMNGELAELDRTETFNLKGWQACADLGVLGYRVPRRYGGQELDVLDTVAALEGLGQGCRDNGLMLAVGAHIWACEVPILAFGTEEQKLEYLPKLASGELVACHAVSEPQAGSDVSSVSTTAVRRGDRYVLNGRKLYVTNAPIAGLCIVFATLDPAAGPRGLTAFLVEPDSAGMAVRKVSKMGLRTAQMGEISLVDCEVPLKNLLGKEREGLDIFNHSMEWERGFILAPAVGSMERVLQRCVRHARSRKQFGAPISSFQAISHKLVDMKLRIETSRSLLHGVAHLKQQGRSALGAAAMAKLHISESWTQVCLDALQIHGAQGYLCENELEREVRDVLGSKIFSGTSEIQRRIIAQLMGL	MVITSKQNWLLSSLMGSLLLAGCSLAPEYQPAKVIVPVKFKESDPKLEDNNWKIAQPADQQTRGEWWRIYNDAQLNELEQQAIAGNQNLKAVAANIQASRALRSAAQAERLPSIDAGFGPTRQKPSPASLGLDDNAHTSAQTLWRAQANVSYELDLFGRVASSVNAATADLQQQEALYQSALLALQADVAQGYFLIRQLDTEQAIYNRTIKLLGETRDLMQLRFKNGLVSELDVSRAQTELATAQTTALNIARNRASAEHALAVLLGKPPADFNLAVQPLTANSIRLPAGLPSTLLERRPDIAAAERAMAADNARIGIARAAFFPKLSLTGALGYESSSLSELGKWSSRTFLLGPVAGTILSLPLFDGGQRKAGVAQARAAYEESVANYRQTVLNAFREVENGLSDQRILDQQIQAQNQALSSSRHANQLSHLRYREGAISYLDVIDSDRTILQQEQLAAQLKGSQIIASINLIRALGGGWSS	76.81	gnl|BL_ORD_ID|493|hsp_num:0	542			495	606	tetracycline
BGC0000380.1|Leupyrrin_12 # 15471 # 15749 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=13bp;gc_cont=0.581	BGC0000380.1|Leupyrrin_12 	15471	15749	+	Loose	1000	24.6386	tva(A)	22.67	3004730	protein homolog model	n/a	n/a	pleuromutilin antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	ATGGACAAGGAGTACAGCGTGGAGGACATCAAAGCTCCGCTCCGGAACTATCTCGATGAAGAATTCATGTTTCGGCACCCCGACGTCACCTTGCACGAGCAGCTTGATCTGATTCGTGAGGGCATCATCGACTCGCTGGGGATCGTTCGCCTGACTCATTTCCTCGAGGAGCGATTCGACCTCGTGCTCGATCCATCCGAGATCGTCGCGGCGAACTTCCAGACGCTCAGCGCCATACATCACCTCGTGGCCACCAAGCTGCGGGCCCGCAGCGTCTAG	MDKEYSVEDIKAPLRNYLDEEFMFRHPDVTLHEQLDLIREGIIDSLGIVRLTHFLEERFDLVLDPSEIVAANFQTLSAIHHLVATKLRARSV	MFIKFNKVSFSYDSSDNILNDVSFHIDNSCTAIVGENGCGKTTLAKLITGILKPNSGSIEYSNKNIITAYCDQECINLPDNAENLFYDDSSYSGYLTSIFKIDYNYLYRFDTLSFGERKRLQIASALYSNPDILVLDEPTNHIDIECKDILINVIKRLDCIVIIISHDIDFLDELVEKCIFIRNGNCKIRIGNYTQCRGYEKDEEDYNFSLYEESRKKAKILENRYKKLQNESDAKKSKCGSKRHIDKKDHDAKGKIDAARLAGKDSRLATKAKQAKSLYNNTVMEMESLYTKKREVMDMEFIGERYKGKFLFYLEAGETKINSIVLRHPELIVKKDSRIGIEGVNGAGKTSLLNYIIETMYDNSIDKEKIIYIPQDIDRESWNNTFNNIKALDHESLGFLMSFVNRLGSNAKSVINSLNHSPGEMRKIMLGMAVIKKPYIIMLDEPTNHLDIDSIERLEEALISFNCALIIVSHNRNFIKNAVNTLWSIKIEYNYSILDIKNTI	18.22	gnl|BL_ORD_ID|2257|hsp_num:0	3484			891	1116	pleuromutilin
BGC0000380.1|Leupyrrin_13 # 15927 # 16751 # -1 # ID=1_13;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.672	BGC0000380.1|Leupyrrin_13 	15927	16751	-	Loose	500	25.7942	OXA-360	47.62	3001547	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	TTGTTCAACTGGGAGCGCAGAATGGTGAATAGTGCATCCTCCGGTCGTCGAAGCGGCACAGCGATGATCGCTGGCGCGTCGAGCGGCATTGGCGAAGCGTTCGCGCGCCGCCTCGGGGCGGACGGCATGGATCTGATCCTCGTCGCCCGGCGGGGAGAGCTCCTGCAGGCGCTCGGCAACGAGATCGAGAAGAAGCACAAGGTCCGCGTCGAGACGCTGGTGGCCGACCTCGCCGCCAAGGAGGACGTGGCCCGGCTGGAGGAGAAGGTCGCGCAGACACCTCGGCTGGAGATCCTCGTGAATTGCGCCGCGCACTGCCGGATGGGCGCCTTCAGCGAGCTGGACCCCGACCTGATAGAGTACCAGGTCCGGCTGAACGTCATGGCCCCCCTGCGCCTGACGCGCGCAGCGCTTCCTCGGATGATCGAGCGCAATTCGGGCGCGATCATCAACGTCTCGTCGATCGGCGGCCTGGTGGCCGCTCCCCACGGCGCGACCTACTGCGGGAGCAAGGCGTTCTTGATTCGTTTCACCGAGGCCGTCGCCGGAGAGGTGTACGGTACGCGGGTGCAGGTCCAGGCCCTCTGCCCGGGGCTCACCCGGACCGATTTCCCCGGCATCGCTGGGATGAACACGGCTGATTTGCCCGACTCGGCCTGGATGCAGCCGGAGGCGGTCGTGGATGCCTCGATGCGTGCCCTGAAGCGGGACACGGTCCTCTGCATTCCTGGCTTCACGAACCGCGTGCTGCCGAAGGTGATGAACTCGCTGCCGCGCGGCATGGTGCAGTGGCTGGGTCGCCGAGCGAGCGGGAGCGCCTCGTAG	MFNWERRMVNSASSGRRSGTAMIAGASSGIGEAFARRLGADGMDLILVARRGELLQALGNEIEKKHKVRVETLVADLAAKEDVARLEEKVAQTPRLEILVNCAAHCRMGAFSELDPDLIEYQVRLNVMAPLRLTRAALPRMIERNSGAIINVSSIGGLVAAPHGATYCGSKAFLIRFTEAVAGEVYGTRVQVQALCPGLTRTDFPGIAGMNTADLPDSAWMQPEAVVDASMRALKRDTVLCIPGFTNRVLPKVMNSLPRGMVQWLGRRASGSAS	MKILILLPLLSCLSLTACSFAVSNSPSQITSTQSIQAIVKLFDQAQSSGVLVIQRGPHLQVYGNELSRAHTEYVPASTFKMLNALIGLQHGKATTNEIFKWDRKKRSFAAWEKDMTLGQAMQASAVPVYQELARRIGLELMQQEVQRIQFGNQQIGQHIDNFWLVGPLKVTPKQEVKFASALAQEQLAFDPRFQQQVKTMLLLQERQAYRLYAKSGWGMDVEPQVGWLTGWIETPQDEIVAFSLNMQMQSNMDPAIRLKILQQALAELGLYPKAEG	99.28	gnl|BL_ORD_ID|1080|hsp_num:0	1169			147	210	cloxacillin; oxacillin; cefalotin
BGC0000380.1|Leupyrrin_14 # 17631 # 19277 # 1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=GGG;rbs_spacer=15bp;gc_cont=0.706	BGC0000380.1|Leupyrrin_14 	17631	19277	+	Loose	500	26.9498	AxyX	40.82	3004143	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGCATCACCTGCTCTGCCTGCGGGGGGCGCTGAATCGTGAGGCGCTCGAGGCCGGCCTCAAGGCCGTCGTAGCGCGGCACGAGGCGCTGAGGGCGCAGATCGTGCCGAGCCGCCAGCGTGTCCTCCAGCGTCCGCTGCCCGCGAGCAGCTTCGGGGTGGCGCACTTCGATCTACGGCGATACGGCGACGCCGAGCCGGAAGGGCGAGCCCGCCGGATCGCGTACGAGGCGGCGAGCCGCCCCTTCAAGCTCGGGGAAGAGCCACCGTTGCGCGCGGTCCTGCTGCGTTTCGACGACGAGACCCACTGGCTGCTGCTGGTCGTGCACCACATCGTGTACGACGGCTGGTCGAAGGACATCCTGTGCCGCGAGCTGAGCGCTCATTACGTGTCCTTTGCCCGCGGCGAGGCGCCGCGCGTCCCGGAGCTCCTCGCGCAGTACGCTGACTTCGCGGTCTGGCAGAGGCAGTTCCTGCAAGGCGAGGTGCTGTCCGAGCTCACGCGCTACTGGACCGAGCAGCTGCGCGGCCGGCTGCACGCAGGACAGCTGCCGAAGCGGCCGGATCCGGCGCTGTCGGGGCGGCGCGCGGTGGCGACGCGGACGTCGAGCGTGCCGGCGGCGCTGCTCCAGCGGCTGCGGGCGCTGAGCTCCGCGGAGGGGGTCAGCCTCTTCGTGACGTTGCTCGCCGCCTACAGCCTGCTCCTCCGCGGCTACACGCGCGAGGACGATCTCTTCGTGTGCAGCCCGGTCGGGAGCCGGGCGCATCGCCAGCTCGAGCCCCTGATCGGCTACTTCGTCAACATTCTCATCCTGCGGTCCGACCTGTCCGGCAATCCGAGCTTCCGAGAGCTGCTCCGGCGAGCTCAGGGCATGGTCGCCGGCGCCTACGCACACCAGGATCTGCCGATGCAGCTGCTCGGCGACCTCGATCTTGCGCCGGGCAGCGAGTCGCGGACGCTCTTCGCGCTCCAGAACACGCCCGGCTACAGGCTCGCGCTGCCGGGCGTCGAGGTGACGGAGGTCGATCTCGACGCGGGATCGGCGGATTTCGACACGTTCTTGTCCCTGGAGCACGACGGCGATCAGCTGCGGATGCGGCTCGCCTACAACACGGACCTCTTCGACGCCCGCGCCGTCGAGCAAGCGCTCCTCAGCTACCGCGATCTGCTCGAGCAGGTGGTCGCCCGTCCCGACGCTCCGATCGCCTCGTACGGCGCGTCGGCGGGCGCGGCGCCGCCGAGGTCGCCCGCCGCATCGGCCTCGCCCGCCCCGGCGACGAAGGCGCAGCCGGCTGGAGGCGAGCTCCTGCAGCAGCTGTCCACCGCGAGGGCGGCGCAGCGGGTGCATCTCCTCGCCGAGCACCTGGCCGCGATCGCGTCCGCGCTCAAGGGGGATCCCGCCGCGCCGAAGCTGAGCCCGAGCCGCTCCCTGCAGGAGCTGGGCATGGACTCGCTCAAGCTGTTTCAGTTCATCGCCAAGGTGAAGAGCTCGGTCGGCGTCGATGTGCCCATATCGCAGGAGCTCGCGATCGCGCCGCTGAGCGTGATCGCAGAGGGGCTGGCCGCGCGGCTGATGCTCGAAGAGCTGCTGCAGTCGCGCGCCAAGAACGAGTTCGAGGACTCCGAGACGGAGGTGCTCCTGGTGTGA	MHHLLCLRGALNREALEAGLKAVVARHEALRAQIVPSRQRVLQRPLPASSFGVAHFDLRRYGDAEPEGRARRIAYEAASRPFKLGEEPPLRAVLLRFDDETHWLLLVVHHIVYDGWSKDILCRELSAHYVSFARGEAPRVPELLAQYADFAVWQRQFLQGEVLSELTRYWTEQLRGRLHAGQLPKRPDPALSGRRAVATRTSSVPAALLQRLRALSSAEGVSLFVTLLAAYSLLLRGYTREDDLFVCSPVGSRAHRQLEPLIGYFVNILILRSDLSGNPSFRELLRRAQGMVAGAYAHQDLPMQLLGDLDLAPGSESRTLFALQNTPGYRLALPGVEVTEVDLDAGSADFDTFLSLEHDGDQLRMRLAYNTDLFDARAVEQALLSYRDLLEQVVARPDAPIASYGASAGAAPPRSPAASASPAPATKAQPAGGELLQQLSTARAAQRVHLLAEHLAAIASALKGDPAAPKLSPSRSLQELGMDSLKLFQFIAKVKSSVGVDVPISQELAIAPLSVIAEGLAARLMLEELLQSRAKNEFEDSETEVLLV	MTHRVPFRTLAFASVLVLVSACSKQEAPEAAKAPAEVGVIVARATPTAVASELPGRLEPYREAEVRARVAGIVTRRLYEEGQEVTRGTPLFQIDPAPLQAAYDSEAAALARAQANLSAAADKLRRYADLVSDRAISERDHAESVAQERQARAEVALAKANLQSARLRLEYARVTSPIDGRARRALVTEGALVGEGQATPLTVVQQLDPIYVNFSQPAAEVMQLQKQIRAGALQGVAPDKMRVRLLLPDGSEYGQGGTLSFADLAVDPGTDNVTMRALFANPGRELLPGMYVRVRLEQAVNRDTFLVPRNALLRNADGAHVLVAGDDGELRSVAVTAHRLLGPNWVVTEGLAGGERVVVENAAQLAPGQKIKPVERTAPSAPVATAGNNEKR	140.15	gnl|BL_ORD_ID|2409|hsp_num:0	2797			777	915	erythromycin; cefepime
BGC0000380.1|Leupyrrin_16 # 20723 # 29653 # 1 # ID=1_16;partial=00;start_type=GTG;rbs_motif=GGG;rbs_spacer=13bp;gc_cont=0.723	BGC0000380.1|Leupyrrin_16 	20723	29653	+	Loose	1000	134.035	almE	26.05	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGAGCGCCCCCAAGGGAGCGCTCACCCCGGACTTGCGAGCTCGCCTCGCGGAGCGCCGCGCAGAGCTCATCGCGATGATCGCGCAGAGCAGCCGGGCCAAGGCGGAGGTGGAGCTGCCCGAGGTCCAGCACCGGCCGCAGGAACGCCACGAGCCCTTCCCGTTCACGGATATCCAGCAAGCGTACTGGGTCGGCCGCAGCGGCAACCTGGAGCTCGGGGCGGCGATCCACGTTTACGTGGAAATCGAGAGCGCCGACCTCGACCTGCCCCGCCTGTCCGCTGCGTGGCGGCAGATGGTCGCTCGGCACGAGATGCTGCGCGCCGTGGCGCTGCCCGACGGAACACAGAAGATCCTGCGCGAGGTCCCGGCGTACGAGATCGAGGCCGTGGACCTGCGCGGCGCGAGCGCCGAGCGGCAGGAGGCGGAGCTCGCGGCGCTGCGCAAGCGCATGTCCCACCAGGTGCAGGCCATCGACACGTGGCCCTCGTTCGAGATCCGGGCGGTGCTGCTCGACGACCGCAGGACGCGCCTGTTCTTCGACATCGACTGCACGTTCAGCGATTCGTGGGGTATCCAGATCATCTTTCGCGAGTGGATCCAGCTGTACCGGTCTCCGGAGTCGCCCCTCGACCCCGAGACCCTCGAGCTCTCCTTTCGTGACTACGTCCTCGCGCTCGCCAAGCTGCCGGAGACGGCCGTGTACCGCGAGGCGCTCGACTACTGGGGGAAGCGGCTCGAGACGCTGCCGCCTGCGCCGGACCTGCCGCTCGCCAAGGACCCGAGCTCGGTCAAGCGGCCGCGCTTCCGCCGCCTGGTCTCGCGGCTCGACGGCGCCACGTGGGACAAGCTCAAGACGCGGGCGCGCGAGGCGGGCCTGACGCCGCCGGTGCTGCTGCTCGCGGTCTACGCCGAGGTGCTGGCCCACTGGGCGAGGGAGCCGCGGTTCACGCTGAACGTCCCGCTCTTCAACCGCTATCCTCTCCATCCGCAGGTCAACCGCATCGCCGGCACGTTCTCCTCGTTCACGCTGCTCGAGGTGGACCACCGGAGCGGGGCGAGCTTCGCGGAGCGGTCCAAGAACCTGCGCGCCCAGCTCTGGCGCGACCTCGAGCATCGGTACGTCAGCGGGGTGAGCCTGCTCCGCGCGCTGTTCCGGCGCGAAGGCGGCATCTCCCGCGCGGTCATGCCGGTCGTCTACACGAGCTTCGCGAGCGGCGTCGACGGCCTGGGCGCGTCGTGGGTGGATTACCTCGGCAGCGAGCTGGGCGAGGTGAAGCACTCGGTGACGCAGACACCGCAGGTGTGGCTCGACCACCAGGCGATCGACGAGGACGACGGCCTGTTCTTCAACTGGGATGTGGCGGACGAGCTGTTTCCGCCCGGCATGCTGGACGACATGTTCGCGGCGCACTGCCGCATCCTGCGCGCGCTCGCGGAGGATCCGGAGCTGTGGAGCCGCCCCACGCCGCAGCTCGTCGTCGCGACCGCGGAGCCGCCCGCGCCGGGCGCGTCCAGCGCGGCGGCGCCGCTGCCCGATCGGCTGCTCCACGACGATTTCGCGGAGCGCGTCGCGGCCCACCCGCATCGCACCGCCGTGGTGGCCGCCGGGCGGCGGCTGAGCTACCTCGACGTATCGAGGCTCGCCAACCGGCTCGGGCATCAGCTCCGGCAGCTCGGGACGGAGGCCAATCAGCCGGTCGCCATCGTGCTGGAGAAGGGATGGGAGCAGGTCGTCGGCGTGCTCGGCATCCTGCGGGCCGGCGCCCCTTACCTGCCGATCGACGCCAAGCTTCCGGCGGAGCGGCTCTCGTATCTCCTCAAGAACGCCGACGTCCGCGTGGTCGTGACGCACTCGTCGCTGCAAGGGCGCCTCAGCTTTCCGGAGGGCGTCGCGATCGTGTGCGTCGATCGCCTGGAGGAGGGCGCAGCGCCCGAGGCGCCGCTCGAGGCTCGCCGGAAGCCGGACGATCTCGCGGTGATCATCTACACGTCCGGCTCCACGGGCACGCCCAACGGGGCGATGATCGCTCACCGCGGGCTCGTCAACGCGATCGACGAGACAAATCGCACCTTCGACGTCCGCGAGACGGACCGGACGCTCGCGCTGACGGCGCTCCACCACGACATGTCGATCTTCGACATCTTCGGGGTGCTCTCCGTCGGCGGCAGCGTGGTCGTCCCGGAGCCGGATGCGTCGAAGGACCCCGGGCGCTGGGCGGAGCTCATCCGCACCGAAGGCGTCACGATCTGGAACTCCGTGCCTGCCATGATGGAGATGATCGTGACGCACCTCGAGGCGAGGTCGGAGCCCGCCGGCCGATCGATCCGGCTCGCCTTCCTGGGCGGGGACTGGATCCCCGTGAGCTTGCCCGATCGCGTCCGCGCCCTCTTCGAGCAGGCCCGCATCGTCAGCGTCGGCGGCCCGACCGAGACCACGCTCTGGAACATCTGGTATCCGATCGAGGAGGTCGATCCGAGCTGGAAGAGCATCCCGTACGGCCGGCCCATCGCGCACACGAAGTACTACGTGATGGACGACGCGCTGGAGGAGCGCCCCGTCTGGGTGCCCGGCGAGCTGTGCTGCGCCGGCGTGGGGGTGGCCAAAGGCTACTTCCGCAACCCGGCCCGCACCCAGGAGAAGTTCGTTGTTCACCCGCGCACCGGGGAGCGCCTCTACCGGACGGGCGACCTCGGGAGGCTCCTGCCCGACGGGAACATCGAGTTCCTGGGCCGTGTCGATCTGCAGGTCTCGCTGTCTGGATACCGGGTCGAGCCCGCGGAGATCGAAGCCGCGCTCAGCCAGCACCCGCGGATACGTGCGGCCGCGGTCGTGCCGGTCGGAGACAGGCACGGTCGCCGCCTGACCGCCTATGTCGTCCCCCACGAGGGCGGGAGGCCCACCGAGGAGGAGCTCCGCGCTTTCCTGCAGGGCAAGCTGCCCGAGCACATGGTCCCGCGGGCCTACGGCTTCCTGAAGGAGCTGCCGCTCACGGCCAACGGCAAGGTGGATCGCCGGCGGCTCGCAGAGACGCCCCTCAAGCCGTCGAGCCGCGCCGGCGCGGCGCCGGCGAAGGTGGAGTCCGCCCTCGCCGAGATCATCCGGGAGGTGCTGAACATCAGCGAGGTCGACCCGAAGGCGAACTTCTTCGACCTCGGCGCCCACTCGGTCCACCTCGTCCGGATCCATGGCGAGCTGCACAGGCGCCTCGGCGTGGACGTGCCGGTCGTGGACCTGTTCAAGCATCCGACCGTCGCCTTCCTGGCCAAGCACCTCCATGCGGGGGGCGAGGGCTCCGCGGCCATCGAGGAGACGCGGCAGCGGGTGCAGCAGCGGCGAGCCGCGCGCGCGCCCGACGAGGACACCGCCATCGCCGTCATCGGGATCGCCTGCCGCTTCCCCGGCGCCGAGAGCCCGGAGGCGTTCTACAAGAACCTCGCTGGAGGTGTCGAGTCGGTCTCGTTCTTCAGCGAGGCCGAGCTGCTCTCCTCGGGGCTGAGCCTCGGCACCATCCGCGGTCCGGGGTACGTGCCCGCCGCGGCGATCCTGAGCGATATCGACGCGTTCGACGCCGAGTTCTTCGGCTTCAGCCCGGGGGAAGCGACGCTGACCGACCCCCAGAACCGCGTCTTCCTGGAGGTCGCGTGGGAGGCGCTCGAGCACGCCGGCTACGCGCCGAACAGCGGTGAGTCCAGGGTCGGCGTCTTCGCGGGCAAGAGCATCAGCAACTACCTGTTCCCCGCGCTCGACCTCTCCCGCCCAATCGAGTACTTCCAGCGGCTGTTCGGCAACGACAAGGATTTCATCGCGACGCAGATCTCCTATCACCTGAACCTCAAGGGCCCGAGCATCTCGGTGCAGACGGCGTGCTCGACCTCGCTGGTCGCCGTGGCGCTCGCGTGCCAGAGCCTGTGCGAGCGCGAGTGCGACATGGCCCTCGCGGGCGGGGTCTCGGTGAAGCTCCCGCACAAGGCGGGATACCTCGCCGAGGCGGGCAACGGCATGTTCTCTCCCGACGGCCATTGCCGGAGCTTCGACGCCAACGCCCAGGGGCTCGTCCCCGGCAGCGGCGCGGGGATGGTCGTGCTCAAGCGCCTCAGCGACGCGCTGCGGGACGGCGATGAGGTCCACGCGGTCATCCGCGGCTGGGCGACGAACAACGACGGCGGCCACAAGGTCGGTTTCTCCGCGCCCGACGTGAACGGGCAGGCCGAGGTGATCGCCGCCGCGCACGCGAAGGCTCAGGTCAGCGCCGACTCCATCTCCTACGTGGAGACCCACGGGACAGGGACGCCGCTCGGGGATCCGATCGAGATCGCCGCCTTGACCCAGGCCTTCGCGCTGGGCACGAGCCGCAAGGGCTTCTGCGCGGTGAGCTCCGTCAAGTCGAACATCGGGCACCTCGACTCGGCCGCCGGGGTCGCGAGCCTCATCAAGGCGGTCCTGGCCCTCAAGCACCGCCAGCACCTGCCGAGCCTGAATTTCCGGCAGCCGAACCCGCGCATCGGGTTCGACCAGACACCCTTCTACGTCAACGCCGAGCTCCGCCCGTGGGAGAGCGAGCAGCCGAGGCGCGCCGGCGTGAGCTCCTTCGGGGTCGGCGGGACCAACGCGCACGTCGTGCTCGAGGAGGCGCCGCGCGCGCCGGCGCGCCCGGCGCCGGAGCACGCCTCCGATCACGTGCTCGCCCTCTCGGCCAGGAGCGACGCCGCGCTCGACGCCCTGATCGAACGTTACGCGGCGGCGATCGAGCAGCAGCAGGACGTCGATCTCGCGAGCCTCTGCTTCACGGCTGCAGCCGGACGCGCGCATTTCGAGCGCCGCATCGCGTGCGTCGCCCCGTCCGCGCCGAAGATGCTGGAGCTCCTGCGCGCGGCGCGGGCCGGCTCGAACGCGCGCGGGATCGCCCGGGCGACGCTGAGCTCGCGCCGGGAGCGGCGGGTAGCGTTCCTGTTCTCGGGGTTCGGCAGCGAGTCCGTCGGCATGGGGCGCGAGCTCTACGAGACCGAGCCGGCGTTCCGCGAGGCGATGGATCGGTGCGCCGATCTGCTCGCGCCGCACCTCCCTCGTCGGCTCACCGACGTGCTGTACCCTGCGCGAGACGCGGCCGGGGGCGCCGCCGCTTCGCTCGGAGACCTCTCCTACGCCCAGCCGGCGCTGTTCGCGCTCGAATACTGCCTCGCCGAGCTGTGGAAGTCGTGGGGGATCACGCCCTCCGCCGTGGTCGGCCACAGCCTCGGAGAGTGCGTCGCCGCCTGCGTGGCCGGCGTCTTCAGCCTGGAAGACGCGCTCACGCTGGTGGCCGCTCGGGGGCGCCTGATGGAGTCGCTCGCCGGGGAGGGCGAGACCTTCCTCGTCAGCGCCGACGAGGCCACGGTCCGGAGGGTGATCGCCTCGGATCCCGTGTCGATCGGCTCGATCAACGGGCCCGCCAACATCGTCATCTCGGGGGCTCCGGCCGGCGTGAAGAGCGTCGTCGAGCGGCTGAGCCAGGAGGGCATCGAGGTGAAGAAGCTCGACGTGCGGCGCGCCGCGCACTCTCCGCTCATGGATCCGATGCTCGAGGCGTTCGGGAAGGTCGCGCGCTCGATCCGCTACGCGCGGCCGACGATCGACCTCGTCGCGAACCTCACCGGCGAGGTCGCCGGCGAGGAGATCGCCACGCCCGAGTACTGGTGCCGGCAGATCCGCGAGACGGTGCGGATGAGCGCTTGCCTGAGGACGCTGCATGACGCCCTGGGCTTCGAGGTGTTCCTCGAGCTCGGGCCGTCGCCCGCCCTCGTGTGGAACGGCATGCAGTGCGTCCCCAAGCGCAGCGGGGCCTGGATCGCGAGCCTGCGCCCCGGCCGGCCGGATCGAGCGCAGATCCTGGCCGCCCTGGCGTCGCTCTACGCCAATGGAGTCGATGTCAACTGGACCTCGGTGGCCCGCGAGGAGCAGCGGCGGCGCGTCCCCCTTCCGACGTATCCGTTCCAGCGCAAGCGGTACTGGCTCGAGGCAACCCCGGGGCTCTGGGGCGTCGCCGCCGCGGCGCAGCCGGCGAGGGGGCTGGACGGCGGCCACCCGCTCCTCGGATGCCGCCTGCGCTCACCGCTGCTCAAGCCGGGCCAGCGGCAGTTCGAGAGCCGCGTGGCGCCGGAGACGCTCGGCTACCTGAAGGATCACCGGGCGCACGGGCAAGCGATCCTCCCGGCCTCGGCGTACCTCGAGATCGCCCTCTCGGGCGGCGCGGCGGCGCTCGGGGCCGCGGGCGCAGCGACCATGACGCTGAAGGACTGCGTGTTCGAGCGGGCGCTGCTGCTGCCGGAGAGCGGCTGCATCCTGCAGACCGTCGTCAGCAGCGAGCCGCGCGGCCGGCTGCGGGTGGAGGTCTTCTCGATGAGCGACGCGGACGCCTCCGGCGCCGGGGACGCTCAGGAGGGCGCCGATCCGGGCTGGCAGAGGCACGCCTCCGCCGTGGTGATCGCGGGAGCAGCGCCGCCGGCCAGCGACGTCTCCCTCGACGCGTGGCGGGCGGCCTGCTCCGGCGAGCTCGACGTCGCCGCGCACTACGACGCGCATCGCCAGCACGGCTCCGAGTTCGGCCCGGCCTTCCAGGGGATCCGCGCCCTCTACCGCCATCCGGAGGGCGGGCTCGCCCGCGTCGAGCTCGCCCCCGAGCTGGCGCGCGGCGGGTCCTCGTACCTCGCGCACCCGGCCCTGCTCGACGCCTGCCTCCAGGTCGCGAGCGCCGCGTTCCCGAGCTTGCCGCCAGGCACCCTCTACATGCCCGCGGCGGTCGAGGAGCTGTCGTTCCGGGAGCGGCCGGAGGCCAGCCTGTGGGTATGGGCCCGCGGGCGCTCCGCCGCGGCGGAGAGCGCCGGCCGGATCGTCGTCGATCTCGAGGTCGTCACCGACGAGGGCAGGTCGGTGCTGACGGTCCGCGGCTTGACCCTGGCCCCCGTGAAGCGCGAGGTCCTGCTCGACCGAAAGCGGAGCGAGATCGAGACCTGGGGCTACGAGCTCTCGTGGCGGCCCGGGGACGGCGGAAGCGGCCAGCGCCGGCGGCCGGAGGCCGGGACGGCGGCGGTACCCCGGCCGTGGCTCATCTTCACGGACGAGTCGGGCATCGGCGTCGAGCTCAGGGCCCTGCTGCTCGAGCGCGGCCAGACCAGCGCGCTCGTTCGCCGCGGGCAGGGCTACCGCCGGCTCGGCGGCGGCGAGTTCGAGATCGATCCGCTGGAGCCGGCCGCGTTCCAGCGATTGCTCGGTGAGCCGGAGTGGTCGCGCGGGGCGCCGCCGCGGGTCGTCCACCTGTGGAGCTCGGAGCTCGTCGGGGCCCTCGACCTCTCGGCCGACGATCTGCGGGCGGCGCTGGAGGTCGGCTGCGCCGGCGTGCTGCACACGGCGCAGGCGATCCTCAAGAGCGGCGCGCCGGGCGCCAAGCCCGAGGTGTGGATCGTGACCCGCGGGGCGCTGCGCGTCGGCGACGGCGACGGCGGCGATCTCTCCGGCCTGCCCCAGGCGCCGGTGTGGGGCCTCGGCCGCGTCCTCGCGCTCGAGCACCCCGAGCTGACGTTCGCCCGAGCGGACCTCGATCCGCGCGCGCGACCGGGGGCGGCGGCCCGGCAGCTGCTCGACGAGATGCTCGCGGACACGACCGAGGATCAGATCGCGCTCCGGGGCGCGAGCCGCTACGTCGCGAGGCTCACCCGCGCGCCGCTGCCCAGGCGGCACGCGAGGCGCCTCGATCCCGCGCGGAGCTACCTGATCACGGGAGGGCTGGGCAGGCTGGGGCGCCTCGTGGCCTCCTGGATGGTGGAGCGCGGCGCGCGGCGCCTCGTGCTGGTGGGCCGCTCGCGCGCCGGCGAGCCCGCGCTCGCCCTGCTCCGGAGCCTCGAGGAGCGCGGCGCGAGCGTCGTCGTCGAGCAGGCGGACGTGTCCGACGAGCGCGCCATGGACGGCGTCTTCGCGCGCTGCGCGGCTTCCGGTCACCCGCTCGCCGGCATCGTGCACGCCGCCGGGGCGGTGGACGACGCGCTCGCGCTGAACCAGCCCTGGCCCCGGTTCGCCTCGGTCTTCCCGGCGAAGGCGATGGGCGCGTGGAACCTCCACCGCCTGAGCGCCGGCCTCGACCTCGATTTCTTCGTCCTGTTCGCCTCCTCGGCGTCGCTGATCGGGGGCAGGGGCCAGGCCAACTACGCGGCCGCGAACACGTTCCTCGACGAGCTGGCGAGGGTCAGGCGGGCCCGCGGCCTGCCGGCGCTGAGCGTCGACTGGGGGCGCTTCCTCGGGGAGGCGGCCGCGGCCGACGGCGCCCTCGCCGCGCGCATGGACGCCGAGGGGCTCCTGGGCATCGAGCCCGCGCTCGGGCTCGACGCGCTGGAGCGGCTGCTCGAGCACCCGTCGGCGCAGGTCGTCGTCGCGCCGATCGACTGGGCGCGCTACCTGCCAGGCGCGCCGGACACGCCGTTCCTGTCCGAGCTCCGGCGCGATCGCGACCGCGATCGCGACCGCGATCGCGATCGCGAGGCGCCCCGCCGCGAGACGCTGCTCGACGAGCTCAAGCGCGGCCCGGTCCGGCAGCGCCGCGCGATGCTCGTGCGCAGGATCCGCGCCGAGAGCGCGGAGGTGCTCGGCGTCGCGAACCCGGAGCACCTCGGCCTCGACCAACAGCTCAGCGCCTTCGGGCTGGACTCGCTCGGGGCGCTGAAGCTGAGGAACACGCTCCAGGACATCCTCTCGTGCGAGCTGCCGGTGACCCTCGCGTTCAACTACCCGACGGTCGAGGCGCTGGTGGACCACCTGATCGAGCGGGTGATCGATCTCGATTTCTCACCGGGGAAGAGGCCTGCGGACGTGGCGCCGGCCGCCCTCGGAACGAACCTGGACGCGCTGTCGAGCGACGAGGTCGCGGAGCTCCTCTCGCAGAAGCTCCAGGCGCTCGACTGA	MSAPKGALTPDLRARLAERRAELIAMIAQSSRAKAEVELPEVQHRPQERHEPFPFTDIQQAYWVGRSGNLELGAAIHVYVEIESADLDLPRLSAAWRQMVARHEMLRAVALPDGTQKILREVPAYEIEAVDLRGASAERQEAELAALRKRMSHQVQAIDTWPSFEIRAVLLDDRRTRLFFDIDCTFSDSWGIQIIFREWIQLYRSPESPLDPETLELSFRDYVLALAKLPETAVYREALDYWGKRLETLPPAPDLPLAKDPSSVKRPRFRRLVSRLDGATWDKLKTRAREAGLTPPVLLLAVYAEVLAHWAREPRFTLNVPLFNRYPLHPQVNRIAGTFSSFTLLEVDHRSGASFAERSKNLRAQLWRDLEHRYVSGVSLLRALFRREGGISRAVMPVVYTSFASGVDGLGASWVDYLGSELGEVKHSVTQTPQVWLDHQAIDEDDGLFFNWDVADELFPPGMLDDMFAAHCRILRALAEDPELWSRPTPQLVVATAEPPAPGASSAAAPLPDRLLHDDFAERVAAHPHRTAVVAAGRRLSYLDVSRLANRLGHQLRQLGTEANQPVAIVLEKGWEQVVGVLGILRAGAPYLPIDAKLPAERLSYLLKNADVRVVVTHSSLQGRLSFPEGVAIVCVDRLEEGAAPEAPLEARRKPDDLAVIIYTSGSTGTPNGAMIAHRGLVNAIDETNRTFDVRETDRTLALTALHHDMSIFDIFGVLSVGGSVVVPEPDASKDPGRWAELIRTEGVTIWNSVPAMMEMIVTHLEARSEPAGRSIRLAFLGGDWIPVSLPDRVRALFEQARIVSVGGPTETTLWNIWYPIEEVDPSWKSIPYGRPIAHTKYYVMDDALEERPVWVPGELCCAGVGVAKGYFRNPARTQEKFVVHPRTGERLYRTGDLGRLLPDGNIEFLGRVDLQVSLSGYRVEPAEIEAALSQHPRIRAAAVVPVGDRHGRRLTAYVVPHEGGRPTEEELRAFLQGKLPEHMVPRAYGFLKELPLTANGKVDRRRLAETPLKPSSRAGAAPAKVESALAEIIREVLNISEVDPKANFFDLGAHSVHLVRIHGELHRRLGVDVPVVDLFKHPTVAFLAKHLHAGGEGSAAIEETRQRVQQRRAARAPDEDTAIAVIGIACRFPGAESPEAFYKNLAGGVESVSFFSEAELLSSGLSLGTIRGPGYVPAAAILSDIDAFDAEFFGFSPGEATLTDPQNRVFLEVAWEALEHAGYAPNSGESRVGVFAGKSISNYLFPALDLSRPIEYFQRLFGNDKDFIATQISYHLNLKGPSISVQTACSTSLVAVALACQSLCERECDMALAGGVSVKLPHKAGYLAEAGNGMFSPDGHCRSFDANAQGLVPGSGAGMVVLKRLSDALRDGDEVHAVIRGWATNNDGGHKVGFSAPDVNGQAEVIAAAHAKAQVSADSISYVETHGTGTPLGDPIEIAALTQAFALGTSRKGFCAVSSVKSNIGHLDSAAGVASLIKAVLALKHRQHLPSLNFRQPNPRIGFDQTPFYVNAELRPWESEQPRRAGVSSFGVGGTNAHVVLEEAPRAPARPAPEHASDHVLALSARSDAALDALIERYAAAIEQQQDVDLASLCFTAAAGRAHFERRIACVAPSAPKMLELLRAARAGSNARGIARATLSSRRERRVAFLFSGFGSESVGMGRELYETEPAFREAMDRCADLLAPHLPRRLTDVLYPARDAAGGAAASLGDLSYAQPALFALEYCLAELWKSWGITPSAVVGHSLGECVAACVAGVFSLEDALTLVAARGRLMESLAGEGETFLVSADEATVRRVIASDPVSIGSINGPANIVISGAPAGVKSVVERLSQEGIEVKKLDVRRAAHSPLMDPMLEAFGKVARSIRYARPTIDLVANLTGEVAGEEIATPEYWCRQIRETVRMSACLRTLHDALGFEVFLELGPSPALVWNGMQCVPKRSGAWIASLRPGRPDRAQILAALASLYANGVDVNWTSVAREEQRRRVPLPTYPFQRKRYWLEATPGLWGVAAAAQPARGLDGGHPLLGCRLRSPLLKPGQRQFESRVAPETLGYLKDHRAHGQAILPASAYLEIALSGGAAALGAAGAATMTLKDCVFERALLLPESGCILQTVVSSEPRGRLRVEVFSMSDADASGAGDAQEGADPGWQRHASAVVIAGAAPPASDVSLDAWRAACSGELDVAAHYDAHRQHGSEFGPAFQGIRALYRHPEGGLARVELAPELARGGSSYLAHPALLDACLQVASAAFPSLPPGTLYMPAAVEELSFRERPEASLWVWARGRSAAAESAGRIVVDLEVVTDEGRSVLTVRGLTLAPVKREVLLDRKRSEIETWGYELSWRPGDGGSGQRRRPEAGTAAVPRPWLIFTDESGIGVELRALLLERGQTSALVRRGQGYRRLGGGEFEIDPLEPAAFQRLLGEPEWSRGAPPRVVHLWSSELVGALDLSADDLRAALEVGCAGVLHTAQAILKSGAPGAKPEVWIVTRGALRVGDGDGGDLSGLPQAPVWGLGRVLALEHPELTFARADLDPRARPGAAARQLLDEMLADTTEDQIALRGASRYVARLTRAPLPRRHARRLDPARSYLITGGLGRLGRLVASWMVERGARRLVLVGRSRAGEPALALLRSLEERGASVVVEQADVSDERAMDGVFARCAASGHPLAGIVHAAGAVDDALALNQPWPRFASVFPAKAMGAWNLHRLSAGLDLDFFVLFASSASLIGGRGQANYAAANTFLDELARVRRARGLPALSVDWGRFLGEAAAADGALAARMDAEGLLGIEPALGLDALERLLEHPSAQVVVAPIDWARYLPGAPDTPFLSELRRDRDRDRDRDRDREAPRRETLLDELKRGPVRQRRAMLVRRIRAESAEVLGVANPEHLGLDQQLSAFGLDSLGALKLRNTLQDILSCELPVTLAFNYPTVEALVDHLIERVIDLDFSPGKRPADVAPAALGTNLDALSSDEVAELLSQKLQALD	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	535.25	gnl|BL_ORD_ID|4935|hsp_num:0	5928			117	1635	colistin A; colistin B
BGC0000380.1|Leupyrrin_17 # 29693 # 36448 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=14bp;gc_cont=0.745	BGC0000380.1|Leupyrrin_17 	29693	36448	+	Loose	500	28.1054	bcr-1	29.81	3003801	protein homolog model	n/a	n/a	bicyclomycin-like antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAAGCAGGCGCTCCTCAAGATCGAGGAGACGGAGGCCAAGCTCAAGGCCCTCAAGCAGGCCGCCACCGAGCCGATCGCCATCGTCTCGGCGGCGTGCCGGTTCCCCGGCGGAGCGACGACGCCCGAGCGGTACTGGGACGTCCTCTCGCAGAAGCGCGAGATCGCCACGCTCGTCCCGAAGTCGCGCTGGGACGTCGACGCCTACTACGACGCCGACCTCGAGGCGCGGGGAAAGACGTACAGCCGCAAGGCCTGCTTCGTGGACGACGTGGAGCAGTTCGACGCCGACCTCTTCGGGATCACGCCGAGGGAGGCGGAGCTCATGGATCCGCAGCAGCGCCTGCTCCTCGAGGTGAGCTGGGAGGCGTTCGAGCGGGCGGGGCTGCACCTGGCCGACCTGAAGGGCAGCCGCACCGGGGTCTTCGTCGGCGCCTCGAGCGACGACTACTTTCACCTCGTCACCCGCGACCCCAGGATGATCGACGCGCACACCGGGACGGGCACCGCGCTGAGCGTCGTCGCGGGGCGCCTCTCGTACGTGTTCGGCCTGCGCGGGCCGAGCCTCAGCATCGACACGGCGTGCTCGGCGTCGCTCGTGGCGGTGCACATGGCCTGCCAGAGCCTGCGCCACGGCGAGTCGGAGCTGGCCATCGCCGGCGGGGTCAGCCTCATGCTGGCGCCGACCATGGCGCTGATCGAGGCCCGCACGCGGATGCTCTCGAGCGACGGCAGCTGCAAGACGTTCGACGCGCGCGCCGACGGCGTGGTGCGCGGCGAGGGCGTCGGCGTCGTCCTGCTCAAGCGCCTGTCCGACGCCCTCGCGGCCGGCGACCCCGTGATCGCGGTGATCCGCGGCTCCGCGACGAACCAGAACGGCAGGAGCGGCGGCCTGACCGTGCCGAACGGGATCGCGCAGCAGGCCCTCGTCCGCGACGCGCTGGCCCAGGCAGGCGTCCGCCCGGAGGAGGTGGGGTACGTGGAGGCGCACGGCACCGGCACGGCGCTCGGGGATCCGATCGAGGCCGAGGCGCTGGGGGCCGTGCTGGGCGCGGCGCGCGCGGCGGGCGATCCGCTGTGGATCGGGTCGGCGAAATCCACCGTCGGCCACCTGGAGGCCGCCGCCGGCGTGGCCGGCCTGATCAAGCTCGCCCTCATGCTCCAGCGCGGGCTCATCCCGCCGAACATGCACCTCGAGACAAAGAACCCGCGGATCGCGTGGGACGACTGGAGGCTCGACGTCCCCACCGAGATGGTCGCCTGGCCCCGGCGCGGCGGGCCGCGGATAGGCGGCGTGAGCGCCTTCGGGTTCAGCGGGACGAACGCCCACGTCGTCGTCGAGGAGGCGCCGGCGCCCCAGGGCGACGCGGCGGAGCGCGCGGCGCCGCCTCACCTCTTGCTCCCGCTGTCGGCCGGCAGCGACGAGGCGCTGCGCGCGCTCGCGCTGCGCTACGCCGATCACCTCCGCCGCGAGCCGGGCGCCTCCGCGGTCGACGTGTGCTTCACGGCGAGCGCCGGCCGGACCCACCTCGCGCGGAGGATGGCCGTCGTCGCCGACGACCTCGCCGGCGCCGCGCTGGCCCTCGAGCAGGCGGCGCGCGCCCCGTCGCTCGGCCAGGTGGAGGACGCGGGCGCCGGGGCGTACATCGCGGTCGGACGGGCGAGCGGCGGCGCCGCGCCGAAGATCGCGTGGGCCTTCGGCGGCCAGGGCGCCTACCAGCCCGGGATGGGGCGCGAGCTCTACGAGCGCGAGCGGACGTTCCGAGAGCTGGTCGACGAGGTGAGCGAGCGCGCCGAGGCCGCCTGCGGGCGACCGCTCGACGGCCTGGGCGCGCCGCCAGGAGGCGGCGCGGCGCCGGCGCGCGACGCGGTGACCGCGCAGCTCTCGTTGTTCGCGCTCCAGTACGCGCAGGCGGGTCTGTGGCGGCGCTGGGGCATCGAGCCGGATTACGTCACCGGCCACAGCCTGGGCGAGATCGCCGCGGCGTGCGTCGCGGGGGTCTTCAGCCTGGACGACGCGCTGACGCTCGTGACCCTGCGCGCCCGCCTGATCCAGTCGCTGCGGGTATCCGGCGGCATGGTGAGCGTCTTCGCCGGGGAAGACTGGGGCCGGCGCGCGATCGCGGGGGAAGCGCAGCTCGACGTCGCCGCGATCAACGGCCCCGCGCTGATCGTCGTCTCCGGCGAGCTCGGGGCGCTCGAGCGCCTGCTGCAGGCCTGCGGCGCGGCCGGCGTCAGGGCGCAGCGGCTGCACGTGGACCACGCCTTCCACTCGCCGTTGATCGATCCCATCCTCGCCGAGTTCGAGCGCGGCGCGCGCGCGATCGCCTACCAGCCGCCGAGCATCGAGCTCGTCTCCACGGTCACCGGCGGGCTCGCCTCCGACGAGGTCGCCAGCGCCGACTACTGGGTGCAGCACCTGCGCCGGCCGGTGCGCTTCGTGGACGCGGTGCGCACGCTCTCGGGCCTGGGCGTCCGCACGTTCGTGGAGATGGGCCCGCGCCCCGTCCTGTCGACCCTCGGTCGCGACCTCGAGCCGGGGAGCGACTGCGTCTGGCTGCCGACGATGGGCCCGGGTCGAGAGCACCGCGCCGCGCTGGAGACCCTCGCGGCGCTGTACAGCCGGGGTGCCTCGCCTCGCTGGCCCGAGATCTACCGGCACGCGGCGGCGAAGAAGCTCGTCCTGCCCACGTACCCCTTCCAGCATAAGCCCTACTGGCACGCGCGCGCCCCCGGCGACGTCGTGCCGGCGCCGGCGCCCAGGGACGACGGCGGCCATCCGCTGCTCGGAAGCCGGCTCCACGTGGCGCGGGGCGCCGACAAGCGCGCCGTCTTCGAGCGCCGCGTCCGGCCGGACGACCCCGCTTTCCTGAAGCACCACCGGGTCTTCGGCGCCGTCGTCTTCCCGGGCGCCGGTTACCTGGAGATGGCCCTGTCCGCCGGGAGCCGGCTGCTCCGCACCGACGCCCTGGCGCTCGAGGACGTGGCCTTCCTTCAGCCGATGCTGCTCGACGAGGACAGGCCGCGGGTCGTCCAGACGCACCTCGAGCCGCTCGCCACCGGGGGTTACTCGTTCGAGATCTTCAGCGCCGCGCCGGCCGCGGAAGATCAGGAGCTGCGCTGGACGCAGCACGTGTCCGGGAAGGTGCGCGCCGGGAGCGGCGCGGACCTCGGCGACGGCGCTCGACTGCCGTCGCTCCAGCCCATGGTCGCCCTCTCCGTCGACGACCTCTACGCGCGCGCCTCGCGGTCCGGCGTCGACTTCGGCGCCGCCTTCAAGGGCGTCGAGCAGCTGTGGAAGCAGGGCCAGGCGGTCGTCGGCCGGGCGCGGCTGCCGCTCCAGCTGGCCGCCGAGGAGGCCCGGTACTTCGTGCATCCGGCGCTCCTCGACGCGTGCCTCCAGGTGGTCGGGGCGACCTTCGACGCCGAGGTGGCCGGGGAGGCTTACCTCCCGGCGCGGCTCGGCAGGCTCGAGGTGCGCACGCGGCCGGGCGTCGAGCTCTGGTGCCACGCCCAGGGGAGCGCGGGCCCCGAGGGCTCCTTCCGCATCGGCGCGCGCGTCTTCGGCGAGGCGGGCAGCCTCGTCCTCGACGTCGAGGACCTCGAGCTGCGCCGCGCCCGGGAGCTCCGCTCGCCGGCCCAGGAGACGCAGGGCTGGCTCTACGAGGTGGCGTGGCGTCCGGCCGGAAAGGCGCGGAGCGAGCGCCGCGACCTGCCCGGGGTGGCCGAGGTCGCGCGCTCCGTCGGCGAGCAGGCCCCGGACGCGGCGCTCCTGGAGCGGATCCGCGCGTTCGAGCTGGGCCTCGCCGAGCTCGAGGACGCGAGCGTCCAGTATGTCCTCTCCGCGCTCCGATCGCTCGGGTGGAGCCCGGCCCCGCGGGAGGTCTTCTCGACCGACCAGCTCGCGCGGCGGCTCGGCGTGGCCCGGCGCTTCGATCGGCTGCTCGGGCGGCTGCTCGAGATGCTCGCCGAGGAAGGCTGGATCCGGCGGCGCGGGGACGGATGGGAGACCGTCGCGCTCCCTCCGGGGAGCGACCAGGGCCCGCGGGTCCAGCGGCTCGGCGAGGCCCACCCGGCCGTCCGCAACGAGGCCTCCGTGCTGCTGCGCTGCGGGTCGAGCCTGGCCGGGGTGCTGCGAGGCGACGTCGACCCCTTGACCCTCCTGTTCCCCGGAGGCGACACCGGCGTCGTCCACGCGCTGTACCAGGCGCCGCTCGTCCAGCTGAAGAACGACGTCATCCGGCGGGTGATCGCCGCGGTCCTCGCGCGCACGGCGTCGAACGGCGGCCTGCGCTTCCTCGAGGTCGGCGCCGGGACCGGCGAGACCACGGCGCACGTCCTGCCGTGCTTGCCGGCCGTCGGCACCGAGTACGTCTTCAGCGACGTCTCCTCCGTCTTCATCAACAGGGCGAGCGAGCGGTTCCGCGCGTATCCGTTCCTGCGCACCGCGCTCGTGGACATCGAGAAGGAGCCGCCCTCCGGCGCGAGCGGGCTCGGGACGTTCGACGTGGTGATCGCGTCGAACGTCGTGCACACGACGAAGGATCTCCGGGCGACCCTCGGCAACCTCCGCCGCTTCCTCTCGCCGCGAGGGATCCTCGTGCTCATGGAGGGCACCCAGGCCCTGCGCTGGGTCGATCTGAGCTTCGGGTTGACCGAGGGGTGGTGGCGGTTCGAGGACGCGGACGTCCGGCCGAGCTACCCGCTGCTCACGGCGGAGCGCTGGCGATCCTTGCTCGCCGAGTGCGGGCTGCAGCAGCCGGTGGTCGTGCCCACGCGCGCAGACCGGCTCCGGACGCTCGAGCAGCAGGTGGTGCTCCTGGCCGAGGAGCCGGCGCAGCCGCTCGCCGACGAGGGGCGCGCGTGGCTCTTGCTCGCCGACGCCACCGACGTCGGCGACGTCGGCGAGCAGCTCGGCGCGATGCTCGCGCGTCACGGGCAGCGGCCCGTCGTCGTGACCCGCGGCGCGGAGGGCGCCGCGATCCACGGCGGCGCGCCGGAGCTCGCCGGGCTGCGCTTCGATCCAGGGAGCGCCGACGGCTTCCGGAGCTTGCTGCGCGCGCTCGACCAGCACGGGCTCCGGCCGGACGGCGTGGTGCACCTGTGGAGCCTCGACGCGGTGAAAGGCGACGATTTCGACACGAGCGAGCTCCGCTACGCCTCGCGGCACGGCTGCCAGAGCGCCCTGTTCCTGCTCCAGGCGCTCGTCGAGGCGTACGGCGAGCGCCCGCCCGGGCTGTGGCTCGTCACGGGCGGCTCGCAGGCCGCTCGCGAGGGCGACACCGTCGACGGCGTGGCGCACGCCGGCGTCTGGGGCCTGGGACGGGTGATCGCCCGCGAGCACCCCGAGCTCTCCTGCCGGCGCATCGACCTCGACGCGCGGCCGGGCGAAGCGGACATCCGCGCGCTCTTCGACGAGATCCAGCTCCGGTCGCAGGAAGACGAGGTCGCGCTGCGCGGCGGAGAGCGCTACGTGCCCCGCGTTGTGCGCCGCGCGGAAGCGGCGCGCTCGGCGGCGAGGCGAGGCGCCCCGCGCCCCTCGGTCCACGGGCCGGGCGACGCGCTGCGCGCCGATGGCACCTACGTGATCACCGGGGCCTTCGGGGGCCTCGGGCTGCGCGTCGCCGAGTGGATGGTCGAGCGCGGCGCGCGGAACCTCGGCCTGCTCGGGCGCCGCCCGCCGGGCGCCGAGGCGGCCCAGGTCATCGAGCGGCTCGCGCAGCGCGGGGCGCGGGTGCGGGAGATCCTCGTCGACGTCGCCCACGAGGGCCGGCTGGCGAGCGCGCTGGCCGAGCTCCAGGCGTCGATGCCCCCGCTGCGCGGCGTGGTCCACTCGGTCGGGGCGATCGACGACGGGATCCTCCAGAACCTGACCTGGGAGCGCTTCGAGCGCGTGCTCGCGCCGAAGGTCGAAGGGGCGTGGAACCTCCACCGGCTCACGCGAGGAATGGAGCTCGACTTCTTCGTGTTGTTCTCGTCGGCGGTCGCCCTGCTGAGCGCCTGGGGACAGGCCAACCACACGGCCGCCAACACCTTCCTCGACGCGCTCTCGCACCACCGGCGCGCCCGCGGGCTGCCGGCGCTGACCATCGACTGGGGCGCCTGGGATCAGGTGGGCGCGGCAGCGCGGCCGGAGGCCGATCAGAAGATGCGCGACCTCGGAATGGGCACGATCCCGCCCGACGCCGGCCTCCGCGTGCTCGAGCAGCTCCTCTCCGAGGGCGCGGTCCAGACCGGGGTCATGCCGATCGACTGGAGCCAGTTCGCGCGGAAGCTCCGCTGGTCGCCCCTCGTCTCCGAGGTGCTCTCCGACACCGGCAACGAGGAGCGCGCCGAGCCGGAGCTCCTCCACCGCCTCGAGCAAGCAGGGCCCGCGCAGCGCCGCGCGCTCCTGCGCGAGCACGTCCGCGAGCAGATCGCCCGGGTCATGCACCTCTCCGACCCGTCGCAGATCAGCGAGCAGCGGCGGCTCTTCACCATGGGGCTCGACTCCCTCATGTCCGTGGAGCTGAAGAACAACCTCTCCACGAGCCTCGGCAAGCCGCTCCGCGCGACGCTCGTGTTCGACTTCCCGACGCTCGGGGCGCTCGTGGAGCACCTCTCGGAGCTCCTCCCCGGCGCGGAGAGGCCCGCGAGCGCGGCGCCCGCCGGCGCCCCGGGCGACGCGGGCAGGCAGGAATTCACCGAGATCGAGCCGCTCTCTCCGGGCGAGCTCGAGGCCATCATCGACAGCGAATTCAACGCCATAACGGACTGA	MKQALLKIEETEAKLKALKQAATEPIAIVSAACRFPGGATTPERYWDVLSQKREIATLVPKSRWDVDAYYDADLEARGKTYSRKACFVDDVEQFDADLFGITPREAELMDPQQRLLLEVSWEAFERAGLHLADLKGSRTGVFVGASSDDYFHLVTRDPRMIDAHTGTGTALSVVAGRLSYVFGLRGPSLSIDTACSASLVAVHMACQSLRHGESELAIAGGVSLMLAPTMALIEARTRMLSSDGSCKTFDARADGVVRGEGVGVVLLKRLSDALAAGDPVIAVIRGSATNQNGRSGGLTVPNGIAQQALVRDALAQAGVRPEEVGYVEAHGTGTALGDPIEAEALGAVLGAARAAGDPLWIGSAKSTVGHLEAAAGVAGLIKLALMLQRGLIPPNMHLETKNPRIAWDDWRLDVPTEMVAWPRRGGPRIGGVSAFGFSGTNAHVVVEEAPAPQGDAAERAAPPHLLLPLSAGSDEALRALALRYADHLRREPGASAVDVCFTASAGRTHLARRMAVVADDLAGAALALEQAARAPSLGQVEDAGAGAYIAVGRASGGAAPKIAWAFGGQGAYQPGMGRELYERERTFRELVDEVSERAEAACGRPLDGLGAPPGGGAAPARDAVTAQLSLFALQYAQAGLWRRWGIEPDYVTGHSLGEIAAACVAGVFSLDDALTLVTLRARLIQSLRVSGGMVSVFAGEDWGRRAIAGEAQLDVAAINGPALIVVSGELGALERLLQACGAAGVRAQRLHVDHAFHSPLIDPILAEFERGARAIAYQPPSIELVSTVTGGLASDEVASADYWVQHLRRPVRFVDAVRTLSGLGVRTFVEMGPRPVLSTLGRDLEPGSDCVWLPTMGPGREHRAALETLAALYSRGASPRWPEIYRHAAAKKLVLPTYPFQHKPYWHARAPGDVVPAPAPRDDGGHPLLGSRLHVARGADKRAVFERRVRPDDPAFLKHHRVFGAVVFPGAGYLEMALSAGSRLLRTDALALEDVAFLQPMLLDEDRPRVVQTHLEPLATGGYSFEIFSAAPAAEDQELRWTQHVSGKVRAGSGADLGDGARLPSLQPMVALSVDDLYARASRSGVDFGAAFKGVEQLWKQGQAVVGRARLPLQLAAEEARYFVHPALLDACLQVVGATFDAEVAGEAYLPARLGRLEVRTRPGVELWCHAQGSAGPEGSFRIGARVFGEAGSLVLDVEDLELRRARELRSPAQETQGWLYEVAWRPAGKARSERRDLPGVAEVARSVGEQAPDAALLERIRAFELGLAELEDASVQYVLSALRSLGWSPAPREVFSTDQLARRLGVARRFDRLLGRLLEMLAEEGWIRRRGDGWETVALPPGSDQGPRVQRLGEAHPAVRNEASVLLRCGSSLAGVLRGDVDPLTLLFPGGDTGVVHALYQAPLVQLKNDVIRRVIAAVLARTASNGGLRFLEVGAGTGETTAHVLPCLPAVGTEYVFSDVSSVFINRASERFRAYPFLRTALVDIEKEPPSGASGLGTFDVVIASNVVHTTKDLRATLGNLRRFLSPRGILVLMEGTQALRWVDLSFGLTEGWWRFEDADVRPSYPLLTAERWRSLLAECGLQQPVVVPTRADRLRTLEQQVVLLAEEPAQPLADEGRAWLLLADATDVGDVGEQLGAMLARHGQRPVVVTRGAEGAAIHGGAPELAGLRFDPGSADGFRSLLRALDQHGLRPDGVVHLWSLDAVKGDDFDTSELRYASRHGCQSALFLLQALVEAYGERPPGLWLVTGGSQAAREGDTVDGVAHAGVWGLGRVIAREHPELSCRRIDLDARPGEADIRALFDEIQLRSQEDEVALRGGERYVPRVVRRAEAARSAARRGAPRPSVHGPGDALRADGTYVITGAFGGLGLRVAEWMVERGARNLGLLGRRPPGAEAAQVIERLAQRGARVREILVDVAHEGRLASALAELQASMPPLRGVVHSVGAIDDGILQNLTWERFERVLAPKVEGAWNLHRLTRGMELDFFVLFSSAVALLSAWGQANHTAANTFLDALSHHRRARGLPALTIDWGAWDQVGAAARPEADQKMRDLGMGTIPPDAGLRVLEQLLSEGAVQTGVMPIDWSQFARKLRWSPLVSEVLSDTGNEERAEPELLHRLEQAGPAQRRALLREHVREQIARVMHLSDPSQISEQRRLFTMGLDSLMSVELKNNLSTSLGKPLRATLVFDFPTLGALVEHLSELLPGAERPASAAPAGAPGDAGRQEFTEIEPLSPGELEAIIDSEFNAITD	MPASASRIQVGSGERRLLLLLSALVAFGPLSIDMYLPSLPAIAADLGASDAQVQRSISGFLVGFCVGMLFYGPLSDRFGRRPVLLAGIALYLFSSLACALADSAGQLVLLRVLQALGGGAASVLARAMVRDLYPLGEAARMLALMHMVTMLAPLAAPLLGGYLMLWAGWRALFVVLALFAGLCLLAVWRVAESHPPERRGGSLAQAFLAYGRLLGDRRALGYVLCMGLAFAGMFAYISAAPFVFIEHFGVRAERFGWFFGLNILGVMLATWCSARLVRRHGPRPLLRAGSLLACVSGLFLLGYAALGERGGLWALVPGLLCFVSVTGLLGANCIASLLALYPGQAGAASAVAVSGQFGLGCLASLAVGWLALPGVLPMALVMAVCGVGSLLALGLALHGGNR	559.95	gnl|BL_ORD_ID|2332|hsp_num:0	2303			612	903	bicyclomycin
BGC0000380.1|Leupyrrin_18 # 36457 # 42057 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.726	BGC0000380.1|Leupyrrin_18 	36457	42057	+	Loose	750	29.261	tet(51)	33.33	3004586	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGACGACGACCACCCCAGAGGCGCGGAAGGAGCTCTCCCAGCTCGAGCGCGCAGCGTATGCGCTCAAGCACCTGCGCGCGCAGCTCGACAAGTACCGGGAGCCGATCGCCATCGTCGGCATGGCCTGCCGCTTCCCTGGCGGCGCGAACGATCTCGATAGCTACTGGCGCCTGCTCTGCGAGGGGCGGAGCGCCGTGGTGAAGGTGCCCCGGGACCGCTGGGACGCCGACGAGCTCTACCGGCCGGATCCGGATCCGGATCGATTCTGGGAGACGTACATGCAGTACGGGAGCTTCCTGGATCACCACGTCGACGGCTTCGACGCGGAGTTCTTCAAGATCTCTCCGCGCGAGGCCATGGTGATGGATCCGCAGCAGCGCCTGCTCCTCGAGGTCGCCTGGGAGTCGCTCGAGCACGCCGGGGTCGCCCCCGACAGCCTGCTCTGCAGCCGGACGGGCGTCTACGTCGGCCTCATCACGGGCGATTACGGGCGCATCCCGTTCGAGGAGGTGGTGCCCGCCGATCTGCCCTATTACGGCACGGGGAACTCGGTCAGCTTCCCGGCGGGGCGCCTCTCGTTCTCCCTCGGGCTGCAGGGACCCTGCATGGTGGTGGACACCGCCTGCTCATCGACGCTGGTGTCCACCCACCTCGCCTGTCAGGCGCTGCGATCGGGCGAGTGCGATCTGGCGATATCAGGCGGCGTGAGCCTGATGATCTTCCCCGACACGAGCATCATCCTGTCGAAGATGCGGGCGACGGCGCCCGACGGGCGCTCGAAGACGTTCGACGCCGGCGCGGACGGCTTCGGGCGCGGCGAGGGGTGCGGGGTCGTCGTCCTCAAGCGCCTCGAGGACGCGCTGCGCGACGGCGACAAGATCTGGGCCCTCATCCGGGGCGCCGCGGTCAACCACGATGGCCCGAGCGGCGGGATCACGGTCCCGAACGGCCCTGCCCAGGAGAAGCTCCTCAAGTCTGCGCTGGAGTCGGCGCGGCTGCGGGCCGAGGAGGTCAATTACATCGAGGCCCACGGCACGGGCACGCCGCTCGGAGACCCCATCGAGCTGCAGGCGATCCACACGGTGATCGGACAGGCGCACACCCAGGATCAGCCGCTGCTCATCGGCTCGGTGAAGACGAACATCGGCCACCTCGAGGCGGCGGCCGGCGTGGCCGGCCTCATCAAGGTCGCGCTCGCCCTCCATCACGAGCGGCTCCCGGCCAGCCTGAACTTCAAGACGCCGAACCCGGCGGTCCCCTGGAACGACATGCCGCTGCGCGTGGTGACAGAGCTCACCCCCTGGGCGAGACGCGAGCTGCCGCGCATCGCCGGCATCAGCAGCTTCGGCCTCAGCGGCATCAACGGCCACGTCCTCGTCCAGGAGGCGCCGGTGGCCGCGCCGAAGCGCCCGCCGGAGCGGGATCGGCCGCTGCACCTGCTCACGCTGTCGGCGCGGACCCCCGAGGCGCTCCGGGAGCTCTCGCGCCGCTATGCGGACTTCCTCGAGCGCAAGCAGGCCGAGGTCTCGCTCGCGGACGTGTGCTTCACGGCGAACACCGGGCGCTCGCTCTTCGAGCACCGCCTGGCCGTGACGGCCGCGTCGAGCGCGGAGCTGTGCGCGCGGCTCAAGGAGTTCACGGACGCCGGGCGAGCCGACGACGTGCGGTCGGCGCTCTCTGGCGACGCGCCGCAGGTGGCGTTCCTGTTCACCGGGCAGGGCGCGCAGCACGTCTCGATGGGGCGCGAGCTGTTCGAGACCCAGCCGAGCTTCCGCGCGACCCTCGAGCGCTGCGATGAGCTCCTGCGCGCCGAGCTCGAGCAGCCGCTCCTCTCGGTCCTGTACCCGGAGCCCGGCCGGCCCTCGCCCATCGACGACACGGCGTACGCGCAGCCGGCGCTGTTCGCGATCGAGGTCGCGCTCGGCCAGCTGCTCCTCTCCTTCGGGGTGCGCCCGGCCTACATGATGGGGCACAGCATCGGGGAGTATGCGGCCGCGTGCCTCGCCGGCGTGTTCACCCTCGAGGAGGGGCTGCGCCTCGTCGCCACGCGCGGCCGGCTGATGCAGTCGCTGCCCCGCGACGGGGCGATGTTCAGCGTGAAGGGGGACCTCGACCGGATCGGGGCGGCGGTGGTGAGGCACGCCGCCGACGTGGCGATCGCGGCCGTCAACGGCCCCCAGCACGCGGTCATCTCCGGGCGCGAGGAGGCGGTGCATCGCCTCGTCGCGCGCTTCGAGGCGGAGGGGATGCCCTGCAAGCGGCTGAAGGTCTCGCACGCCTTCCACTCGCCGCTGATGACGCCGATCCTCGACGAGTTCGCCCGGGTGGTCGAGCAGGTCCACATGAAGCCGCCGTCCATCCCGATCGTGTCCAACCTGACGGGGCGCGTCGCGGGCGACGAGCTGCTCACCGCGAGCTACTGGCGCCAGCACCTCCTGCGCACCGTCGCGTTCGCCGACGGCATCGCGTCGCTCGGCCGCGAGGGGGTGCACGCGTTCGTCGAGATCGGCCCGACGCCCACGCTCTCGGGCCTGGGGCAGCTCTGCCTCCCGCAGGGCGGCAAGGCCTGGCTCCCCACGCTGCGCCCCGGCGTGTCCGACTGGCGCATGCTGCTCGACGCGCTGGCAGAGCTCTACGTGGCCGGGCAGCGCATCGACTGGCGGGCCTTCGAGCGCGACTACCCCCGGAACAAGGTGCAGCTGCCGACCTACCCCTGGCAGCGCCGCCGCCACTGGATCGAGCTGCCCGCGGACTACGAGCAGCACCGGCGCAGGCGCGGCAAGGCCGGCGCGAAGGAGCACCCGCTGCTCGGGCGCAAGCTCCGCTCGGCGACGAAGGTCCAGCACTTCGAGTCGCTCATCAGCAGCAGCGCGCCGGCGTTCCTCGCCGAGCACCAGGTGTACGGCACGCCGGTCGTGCCCGGCGCCGCCTTCGTCGAGGCGTTCCTCGCGGCGGGCGCGTCCCTGCTCAAGAGCGAGGCCCTCGTGCTGGAGAACGTCGCTTTCCGGAGCGCCGTCAGCCTGCCGGACGGCGAGCCGGTGACGCTCCAGGTCCTGGCGACCCCGCGAGAGGACGGCGGGTACGACATGGAAGTGCACTCGACGGACGCCGCCGCCGAGGGCGACGAGCCCTGGGTGCTGCGCGCGAGCGCGCAGGTGTCCAGGGGGGCGGCGGCCGGGGAGAAGAGGGACGTCGGCGCCCTCAGGGCGCGCTGCTCGAAGGAGCACTCGCCCGAGGCGTTCTACGCGCGGGTGCAGGGCCTGGGCCTCGACTACGGCCCGAGCTTCCGCCCCATCCGCGCGTTCTGGTCGAGCGGCTCCGAGGTCCTCGGAAGGCTGACGCTGCCCGGCGGGCTCGCGGCCGAGAGCGGCGCTTTCCTCTTCCATCCGGTCCTCCTGGACGGCTGCTTCCAGGCGCTCGGCGCCATCTTCCCGGAGCAGCTGGAGAACGACGTCTACCTGCCGATCGCGATCGATCGCCTGGAGCTCTACGGCCGGCCGGGCGCCGAGCCGTGGGTGCACAGCACGATGCAGGCCGGCCCGGGGGCAGAGCGCACGCCCCGCTGCGACTTCGAGGTGCTCGACCCGAGCGGGCGGCCCACCGTGAAGATCGAGGGCCTGCGGTTCCAGCGGGCGAAGTACGAGGCGCTCCAGGCGAGCCTGCGGGGCGGCCTGAGGCGCTCGTATTACAAGGTCGAGTGGGTGAACGAGCCCCTGGAGCTCGCGGACGAGCGCCCCGCGGCCGGCGCGGGCGCGGTAGAAGAGCGCTCCTGGCTCCTGCTCGCCGACCGCTCCGAGGTCGTCGCCGCGCTCGCCGAGAGCCTCCGCGCGCGCGGGGACCGCTGCGTGCTCGTCCACGCCGGGAGCGCGTACGAGGCGGTCTCGCCCGTGAAGTTCGTCATCGATCCGCGGGCCCCGGAGCACTACGGCAGGCTGCTGTCCGACCTCGGGCCGCGATCGATCACCGGGGTCGTCCACCTCTTCGGCCTCGACCAGAGCGGCGCGGAGAAGCTCGACGCGGCCGGCATGAGCGCGGCCTGGAAGCGCTCCTGCGGCAGCCTGCTGCACCTGGTGCAGGGCCTCGCGAAGGCGAGCCAGCAGCGCTCGATGGTGCTCTGCTTCGTCACGCGAGGGGCCGTCGCCGCCTCGGACGGCGAGCCGCTGCCCGGCATCGCGCAGGCGCCGAGCTGGGGCCTCGGGCGCGTCATCGGCAGCGAGCACCCCGAGCTCCGCACCCTCGGCGTCGACCTGCCGCCGGAGCCGATGAAGGGGGAGATCGACGCGCTGCTGAAGGAGCTGCGCGGCCGCGCCGCGGGCGGCGCAGAGGACCAGGTCGCCCTCCGGCCCGAGGGGCGCCTCGTCCCCCGGCTCGCCCGTGCCGAGCTCCAGGGGTCGCCGCAGGGCGTCGACCAGCTGCGCAGCGACGCGACCTACCTCGTCACCGGCGGCCTCGGAGGGCTCGGCAGCTGCGTGCTCCGGCGGCTCGCGGAGCAGGGCGCGCGCCATCTCCTGGTGATCAGCCGCAGCGGCGCTTCGGAGGCCCACGGCCCGCTGCTCTCGGAGCTCGCCGCGATGGGGGTGACCGTCGAGGTGGCGCGCGCGGACGTCGCGCGCGAGGCGGAGGTCCAGGCGGTCTTCCGGCAGCTCGACCGCGCGATGCCCCCGCTCGCCGGCGTGGTGCACGCGGCCGGCGTGCTCGACGACGGCATCCTCCTCCAGCAGAGCGAGCAGCGCTTCGCCCACGTCATGGCCCCCAAGGTCGAGGGGAGCTGGATCCTCCATCGGCTCACCCAGGACCGGCCGCTCGACTTCTTCGTCCTGTTCTCCTCCGCGGCGTCGCTCCTCGGCAGCGCCGGCCAGGGGAACTACGTCGCCGCCAACGCGTTCGTCGACGCGCTCGCGCATCACCGGCGGGCGCGCGGGCTCGTGGCCACGAGCATCAACTGGGGCGCCTGGGCCGAGGTGGGCCTCGCGGCGCAGCCCGAGGCGCGCGAGCGCGTGCGCGAGAGGCGCGTCGCGACCCTCCAGCCGGCGGAGGGGCTCGACGCCCTGACCCAGGTGCTCGCCGCCGCGCCGGCGCAGATCGGCGTGGTCCCCATCCACTGGAACGACATGCAGGCGCTTCTCCGATCGCCTTTCTTCAACAATTTCAAGCGCTTCGAGCCGCCCAAGGCCGAGGCCGACGCGTTCCTGAAGAAGCTCGACGAGGCGCCGTGGAGCGAGCGCCACGGCCTGCTCGTCGAGCATGTCACCGCCGTCGTCCGGAAAATCCTGGGCATCGGCCCGAGCCGCCCCGTCGCGCCCGAGAGGGGCTTCTTCGACATGGGGATGGACTCCATGATGTCGGTCGAGCTCAGGAACCGGCTGCAGAGCAGCCTCGGCTGCTCGCTGCCGGCGACCGTCGCCTTCGATAACCCCACCGTGAACCAGCTCGTCGACTACCTGGAGGGGTCGGCGCTGGCGCGCGGCCAGGAGGAGGCGCCCGTCCGCGCGGCGATCGACGACGCGGAGCTCGGAGCGCTGCTCGAAGAGGTCGACGCGCTGTCGGGCGCCGAGATCAACGCTCGGCTGCAGGGCGCCCGGCTCGGGGCGGCCAGGTAG	MTTTTPEARKELSQLERAAYALKHLRAQLDKYREPIAIVGMACRFPGGANDLDSYWRLLCEGRSAVVKVPRDRWDADELYRPDPDPDRFWETYMQYGSFLDHHVDGFDAEFFKISPREAMVMDPQQRLLLEVAWESLEHAGVAPDSLLCSRTGVYVGLITGDYGRIPFEEVVPADLPYYGTGNSVSFPAGRLSFSLGLQGPCMVVDTACSSTLVSTHLACQALRSGECDLAISGGVSLMIFPDTSIILSKMRATAPDGRSKTFDAGADGFGRGEGCGVVVLKRLEDALRDGDKIWALIRGAAVNHDGPSGGITVPNGPAQEKLLKSALESARLRAEEVNYIEAHGTGTPLGDPIELQAIHTVIGQAHTQDQPLLIGSVKTNIGHLEAAAGVAGLIKVALALHHERLPASLNFKTPNPAVPWNDMPLRVVTELTPWARRELPRIAGISSFGLSGINGHVLVQEAPVAAPKRPPERDRPLHLLTLSARTPEALRELSRRYADFLERKQAEVSLADVCFTANTGRSLFEHRLAVTAASSAELCARLKEFTDAGRADDVRSALSGDAPQVAFLFTGQGAQHVSMGRELFETQPSFRATLERCDELLRAELEQPLLSVLYPEPGRPSPIDDTAYAQPALFAIEVALGQLLLSFGVRPAYMMGHSIGEYAAACLAGVFTLEEGLRLVATRGRLMQSLPRDGAMFSVKGDLDRIGAAVVRHAADVAIAAVNGPQHAVISGREEAVHRLVARFEAEGMPCKRLKVSHAFHSPLMTPILDEFARVVEQVHMKPPSIPIVSNLTGRVAGDELLTASYWRQHLLRTVAFADGIASLGREGVHAFVEIGPTPTLSGLGQLCLPQGGKAWLPTLRPGVSDWRMLLDALAELYVAGQRIDWRAFERDYPRNKVQLPTYPWQRRRHWIELPADYEQHRRRRGKAGAKEHPLLGRKLRSATKVQHFESLISSSAPAFLAEHQVYGTPVVPGAAFVEAFLAAGASLLKSEALVLENVAFRSAVSLPDGEPVTLQVLATPREDGGYDMEVHSTDAAAEGDEPWVLRASAQVSRGAAAGEKRDVGALRARCSKEHSPEAFYARVQGLGLDYGPSFRPIRAFWSSGSEVLGRLTLPGGLAAESGAFLFHPVLLDGCFQALGAIFPEQLENDVYLPIAIDRLELYGRPGAEPWVHSTMQAGPGAERTPRCDFEVLDPSGRPTVKIEGLRFQRAKYEALQASLRGGLRRSYYKVEWVNEPLELADERPAAGAGAVEERSWLLLADRSEVVAALAESLRARGDRCVLVHAGSAYEAVSPVKFVIDPRAPEHYGRLLSDLGPRSITGVVHLFGLDQSGAEKLDAAGMSAAWKRSCGSLLHLVQGLAKASQQRSMVLCFVTRGAVAASDGEPLPGIAQAPSWGLGRVIGSEHPELRTLGVDLPPEPMKGEIDALLKELRGRAAGGAEDQVALRPEGRLVPRLARAELQGSPQGVDQLRSDATYLVTGGLGGLGSCVLRRLAEQGARHLLVISRSGASEAHGPLLSELAAMGVTVEVARADVAREAEVQAVFRQLDRAMPPLAGVVHAAGVLDDGILLQQSEQRFAHVMAPKVEGSWILHRLTQDRPLDFFVLFSSAASLLGSAGQGNYVAANAFVDALAHHRRARGLVATSINWGAWAEVGLAAQPEARERVRERRVATLQPAEGLDALTQVLAAAPAQIGVVPIHWNDMQALLRSPFFNNFKRFEPPKAEADAFLKKLDEAPWSERHGLLVEHVTAVVRKILGIGPSRPVAPERGFFDMGMDSMMSVELRNRLQSSLGCSLPATVAFDNPTVNQLVDYLEGSALARGQEEAPVRAAIDDAELGALLEEVDALSGAEINARLQGARLGAAR	MPIINKILVIGAGIAGPAVCYWLRRFGFSPILVERCANLRKGGHAVDIRGVAIDLAKSMGIYKKICNMRTQVELGRYVDAEGNILHEEKGERFGFREGDDIEILRGDLVQILIDAMGDVPCHFNQWVESIKQRDNDVEVQFKDGRTELYDLVIGADGLHSTTRRMVFDKDEYKLTNLGAYFSAFSIPNYLNLNHTDVQFEANQKLISMASDKNPKIAITGFCFRAQNVLNNLRDENEQRRFLRDTFQDFGWETSKILELMSDSNDFYFDSFTQVKMKSWTKGRVALVGDAGYCASPFPGQGSNQALVGAYIFAGELKQAEGNYHRAFNRYNELLQPFVEANQKFGVLVNESFLVRDEVSKEVAEERSNKIMQEIKIVSNMISLPNYE	482.17	gnl|BL_ORD_ID|2723|hsp_num:0	3288			846	1017	tetracycline; oxytetracycline
BGC0000380.1|Leupyrrin_19 # 42099 # 48761 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.747	BGC0000380.1|Leupyrrin_19 	42099	48761	+	Loose	750	91.6633	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	28.42	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGTCCGTCGCGAAGCTCGCGTACGTCGCGCAGCAGATGCGCGCCAAGCGCGTGGTGACGGAGCCCATCGCGATCGTGGGCATGGGCTGCCGCTTCCCGGGCGGAGCGGACTCGCCGGAGGCGCTCTGGAAGCTGCTCGCCGACGGGCGCGACGGGCTCACCGATGTCCCTCCCGGGCGCTGGGACGTCGACGCGCTCTACGACCCCGAGCCCGGGAGCCCGGGCAAGCTCTACACCCGCCGCGGCGCGTTCCTGCGCGAGGTCGAGGAGTTCGACGCGTCGTTCTTCCACATCTCGCCGCGCGAGGCGACCGTGATGGACCCCCAGCAGCGGCTGCTGCTCGAGGTGAGCTGGGAGGCGCTGGAGCACGCCGGGATCTCGGCGACGTCGCTGCGCGGCTCGTCGACCGGGGTGTTCGTCGGCGTCATGCACCACGACTACGCGCAGCTCCTCGTCGACGCGCGCCGGTTCGACATGCACGCCGGCTCCGGGAGCGGCATGAGCGTGGCCGCCGGCCGGCTGGCCTACGTGCTCGGGCTCGAGGGCCCCACGCTGGCGCTGGACACCTCCTGCTCCTCCTCCCTGGTCGCTTTGCACCTCGCCTGCCAGAGCTTGCGGGAGAGCGAGTGCGACCTCGCCCTGGTCGGCGGCGTCAACCTGATGCTGTCGCCGCTGACCACCATCATCGAGTGCCAGATGCGCATGCTGTCGCCGTCGGGCCTGTGCCGCGCGTTCGACGCGCGGGCCGACGGCTTCGTGCGGGGCGAGGGCTGCGGCGTCGTGGTCCTGAAGCGGCTCTCCGACGCGCTGGCCAGCAGGGACAACATCATGGCCGTCATCCGCGGCTCCGCGGTCAACCACGACGGGGCCACGAGCGGGCTCACCGTGCCGAACGGGCGCGCCCAGCAGCAGGTCATCCGACAGGCGCTGAGCCACGCCTGCGTGCTGCCCGAGCAGGTCAGCTACGTCGAGGCCCACGGGACGGGCACGTCGCTGGGCGACCCGATCGAGGTCGAGGCGCTCGGCGCCATCTTCGGCCGCGGCCGCTCGCGCAACGCTCCGCTCTTCATCGGCTCCATCAAGAGCAACATCGGGCACACCGAGGGCGCCGCCGGGGTGGCCGGGCTGATGAAGGTGGTCCTGTCGCTGCAGCACGGGCGCCTGCCCCCGAGCCTCCACTTCGAGATCCCGAACCCCCACATCCGCTGGTCCGAGCTGCCGATCGAGGTCGTCGACCGGGCGAGGGACTGGGCGGCCCCGGAGGACAGGCGGATCGCCGGCGTGAGCTCGTTCGGGTTCAGCGGCACGAACGCGCACCTCGTGCTCGAGCAGGCCCCCGTGCTCGAGCTCGCGCCCCCGCCGCCCGAGCGGCCGGTGCACGTGCTCGGCCTGTCGGCGAAGAGCCCGGAGGCGCTCGTGCAGGTGGCCGAGCGCTACGTCGAGCGCTTGATGGCCGCCGACACGCTGGAGCTCGGCGCCGTGGCCTACACGGCGAACGCCGGGCGGGCTCACCACGAGCACCGCCTCGCGGTGGTCGCGACGTCGAGCGTGGAGGCGTGCGAGAAGCTCTCGCGGTTCGCGAAGGAAGGGGCCTCCCCCGGGGTGATCGCGGCGCGCGCGGACGCCCGCGCGGCGACGAAGATCGGCTTTCTGTTCTCCGGGCAGGGCGCGCAGTACCCGGGGATGGGGCGCGATCTGCTCGAGAGCGACCCGACGTTCCGCAGCAGCCTTCAGGCCTGCGACGAGCTCCTCAGGCCGCACCTCGAGGTGCCGCTGCTCGAGGTGCTCTCCGCGGGCGAGGGCGCGGGCGACCGGATCCACACGGGGATCTACAGCGCGGTCACCACCTTCGCCGTGGAGTATGCGCTCTCGGAGCTCCTGCGCTCCTGGGGCGTCGTCCCGTCCTGGGTGATGGGTCATAGCCTGGGCGAGTACGCCGCGGCCCAGGCCGCGGGGCTGCTCACCCTGGAGGACGCGCTGAAGCTCGTCGTCCGCCGGGGCCAGCTGGTGGAGACCCTCCGCACGAAGGGGGCGATGGCGACGCTCTTCGCCGCCCCGGAGCTCGTCGGCGAGCGGATCGCGAGGTCGGCGGGGGTGGTCGCCATCGCCGCGTACAACGGCCCGCAGAGCACGGTCGTCTCCGGCGAGGCGGCGGCGGTGCAGCAGCTCGTCGAACGCGCGGCCGCGGACGGGATCGAGACCCGCCGGATGGCGATCCCTCACGCGTTTCATTCCCCGCTGGTCGATCCGATCCTGCCCGAGTTCCGGCGGGCTGCCGCGGCGGTGCAGTTCGGCAGGCCGAGGCTGACGATCGTCTCCAACGTGACGGGCCAGGTGGCCGACGCCAGCATCGCGACCGCCGACTACTGGGTGCGCCACCTGCGCGAGCCGGTGGCGTTCGCGAAGGGCGCTCGAACGCTCCGCGAGCTCGGCTGCCGCCTGTTCGTCGAGCTCGGCCCCAAGCCGGTGCTCCTCAACCTGGCCCGGGAGGCCGTCGCGCCCGGGCCGGAGGGGCCGGTTTGCAAGTTCCTGCCCACGCTGCGCCGCGGCGTCTCCAGCTGGCACGCGCTGCTCGAGGCCATGGCCGAGCTCTACTGCGAGGCCGCCGCCATCGACTGGGAGGCGCTCGATCGCGAGCATGCGCGCCAGCGCGTGCGCCTGCCGACCTATCCGTTCCAGCGCCGCCGCTACTGGGTCTCGCCGGCGAGCAGCTCGGCCGGGCGTCCGGGGGAGGCCTGGGGCGGCGGAGCCGCGCCGCAGCACCCGCTCCTCGGCGCCGCCGTCGACCTCGCGGCGAGCCAGGAGCAGCGCTTCGAGTCGCTCGTCCGCGGCGGTGGGAGCGAGTACTGGAGCGACCACCGCGCCCACGGGCGCGCGGTGATGCCGGCGGCGGCGTTCGCCGAGGCGGCGCTCGCCGCCGCGCGCGCGCTGAAGGGCGACGGCGCCGTCGCCGACCTGTCGTTCCCCGAGCGCCTCGCGCTCGACGAGGGCGAGGCCGCGCGCCTCCAGAGCGTGGTGACGACCTCCGGCGAGGACCGGGAGCTGCGGGTCTTCTGCCGGAAGGCGGAGGGCGGCGGAGCCTGGGCCCTGGTCGCCGCCGCGCGGCTGCCCCGCCTGGGCGGGCAGGAGGACGCCCCAGGCGAGCCGCTCCAGGCGCTCGAGGCCCGGATCGCCGGGGCGGTCGACGTCCAGGCGCATTACGAGCGGCTCGGCGAGCGCGGGCTCGACTACGGCCCGCGCTTCCGCGCCCTCGTCGGCCTGTCCGTGGCCGAGGGGGAGGCGCTGGCCCGGATCGAGCTCCCCGCCCGGCTCACGGCGCAGGCAGGGCGGTTCGTCATCCACCCTGTCCTGCTCGACGCGGGCCTCCAGGCGCTCCTGGCGACGCTCCCCGGCGACGGGGCCTCCGGCCATGCCGTCGCCGGCATCGAGCGGCTCTCCGTCGCCTCCGGCATCGGAAACGACCTCCGGGCGCACGCGAAGCGCCGCGGCCCGGGGGCGGACGCCGCATCGGACGTCGTGTTTTACGACGCGTCGGGGCGGGTCGTCGCGCGGATGCTGGGCGTGACGCTCCGGCAGAGCGCGTCGCCGCGGGAGCTCGGCCGGGAGCGCGGCGAGCTGGAGCGGTGGTTGTTCGAGGTCCAGTGGCGCGCGTCGATCGACCGGGTGACGCCGGACGGCCTGCCGACCCCGCCAGCGCTCGTGGACCACCTGATGCCGGAGATCGAGCGGCTCTCGGGGGCGAGCGCGCTCGCGCGGTACGCCGAGCCGATCCAGGCGCTCGAGCGGGCGGCCGGGGAGTACGGGAGGCAGGCCCTCTCGGACCTCGGGTGCAGGTTCGAGGTCGGACAGCGCTTCACCGCCGCCGAGCTGGCGGAGCGGCTCGGCGTCGTCCCGCGCCACCAGCGCCTGCTCGGGCGCCTGCTCGAGATGCTCGCGGAAGACGGCGCGCTCGAGCAGGTGGGCGGCGCGCTCCGGGTCGTCGAGCGGCCGCGCGCGGGCGACCCCGCGGCCCTCCTGCGGGCGCTCGTGCAGCGTTTCCCGGAGTGCGACGCGGAGTGCACGATCCTCGAGCGCTGCGGCCCCCGCCTCGCCGACGTCCTCCGGGGCAACAGCGACCCGCTGGAGCTCCTGTTCCCCCGCGGGGACGTCGGCACCGCGGAGAAGCTCTACCAGGACTCTCCCGGGATCCAGCGGCTCAACAAGCTCGCAGCGGGGGCGCTCCGGGAGGCCATGTCGCGCCGGCCCGCGGGGACGTCCGTGCGGCTGCTCGAGGTCGGCGGCGGGACGGGCGGGACGACCCAGCACCTCCTGCCGGAGCTCCCGGCCGATCGCTGCGAGTACGTGTTCACCGACATCTCCCCGCTCTTCGTCACGCTGGCGGGCAGGAAGTTCAGGGAGTTCCCGTTCGTCACCACGCGCGTCTACGACGTCGAGAAGGAGCCGACCGCTCAAGGGCTGGAGCGCGGCCAGTTCGACGTCATCCTCGCCGCCAACGTCCTGCACGCGACGGCCGACCTGCGCGCCGTGCTGGAGCACCTGCGCGCGCTGCTGGCGCCGGGGGGCCTCTTGCTGCTCATCGAGGCCACCGGCAAGCGGCGCTGGCTGGACCTGACGTTCGGGCTCACCGAGGGCTGGTGGCGCTTCTCCGACCTGGATCTGCGGGGATCGTACCCGCTGCTCTCGCAGCCGAGGTGGCTCGAGCTGCTGCGCGAGGCCGGCTTCGAGAGCCCGGTCGCGCTCGCCCGCGCCGGAGAGCCGGAGGCGGCCGGCGCCGCCGCGGTGCTCGTCGGGAGGGCCGCGGCCGCCGCCCCGCGGGCGCGCCACTGGCTGATCTTCTGCGACAGCGCCGGCGTGGGCGACGCCTTGGCCGACCAGCTGGCGCGCGAGGGCACCCCGTGCAGCCGCGTGCGCCGGGCCCCGGAGCCCGGTGGGTTCCGCTGCGTCGACCGGGGCCGCTACGAGATCGACGCGCGCGAGCCGGCGCACTTCGCGAGGTTGCTCGCGGACGCGGCGAGCTCCGGCGGCGAGATCTCGGACGTCGTCCACGCGTGGAGCCTGGACGTGCCCCGGGCTCCCGATCTCGAGCCGGCGGCGCTCGAGCGGGCGTCCGACCTGACGGCCGGCGTCGCGCTGCACCTCGTGCAAGCCATCGCCCGGCGCGGGGCGGCGAGCGCGCCGCGCGTGAGCTTCATCACGCAGGGCGCGGTCGCGGCGAGCCCGCGCGACGCGGTCAGCGGCGTCGGCCAGGCGCCGCTGTGGGGTCTGGGCGCTGTCCTCGAGCAGGAGCACCCGGAGCTCAGCAGCGCCCTCATCGACATCGACGACAGGGGGCGCGACGCCGCCGCGGAGCAGATCCTGCGCGCGCTGCGGGGCGACGCCCGCGAGAGCCGGATCGCCCTGCGCGATGGCCAGCGGATCGTACCGCGCCTCGCGAGCTACTCCCCTGCCTCGCGCGGCGGCGAGGGGGATCCAGGGGCTCGGCCGGGCGTGACCGCCGAGGGGACGTACCTCATCACGGGCGGCCTCGGAGGGCTCGGGCTGGTGTTCGCCCGCTGGCTCGTGGACAGGGGAGCTCGCCGGCTGGTGCTGATCGGGCGCCGCGGGGCGAGCCCGGCGGCGGAGCCCGCGCTGGAGGAGCTCCGCCGCGCCGGGGCCGAGGTGATCGTCGAGAGCGCCGACGTCGCGTCGGAGGCGCACCTCACGAGGTTGCTGGCCGCGATCCGCGCGTCGGGCCGCCCGCTGCGCGGGGTCATCCACTCGGCGGGGCTGCTCGATGACGGCATCCTGCTCCAGCAGACCGCCGCGCGCTTCCAGCGCGTCCTCTCCCCCAAGGTGCAGGGCAGCTGGCTCCTGCACCGCCTCACCGCCGGTGATCCTCTCGATTTCTTTGTCCTTTTCGGCTCCTCCGCGGCGCTCATGGGCAACCCCGGCCAGGCCAACCACGTCGCCGCGAACGCCTTCGAGGACGCCCTGGCCCACCACCGCCGCGCCCTGGGCCGGTGCGCCCTCACGATCGACTGGGGCGCGTGGGCCGACGTCGGCGCGGCGTCCGACGAGAAGACGCGGGAGCGGCTCAAGGCGCGCGGCATGGGGCTCATCCCCACCGACGCCGGCGTGGAGATCTTCGAGCAGCTGCTGCGGCGGGCTCCCGCTCAGGTGGGGGTCATGCCGCTCGAGCCGCAGCGGTTCGTCGGGCAGCTCGCGGGCAGCGGCGCCTCGCGCTTCTTCTCCGAGCTCGCCGCCGCGGGGCCGAGCGCGGGGCAGGGGCGCCCCGGGGCGCACGCGAGGGCGCAGCGCAACCGCGAGCTCCTGGCCAGGCTCGACGCGGCCTCGGCCCAGGAGGGCGAGGCGCTGCTCGTGCGGTACCTCGACGAGCGCCTGAGAGAGGTCCTCCGGGCCGGCGGCGATCAACGCCTGTCCCACGACGTGTCGTTGAACGACCTCGGCCTCGACTCGCTGATGGGCATGGATCTGAAGAACATGCTCTCGCAGGAGCTGGACGTGGACGTGCCCGTCGATCGCTTGATCCAGGGGATCAGCATCCGCGCGCTCGCCGCGTACGTGTACGAGCAGGCCGCGTTGAAGAGGCTCGTGGCATCGAAGGGACAGGAGCAGGGGAGCTCCGCGGATCACGCCGCCGACGTGGAGGAGCTCGTTCTATGA	MSVAKLAYVAQQMRAKRVVTEPIAIVGMGCRFPGGADSPEALWKLLADGRDGLTDVPPGRWDVDALYDPEPGSPGKLYTRRGAFLREVEEFDASFFHISPREATVMDPQQRLLLEVSWEALEHAGISATSLRGSSTGVFVGVMHHDYAQLLVDARRFDMHAGSGSGMSVAAGRLAYVLGLEGPTLALDTSCSSSLVALHLACQSLRESECDLALVGGVNLMLSPLTTIIECQMRMLSPSGLCRAFDARADGFVRGEGCGVVVLKRLSDALASRDNIMAVIRGSAVNHDGATSGLTVPNGRAQQQVIRQALSHACVLPEQVSYVEAHGTGTSLGDPIEVEALGAIFGRGRSRNAPLFIGSIKSNIGHTEGAAGVAGLMKVVLSLQHGRLPPSLHFEIPNPHIRWSELPIEVVDRARDWAAPEDRRIAGVSSFGFSGTNAHLVLEQAPVLELAPPPPERPVHVLGLSAKSPEALVQVAERYVERLMAADTLELGAVAYTANAGRAHHEHRLAVVATSSVEACEKLSRFAKEGASPGVIAARADARAATKIGFLFSGQGAQYPGMGRDLLESDPTFRSSLQACDELLRPHLEVPLLEVLSAGEGAGDRIHTGIYSAVTTFAVEYALSELLRSWGVVPSWVMGHSLGEYAAAQAAGLLTLEDALKLVVRRGQLVETLRTKGAMATLFAAPELVGERIARSAGVVAIAAYNGPQSTVVSGEAAAVQQLVERAAADGIETRRMAIPHAFHSPLVDPILPEFRRAAAAVQFGRPRLTIVSNVTGQVADASIATADYWVRHLREPVAFAKGARTLRELGCRLFVELGPKPVLLNLAREAVAPGPEGPVCKFLPTLRRGVSSWHALLEAMAELYCEAAAIDWEALDREHARQRVRLPTYPFQRRRYWVSPASSSAGRPGEAWGGGAAPQHPLLGAAVDLAASQEQRFESLVRGGGSEYWSDHRAHGRAVMPAAAFAEAALAAARALKGDGAVADLSFPERLALDEGEAARLQSVVTTSGEDRELRVFCRKAEGGGAWALVAAARLPRLGGQEDAPGEPLQALEARIAGAVDVQAHYERLGERGLDYGPRFRALVGLSVAEGEALARIELPARLTAQAGRFVIHPVLLDAGLQALLATLPGDGASGHAVAGIERLSVASGIGNDLRAHAKRRGPGADAASDVVFYDASGRVVARMLGVTLRQSASPRELGRERGELERWLFEVQWRASIDRVTPDGLPTPPALVDHLMPEIERLSGASALARYAEPIQALERAAGEYGRQALSDLGCRFEVGQRFTAAELAERLGVVPRHQRLLGRLLEMLAEDGALEQVGGALRVVERPRAGDPAALLRALVQRFPECDAECTILERCGPRLADVLRGNSDPLELLFPRGDVGTAEKLYQDSPGIQRLNKLAAGALREAMSRRPAGTSVRLLEVGGGTGGTTQHLLPELPADRCEYVFTDISPLFVTLAGRKFREFPFVTTRVYDVEKEPTAQGLERGQFDVILAANVLHATADLRAVLEHLRALLAPGGLLLLIEATGKRRWLDLTFGLTEGWWRFSDLDLRGSYPLLSQPRWLELLREAGFESPVALARAGEPEAAGAAAVLVGRAAAAAPRARHWLIFCDSAGVGDALADQLAREGTPCSRVRRAPEPGGFRCVDRGRYEIDAREPAHFARLLADAASSGGEISDVVHAWSLDVPRAPDLEPAALERASDLTAGVALHLVQAIARRGAASAPRVSFITQGAVAASPRDAVSGVGQAPLWGLGAVLEQEHPELSSALIDIDDRGRDAAAEQILRALRGDARESRIALRDGQRIVPRLASYSPASRGGEGDPGARPGVTAEGTYLITGGLGGLGLVFARWLVDRGARRLVLIGRRGASPAAEPALEELRRAGAEVIVESADVASEAHLTRLLAAIRASGRPLRGVIHSAGLLDDGILLQQTAARFQRVLSPKVQGSWLLHRLTAGDPLDFFVLFGSSAALMGNPGQANHVAANAFEDALAHHRRALGRCALTIDWGAWADVGAASDEKTRERLKARGMGLIPTDAGVEIFEQLLRRAPAQVGVMPLEPQRFVGQLAGSGASRFFSELAAAGPSAGQGRPGAHARAQRNRELLARLDAASAQEGEALLVRYLDERLREVLRAGGDQRLSHDVSLNDLGLDSLMGMDLKNMLSQELDVDVPVDRLIQGISIRALAAYVYEQAALKRLVASKGQEQGSSADHAADVEELVL	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	533.65	gnl|BL_ORD_ID|1968|hsp_num:0	1943			447	1239	isoniazid
BGC0000380.1|Leupyrrin_20 # 48758 # 53011 # 1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.730	BGC0000380.1|Leupyrrin_20 	48758	53011	+	Loose	1000	105.916	almE	30.08	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGAGCCTGGGTGAGCTGTTCTCGGATCTCTCGCAGCGCGGGGTCCAGCTCTGGGTCGAGGGGGACGCCCTCCGCATCCGCGCGCCGGCCGGCGCGCTGACGCCGAACGTGCGCGCGTCGCTCGCGACGCACAAGGCGCAGATCGTCTCCTTGCTGAAGCGGATGGAAGCGGGGACGCAGGCCAGCGACGCCCCGATCGAGCGGGCGCCGCGCGACCTGCCCATCGAGCTCTCCGCCGCCCAGAAGCGCATGTGGTTCCTCCATCAGCTCGACGGCGAGACGGGCGCTTACAACGTGCCGGTCGCGGTCCGGATGGACGGGCCGCTGAACGAGCGCGCCCTCGAGCTCTGCTTCACCGAGATCCTGCGCCGGCACGAGGCGCTGCGCGCCACCTACCAGCTCGTCGAGGGCAAGCCGGTGCAGGTGATCGCCGAGGAGGCGAGCTCGCCGCTCCGGGTCGTCGATCTCGGCGACCTCGACCCCGCGGCGCGAGAGGAGCGGGTCCGCGAGCTGCTCGCGCTCGAGGCGCGCCAGCCGTTCGACCTGGCCAAGGGACCTGTGGTCCGGGTGCTGCTCATCCGCCTCGGCGAGACCGCCCGGGTGGTCAGCATGACCATGCATCACATCGCGCTCGACGGCTGGTCGCGGGCCGTCTTCATCCGGGAGCTCGCCGCGCTCTACCGGGCTACCTGCGACGGGCTCCCGTCCCCGCTCCCCGAGCTGCCGCTTCAGTACGCGGACTTCGCCCGGTGGCAGAACGCGTGGCTCGCCACCGGGGCCGCGGCCGCGGAGCTGTCGTACTGGCGCGAGCAGCTCCGCGACCTCCCCGAGCTCCTGGAGCTGCCCACGGATCACCCCCGGCCGCCCACGCCGAGCTACCGGGGCGGCGTGTGGCGGTTCGAGCTCGACCGGGAGCTCGCCGAGCAGCTCCGCCGCCTGAGCAGCGCCTCCTCGGCGACGCTGTTCATGACCCTCCTGACCGGCTTCGTCGTCCTCCTGTCGCGGTACTCCGGCTCCTCGGACATCACGGTGGGGTCGCCGATCGCGAACCGCCTCCGCCCGGAGATCGCGCCGCTCATCGGGTTCTTCGCCAACACGCTCGCGCTGCGGACGTCCACCGACGGCGATCCGACGGTCGAGGAGCTGCTCGCGCGCGTGCGCAAGGCGTGCCTGGACGCCTACGCGCACCAGAACGTGCCGTTCGAGCACCTCGTCGAGGAGCTGAGGCCCGCGCGGAGCGTCGACCGGACGCCGATCTTCCAGGTCATGTTCGCGCTGAACGTCCCGACGCCGAAGCTGGAGCTCTCCGGGATCGAGATCACGCCGATCGAGCTGGGCGGGGTCACCTCCAAGTTCGATCTCGCGCTGTCCCTCGAGGAGAGGGAGGCCGGGCTGGTCGGGTGGTTCGAGCACAGCGCCGACCTGTTCGACGCGGAGACCGTGGCGGACATGGCCGCCAACTACCGCGCCGTGCTCGAGGCCATGGTCCGCGACCCCGCGCGGCCGATCGGCGCGCTGCCCGTCCTGTCGGCCGAGCAGGCCGCGCGGCTCGATCGGTGGAACGACACCCGCGCCGCGGGGCGCGCGCAGACGGTCGTCGAGCGCTTCGACGCGATCGCCGCCCGGTGGCCCGAGGCCATCGCGGTGGAGGACGGGCCGGCCCGCGTCAGCTACGGCGAGCTGAGCCGGCGCGCCGCCCGGCTCGCGCGCCGCCTCGTGGCCGAGGGCCTCGGGCCGGACGAGATCGTGGGGATCCAGCTCGAGCGCTCGGTCGAGCTGATGGTCGCCCTGCTCGGCGTGCTGAAGGCGGGCGGCGCGTTCATGGGGCTCGACCCCAGCCTGCCGAGGCGGCGGATCGAGGCGATGACGGAGGCCGTCGAGGTGCGCTTCGTCGTCACCGACGATCGCGCGAGGGACGGCGCGGTGCAGGGGACGCGCTCGACCCTGCGCATCGAGGACGCCGCGGCGCCCGGCCCCGAGGACGGTCGCCCGCTCGAGCTCCGGTGCTCGCCCGACTCGCTCGCCTACGTGGTGTTCACCTCGGGCTCCACCGGCAAGCCCAAGGGCGTCGCCATGCCGCACCGGTGCCTCGACAACCTCCTTTCGTGGCAGGTGGAGCGCTTCGCGTGGCGAGCGCGCACGCTCCAGTACACGGCTTGCCACTTCGATGTCTTCTTCCAGGAGGTCCTCTCCACGTGGGCCTCGGGGGGCACGCTGGTGCTCGTCTCCGAGCCGGTCCGCCGCGACCCGGTGGCGCTCCTCGGCCACATCAAGCAAGCGCGGGTCGAGCGGTGGTTCGTGCCGTTCGCGGCGCTTCAACAGCTCGCCGAGGTGCACCGAGCGGGCCTGTCCGACGTACCGGAGAGCCTCCGCGAGGTGATCACGGCGGGGGAGCAGCTCCAGGTGACGCCCGCCATCGAGGGCTTCTTCGCGGGCGGCCTCGTCTCGCTGGAGAACCAGTATGGGCCCTCCGAGACGCACGTGGTCACCGCGTTCCGCCTCACCGGGCCGAGCCACACCTGGCCGCGGCTGCCCCCCATCGGCCGCCCGATCAGGAACACCCAGGTCCACGTGCTCGACCGGAATCAGCAGCGCGTCCCCGCCGGCGTCACCGGCGAGCTGTACCTGGGAGGGGAGGGGCTCGCCCGCGGCTATCTCGGGGCCACGCCCGAGGACCGGAGCCGCTTCATGCCCGATCCGATCAGCGGCCGCCCCGGGGCGCGCCTCTACCGCACCGGAGACTTCGCGCGCCTCGGCCGCGACGGAGAGCTCGAGTACCTGGGCCGCCGGGATCAGCAGGTCAAGATCCGCGGCCACCGCGTGGAGCTCGGCGAGATCGAGGCGGCGCTGTCGCGTCACCCCCTCGTGCGCGAGGTGGCCGTGCGGTGCGAGCAGGAGGGCGATCGCAAGTTGCTCGCCGCGTACGTCGTGCTCGCCTCGGAGCCCGGCGACGGGGGCGCGGAGGCGGCCGCCGCCCTGCGGGAGCACCTGCGCGAGCTCTTGCCGGCGTACATGATCCCCGACCGGTTCGCGGCCCTGCCGGCGCTGCCTCGGAGCCGCACGGGCAAGATCGACCGGATGGCGCTGGCCACGGGCGCTCACAGGAGCCTCGGGCCCGGCGTCGCGCCGCGCCCCGATCGCGGGCGAGCGCCGCGCGGGCCGCTGGAGCAGGCGCTGGCAGACATCTTCTGCGGCCTCCTCGACATCTCCGACGTCCGCGACGACGCGAGCTTCTTCGAGCTCGGCGGGCATTCCCTGCTCGCCACGCAGCTCCTGTTCCGGGTGCGCGAGCGGCTCGCCGTCGACCTGCCGCTCCAGCAGGTCTTCGCGACGCCCACGGTCGCAGGCCTCGCCGCGTGGCTCTCGAAGCAGAGCGCGCGCAGGGCCGCCCCGCTGCCCCCTTGCATCCTCCCGCTCCACGGCCGCGGCGACGGGCGCCCGTTGTTCCTGCTGCCGCCCAACGTCGGCAGCCCCTCGTGCTACGCCGACCTCGACTGGCCCGCGCAGCAGCGGGTCTATGGGCTCCAGCTGCCGGGCCTGGTCGACGGTGCCGAGCCCCTCGGGTCCATCGAGCAGATGGCGTCGTATTGCGCGGCCGCCCTGCGCGCGGTGCAGCCCGAAGGGCCCTATCTGCTCGGCGGATGGTCGCTCGGCGCCGTGCTGGCGCTGGCGACCGCCATCGAGCTCGAGTCTCAGGGGCAGGAGGTGCGCCTGGCGGCCCTGATCGACGGCGGGTACGTGCCCGGCGCCGCCGACAGGTCGTGGTGGCAGCTGCCCACCGCGGGGCCGCGGAGCTTCTTCCGCGCGGCCAAGGTGATGCGCGAGGCCGGAATCCCGACCTCGTACGAGGAGCTCCGCCGCTGGACGCGGTGGTGCGGGCTGCTGCTGCCGGACTCCCCGCACGAGCTGCGCGAGCGCGAGCTCGCCCTGCACCTCCAGTATCTCGGCTCGGCGGGCCGGCAGGCGACCCGGGCCTTCGAGATGGCGCGGAGGAACGTCTTCGCGGCGGCCCGCTACAGCCCTGCGCCTTACGGCGGGAAGATCACGCTCTTCCGGAGCGAGCATCACCGGGGCAAGGAGGACCCGCTCGTGGAGCGGCTCCGTCGCGTCGCGCGGGGCGGCGTGGAGGTGATCTACACGCCGGGCAATCACATGACGATGATGCTGGACGCCGAGATGAGGAGACATCTATCGAGCAAGCTCAACGAGCAGCTCCTTTCATCCGAGGGCGGAAAGGCCGTGGTGCAGAGATGA	MSLGELFSDLSQRGVQLWVEGDALRIRAPAGALTPNVRASLATHKAQIVSLLKRMEAGTQASDAPIERAPRDLPIELSAAQKRMWFLHQLDGETGAYNVPVAVRMDGPLNERALELCFTEILRRHEALRATYQLVEGKPVQVIAEEASSPLRVVDLGDLDPAAREERVRELLALEARQPFDLAKGPVVRVLLIRLGETARVVSMTMHHIALDGWSRAVFIRELAALYRATCDGLPSPLPELPLQYADFARWQNAWLATGAAAAELSYWREQLRDLPELLELPTDHPRPPTPSYRGGVWRFELDRELAEQLRRLSSASSATLFMTLLTGFVVLLSRYSGSSDITVGSPIANRLRPEIAPLIGFFANTLALRTSTDGDPTVEELLARVRKACLDAYAHQNVPFEHLVEELRPARSVDRTPIFQVMFALNVPTPKLELSGIEITPIELGGVTSKFDLALSLEEREAGLVGWFEHSADLFDAETVADMAANYRAVLEAMVRDPARPIGALPVLSAEQAARLDRWNDTRAAGRAQTVVERFDAIAARWPEAIAVEDGPARVSYGELSRRAARLARRLVAEGLGPDEIVGIQLERSVELMVALLGVLKAGGAFMGLDPSLPRRRIEAMTEAVEVRFVVTDDRARDGAVQGTRSTLRIEDAAAPGPEDGRPLELRCSPDSLAYVVFTSGSTGKPKGVAMPHRCLDNLLSWQVERFAWRARTLQYTACHFDVFFQEVLSTWASGGTLVLVSEPVRRDPVALLGHIKQARVERWFVPFAALQQLAEVHRAGLSDVPESLREVITAGEQLQVTPAIEGFFAGGLVSLENQYGPSETHVVTAFRLTGPSHTWPRLPPIGRPIRNTQVHVLDRNQQRVPAGVTGELYLGGEGLARGYLGATPEDRSRFMPDPISGRPGARLYRTGDFARLGRDGELEYLGRRDQQVKIRGHRVELGEIEAALSRHPLVREVAVRCEQEGDRKLLAAYVVLASEPGDGGAEAAAALREHLRELLPAYMIPDRFAALPALPRSRTGKIDRMALATGAHRSLGPGVAPRPDRGRAPRGPLEQALADIFCGLLDISDVRDDASFFELGGHSLLATQLLFRVRERLAVDLPLQQVFATPTVAGLAAWLSKQSARRAAPLPPCILPLHGRGDGRPLFLLPPNVGSPSCYADLDWPAQQRVYGLQLPGLVDGAEPLGSIEQMASYCAAALRAVQPEGPYLLGGWSLGAVLALATAIELESQGQEVRLAALIDGGYVPGAADRSWWQLPTAGPRSFFRAAKVMREAGIPTSYEELRRWTRWCGLLLPDSPHELRERELALHLQYLGSAGRQATRAFEMARRNVFAAARYSPAPYGGKITLFRSEHHRGKEDPLVERLRRVARGGVEVIYTPGNHMTMMLDAEMRRHLSSKLNEQLLSSEGGKAVVQR	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	254.86	gnl|BL_ORD_ID|4935|hsp_num:0	5928			588	1629	colistin A; colistin B
BGC0000380.1|Leupyrrin_21 # 53008 # 54138 # 1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.667	BGC0000380.1|Leupyrrin_21 	53008	54138	+	Loose	400	26.1794	EreD	28.0	3004608	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide esterase	ATGAGCAAGTATCGTGTCCTGTCGTTCGACGGCACCTCGGGGAGCGGCAGGCTCGGTTACATCGGCGCAGGTCTCCTCAAGGAGATGCACGCGCTCGCGCAGCAGCAGGGCGCGTCCATGATGAAGAACGTCGACGTGTTCGCCGGGACCTCGGGCGGGGCCTGGAACGCGCTGTTCTTCGCGATGCACGACGACCCGGAGGCAGCGCTGACCGACGTGCTCGACTTCTGGCAGAACGTGGTCGACTGCATGCCGGCCGTGGACAAGCAGACGGTGTCGATCATGCGCGAGCTGCGCGCGCTCACCGGCGGCGCGGCGGTCGTCAACACGAGGCGCGTGCGCGACTTCTTCATCGACTACTTCGGGCGCAACACGAAGCTCGGGGACCTCAAGCAGAAGGTTGTGATCCCGGCGTTCAAGCTCGACAACCGGAAGGCTCGGCGCCGGCACTGGAAGGTCAAGATCTTCAACACGATGAGCCCGAACGAGCCGGATCTCGACGAGCTGGTCGTGGACGTCGCCATGCGCACCAGCGCGTCTCCGGTCATATCGCCCATCTTCCAGTCGATCTTCTACAGGGGGCCCGGCTACATCGACGGCGGCGTCTTCGCGAACGACCCGTCGATGGTCGCCCTCGCGCAGGTCCACTCCGATGCCGTGCTCGGCAGCGGCTCGGGCAAGGAGATCCTCCTCCTCTCCGTCGGCAACGGCCGGCGGCTCCAGTACATCGAGCCGAAGTTCGAGAACGGCATGGCCGACTGGGGCTATCGCCCCTGGCTCCTCAACCTGTTTCAGCCGTTCGCGCTGGTCGATCTCGTGATGGAGGCGAACATGATGACCACGACGTACCAGTGCAAGCGGCTCCTCCGGGATCGATACTTCCGCATCGATCCCGACGTCACGCAGAGCGACGGCCTCTCGACTCAGGACGTGTACGCCGCGGTAGAGACCGAGGTGGCGCAGCAGAACACGCAGAACACGGTGACGCGCGCGTTCGCGTGGCTTCAGGCCTCGGGCTGGCTCATGCCCCTCTGCGACGGCCGCGGCGAGGCGGCGCCGGGCGCGGGCGCCGAGGGGCCGGGGGCCGCGGCGCCGAACGGACACCACGAGCTTGGCCAGGTGATCGGATGA	MSKYRVLSFDGTSGSGRLGYIGAGLLKEMHALAQQQGASMMKNVDVFAGTSGGAWNALFFAMHDDPEAALTDVLDFWQNVVDCMPAVDKQTVSIMRELRALTGGAAVVNTRRVRDFFIDYFGRNTKLGDLKQKVVIPAFKLDNRKARRRHWKVKIFNTMSPNEPDLDELVVDVAMRTSASPVISPIFQSIFYRGPGYIDGGVFANDPSMVALAQVHSDAVLGSGSGKEILLLSVGNGRRLQYIEPKFENGMADWGYRPWLLNLFQPFALVDLVMEANMMTTTYQCKRLLRDRYFRIDPDVTQSDGLSTQDVYAAVETEVAQQNTQNTVTRAFAWLQASGWLMPLCDGRGEAAPGAGAEGPGAAAPNGHHELGQVIG	MKNIKPLTFPFNSENNTSIKQSLFRFREYFDSSTIVGLGENSHFIKEFFTFRHQVIEFLVTECDFDTLAFEFGFSEGLEVDKWIKSQIPFDDLDKLLSHFYYPNEFKDTLLWLRRYNQDNNNQITFLGVDIPKNGGSYFPNFRIVSDYLQRLSIVSSDVLQKILNLAEKFDFYSTSQLALNLSLFDEAEHNELKALLLKVYIRLVTLQPKLESLEFQSILHQVKGLIYMNYNADAMESFITEKGIEGDMGAKDQYMAESIDWFLKNSLGKKIILVAHNAHIQKTPVDFDGFISCYPMGQRLSMTFGEKYKAFAITNLRGETAALYPDNDYQFGFRVDKFPLDSPESDSVEFFMQELSGKECCLIINKSKELKNCSKIRFDSIYLKTEIVDSFDGIFLIEKSTVSEIVD	92.16	gnl|BL_ORD_ID|1193|hsp_num:0	3305			399	681	erythromycin
BGC0000380.1|Leupyrrin_23 # 55402 # 56826 # 1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=14bp;gc_cont=0.675	BGC0000380.1|Leupyrrin_23 	55402	56826	+	Loose	450	31.187	OXA-664	34.69	3004479	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGATGCAAACTTCGTCAATCCCTGGTCCGACGCTCCGGCAAGCCCCGAGCTATGCTTACAGGCTGGCTCGCGATCCGTTCAAGCTGCTCCTGGAGGTCAGGCAGGAGTACGGCGACGTCGTGTCGATGGAGCGCCTGGGCGTGCCGCGCACGTACTTCGTCGCATCGCCTGACGGCGTGAAGCGAATCTTCTTCGAGAACAACCGCAACTACGTCCGGGGGAGCAATTTCCGGAACGTCGAGAAGGTGGTCGGCTACGGCATCGTGGTCAGCGAGGGCGACTTCTGGAGGCGCCAGCGCAAGCAGGTCCAGCCGGCGCTCGCGGCCTCGGTGATAAGCACCCAGGTGGACGCCATGGGTGAGGTGGTCGAGTCGATGCTGCGGCGCTGGAGCGCCGAGGCGGTCCACCAGGACTGGGTGGACATCGCCGCGGAGATGCGCGACGTGACCCGGAGGGTCGCCCTGAAGATCATGCTCGGCATCGACCTGGAGCGCGAGACGAAGGACATCTCCGAGACGTGGGAGGCGATGTACGACGCGCTGACGGAGTTCACGACCAACCCGTGGAAGATCCCGCTGTCGATACCGACGCCCTGGAACCGCCGCTTTCTCCGCACGATTGACCAGCTGAACCGGCGCGTCTACGGGACCATCGGCGAGCACCGGCGCTCCCCCGACGCGCCGGGCGATCTGGTCCGGGACCTGCTCGCCGCGAGGGATCCCGTCACCGGCAAGCCCATGACCGAGCGCCAGCTGCGCGACGAGCTCGTGACGGTGGTGAGCGCGGGCTTCGACACGGCGGCGGTCACCCTCGGCTGGACGTGGTACCTCCTGTCCCAGAACCCCTGGGCCGAGCAGCGGATCGCGGAGGAAGTGCGCCAGGTCATCGGCGATCGCCGCCCGACCGCGGAGGACCTGCCCAAGCTCACCTACACGAAGCTGGTGCTCCAGGAATCCATGCGCCTCTACCCGGCGGCCTGGGTGCTCACCCGGACGAGCGTCAGCGACGACGAGATCGGCGGCTACAAGATCCCGGGCAACTCGATGGTGATCACCAGCGCGTACGTCACCCACCGCCACCCTGATCACTGGGAGAACCCGAGCGTGTTCGATCCGGAGCGCTTCACGCGCGAGCGCTCGGCGAACCGCTCGCGGTTCGCCTTCTTCCCCTTCGGCGACGGCCCGCGCAAGTGCCCGGGAGAGCACTTCGCGCTCGCCGAGATGATGTCGGTCATCGCGATGGTCAGCCAGCGCTACCGGCTGAACATGAAGCCGGATCACCCGATCGCGCTGGAGCCGAGCTTCACGATGCGCGCGCGCCACGGCTTGCTCATGCGCCTCGAGCCGAAGCGCCCCGCCGCCGCGAGCGTCGCTGCTCAAGGCGCGAGCCCCTCCGGGGCCATTGCACAAGGGATGGGACAGTGA	MMQTSSIPGPTLRQAPSYAYRLARDPFKLLLEVRQEYGDVVSMERLGVPRTYFVASPDGVKRIFFENNRNYVRGSNFRNVEKVVGYGIVVSEGDFWRRQRKQVQPALAASVISTQVDAMGEVVESMLRRWSAEAVHQDWVDIAAEMRDVTRRVALKIMLGIDLERETKDISETWEAMYDALTEFTTNPWKIPLSIPTPWNRRFLRTIDQLNRRVYGTIGEHRRSPDAPGDLVRDLLAARDPVTGKPMTERQLRDELVTVVSAGFDTAAVTLGWTWYLLSQNPWAEQRIAEEVRQVIGDRRPTAEDLPKLTYTKLVLQESMRLYPAAWVLTRTSVSDDEIGGYKIPGNSMVITSAYVTHRHPDHWENPSVFDPERFTRERSANRSRFAFFPFGDGPRKCPGEHFALAEMMSVIAMVSQRYRLNMKPDHPIALEPSFTMRARHGLLMRLEPKRPAAASVAAQGASPSGAIAQGMGQ	MWMLKTISCSVLSWMLLSACSQQTLKDQMQQPLMMQQPRLAELNHMFQAVDSAVVFVTYDGEKLQRFGNDLHRAETAYIPASTFKILNALIGLQQHKTTTTEVFVWDGKARALKSWERDMTLAEAMQVSAVPVYQTLARRIGLPLMQKELHRVDYGNAQIGTQVDRFWLDGPLKITPQQEAEFAYRLATQTLPFDIHVQQEVKEMLYVERRGVAKLYAKSGWGADVKPQVG	205.19	gnl|BL_ORD_ID|2588|hsp_num:0	2909			504	651	cloxacillin; oxacillin; cefalotin
BGC0000380.1|Leupyrrin_24 # 56932 # 58128 # 1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=14bp;gc_cont=0.651	BGC0000380.1|Leupyrrin_24 	56932	58128	+	Loose	400	36.965	Erm(30)	29.41	3001265	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGCGATGTTCGGTCTCTCCCGCGCTGTGCGCGCGTGACCGCCGCGTCCAGGCGTTCCGAAGACACGAGCCCGCGGATGCCGTGATTCCTCAACGAGCGGAGAGGCGCCTCGAGTGGCCGCGAGGGTTCGAAGGCGCTTACCGGATGCAGAGGTCCCGTACAATGTCCCTGAGCACAAGCCTTGAATACAAGCTGTACAGGTATATGTTCGACGCGCCGGCGTCGTTTCGACAGCTGCAGGCAAAGTTCGCATATCAGCTGATCTCGAAGGGGCTGGAGCCCATGCTCCAGAAACGAAGCGAGGCGGGCGCGGATCGGAGCACGGACATCGAGACCGTGAGCTCGACGTTCATGGACTACGGCTACATGGACGAGCGGTTCCGGGAGAACCCGCTCCCGCTCAAGGCGCACCACGAGCCGTGCCGTTACGCCATTCAGCTGTACCACCACGTGGTCGGCGACCTCGGCGTGAAGGGCAAGCACGTGCTGGAGGTCGGGTCGGGGCGCGGCGGCGGCAGCAACTACGTCGCCGAGTACCTGGAGCCCGCGAGCGTCACGGGGCTCGATCTGTCCTCGGCGGCCATCGACTTTTGCCGTCGCGCGCACACGGCGGATCGCCTGACGTTCGTGGAAGGCACCGCGATGGACCTGCCTTTCAAGGACAGCTCGTTCGACATCGTGATGAACGTCGAGTCGTCGCACTGCTACCCGTCGTTCGACAAGTTCCTGAGCGAGGCCGCGAGGGTCCTGCGGCCTGGGGGTCTCTTCTCCTGGGTCGACGCGAGGTTCGATGACAGGCTGCTCGATCTCGAGCGCTCCTTCGCCCTGTCCGGCCTGGACCTCGTGCGGCAGACGGACATCACGCAGAACGTCGTCCAGGCGCTCGACGCCATCTCCGACGACAAGAAGCGGGTGATCGAGGAGAAGATTCCGCGGCCGTTCCGGCCCCTCATCATGTCGGGCGTCGCCGTGCGCGGGACGCTTGTGTACAACGCGCTCGAGTCCGGGAAGCTGCGTTACCTGAGCAAGGTGCTGCGCAAGCCGGACCGCGCCGCGGGCGAGGAGGCGAACTACCCCTTCGACTGGAGCGCCGCGGAGCGGTTCGATCCCGGCGCAGGGTCGACGTTGCGCCGGTTCCAGCGCACGAAGACCTGGATGAGCCGATACATCTCCAGCAAGAAGCCGACCATCATTTGA	MRCSVSPALCARDRRVQAFRRHEPADAVIPQRAERRLEWPRGFEGAYRMQRSRTMSLSTSLEYKLYRYMFDAPASFRQLQAKFAYQLISKGLEPMLQKRSEAGADRSTDIETVSSTFMDYGYMDERFRENPLPLKAHHEPCRYAIQLYHHVVGDLGVKGKHVLEVGSGRGGGSNYVAEYLEPASVTGLDLSSAAIDFCRRAHTADRLTFVEGTAMDLPFKDSSFDIVMNVESSHCYPSFDKFLSEAARVLRPGGLFSWVDARFDDRLLDLERSFALSGLDLVRQTDITQNVVQALDAISDDKKRVIEEKIPRPFRPLIMSGVAVRGTLVYNALESGKLRYLSKVLRKPDRAAGEEANYPFDWSAAERFDPGAGSTLRRFQRTKTWMSRYISSKKPTII	MAMRDSIPRRADRDTLRRELGQNFLQDDRAVRNLVTHVEGDGRNVLEIGPGKGAITEELVRSFDTVTVVEMDPHWAAHVRRKFEGERVTVFQGDFLDFRIPRDIDTVVGNVPFGITTQILRSLLESTNWQSAALIVQWEVARKRAGRSGGSLLTTSWAPWYEFAVHDRVRASSFRPMPRVDGGVLTIRRRPQPLLPESASRAFQNFAEAVFTGPGRGLAEILRRHIPKRTYRSLADRHGIPDGGLPKDLTLTQWIALFQASQPSYAPGAPGTRMPGQGGGAGGRDYDSETSRAAVPGSRRYGPTRGGEPCAPRAQVRQTKGRQGARGSSYGRRTGR	118.45	gnl|BL_ORD_ID|1123|hsp_num:0	1224			96	333	narbomycin; methymycin; pikromycin
BGC0000380.1|Leupyrrin_25 # 58220 # 59170 # 1 # ID=1_25;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.669	BGC0000380.1|Leupyrrin_25 	58220	59170	+	Loose	350	26.1794	SatA	26.03	3005045	protein homolog model	n/a	n/a	nucleoside antibiotic	antibiotic inactivation	streptothricin acetyltransferase (SAT)	TTGAAGCGCCTCGGTCAAGACATCGTCCTCTGGCGCCAGAGCTCGGGCAACGTCGCCTGCCTGATCGATCGATGCCCCCACCGCGGCGCGAAGCTCAGCGTCGGGCGCGTCGCGCAGGGGTGCATCGAGTGCCCTTATCACGGGTTCCTGTTCGACGCGGGCGGCGCGTGCCGCTATGTCCCCGCCAACGGCGCCGATCGCCCGGTCCCGAAGGGCCTGCACGTCGACTCCTGGCCCGTTCGCGAGGAGCACGGGCTCATCTGGGTCTGGTGGGGTGAGTCGCGCAGCGAGTACCCCCCGGTGCCTTGGTTTCCGCAGCCTGCCAGCGACGAGGCGCACGCGGCCGAGTCGTCGGGCGTCTACAACTTCCACTACGCCCGCGCGATCGAGAACGCCCTCGACGCGCACCACTTTCCGTTCATTCACGGGTCGATCAGCCCCAACGTCGGCACGCTGATCGATCCTTTCAAGGCGGAGTTCGACGGCGAGACCATCCGCGTCGTCGCCGGCCTGAAGAGGAGCCGCTCCGAGTCGGACGAGGAGGCGGTGCTCTTCAACATGGCCTTCAAGTTCCCGAACGTCTTCTTCGTCCGGCTCCACGACAAGATCCGCCTCATCCAGGTGACCACGCCGGTGGACGACAAGTCGACGTGGGCCTACGTCCGCTATTATCAGACGTTCGTCTCGGTGCCGGTCCTCGGGCGCATCCTGTCTCGCTTCCTCATGGTGGGCGACGCCAAGCTCGCCCAGGAGCTGCAGGACGTCCCCGTCTTCCAGACGCAGACCCCGCACAAGCCAGGTCTGGACTGCGGCTACAAGTTCATCGTCGCCGATCGAGGTATCTACTACTACCTGACGGAGCGGCAGCGGCGGATCGATGCGGCGAAGGCGAAGAAGCTCCCCGTCCTCCAGCCGAGCGACGAGGCGCCGGCCCTGCCCGGCGAGGCGTGA	MKRLGQDIVLWRQSSGNVACLIDRCPHRGAKLSVGRVAQGCIECPYHGFLFDAGGACRYVPANGADRPVPKGLHVDSWPVREEHGLIWVWWGESRSEYPPVPWFPQPASDEAHAAESSGVYNFHYARAIENALDAHHFPFIHGSISPNVGTLIDPFKAEFDGETIRVVAGLKRSRSESDEEAVLFNMAFKFPNVFFVRLHDKIRLIQVTTPVDDKSTWAYVRYYQTFVSVPVLGRILSRFLMVGDAKLAQELQDVPVFQTQTPHKPGLDCGYKFIVADRGIYYYLTERQRRIDAAKAKKLPVLQPSDEAPALPGEA	MSLLIRELETNDLDNFPEIDDSFIVNARLMLSLSKVNRRIEYTVEDVPSYEKSYLQNDNEELVYNEYINKPNQIIYIALLHNQIIGFIVLKKNWNNYAYIEDITVDKKYRTLGVGKRLIAQAKQWAKEGNMPGIMLETQNNNVAACKFYEKCGFVIGGFDFLVYKGLNMTSDEVAIYWYLHFDS	171.74	gnl|BL_ORD_ID|2775|hsp_num:0	3788			33	252	streptothricin
BGC0000380.1|Leupyrrin_26 # 59322 # 60062 # 1 # ID=1_26;partial=00;start_type=ATG;rbs_motif=GGGGGG;rbs_spacer=12bp;gc_cont=0.641	BGC0000380.1|Leupyrrin_26 	59322	60062	+	Loose	375	33.4982	nalD	41.86	3000819	protein overexpression model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; peptide antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; sulfonamide antibiotic; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGCCATTGAATCCACGAACGGCGCTTCAACGGGCAGGGCTGCCGAGCGAGCAGCCATCATCGCGGCCGCCCTGAGCCTGATCGCGGAAGAGGGTTACACGCGCACGTCGATGACGTCGATCGCGCTCAAGGCCGGCTTGAAGCCGGCTGCGTTGCATCGGTCGTTCCAGACGAAAGATCAGATCTTGATCGCCTTCTTCCACGACAGCCTGGAAGCGTCCTTCAACAAGGTACAGGCGATCGATGGGTTCGAGGATTTCTCGCTGCAAGAGAAGCTGCACGCGCTCATCGAGACCCAGCTGGAGCACCTGCTGCCGCACCGCGAGGTGCTCGGGGTGGCCGTCCTCGCCATCGGCGCGAGGGCGCTCCGCAACAGCCGGGAGATGAGCGCGCTGCGCCGCCGCTTCGAGGAGATCATCAAGGGATACGTCCGTGAGGCGATCAGCAAGGGGGAGCTCCCCGACGTCAACGTCGAAGGCCTGACGGTCCGCTCCTTCACGGATCTCCACAGCACGATTGTCGTCTACTGGCTGCGCGACTCGTCCGAAGGCTTCACGAAGACCACGGAGTTCATCAACCGCAGCCTGGAGCTGTTGGTCTCGACGCTGGTCATGGAAAATCGGCTGGGGGGGATGGCGAGCTTCCTGTTCTACCCGGAGAGCCTGGGCGCCCTCGCGAGCCGGCGGCCGGTGGTGAGCGCGCTGCTCCGCAAGATTTTCGACGGCCAGCGCACGTCCTGA	MAIESTNGASTGRAAERAAIIAAALSLIAEEGYTRTSMTSIALKAGLKPAALHRSFQTKDQILIAFFHDSLEASFNKVQAIDGFEDFSLQEKLHALIETQLEHLLPHREVLGVAVLAIGARALRNSREMSALRRRFEEIIKGYVREAISKGELPDVNVEGLTVRSFTDLHSTIVVYWLRDSSEGFTKTTEFINRSLELLVSTLVMENRLGGMASFLFYPESLGALASRRPVVSALLRKIFDGQRTS	MRRTKEDSEKTRTAILLAAEELFLEKGVSHTSLEQIARAAGVTRGAVYWHFQNKAHLFNEMLNQVRLPPEQLTERLSGCDGSDPLRSLYDLCLEAVQSLLTQEKKRRILTILMQRCEFTEELREAQERNNAFVQMFIELCEQLFARDECRVRLHPGMTPRIASRALHALILGLFNDWLRDPRLFDPDTDAEHLLEPMFRGLVRDWGQASSAP	116.04	gnl|BL_ORD_ID|2335|hsp_num:0	1213			33	162	erythromycin; ciprofloxacin; tetracycline; ceftazidime; ceftriaxone; meropenem; novobiocin; azithromycin; trimethoprim; sulfamethoxazole; chloramphenicol; aztreonam; colistin A; colistin B; ampicillin; nalidixic acid; panipenem; ticarcillin; trimethoprim-sulfamethoxazole
BGC0000380.1|Leupyrrin_28 # 62201 # 63649 # 1 # ID=1_28;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.684	BGC0000380.1|Leupyrrin_28 	62201	63649	+	Loose	200	25.409	vanX gene in vanI cluster	30.0	3003725	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanX; glycopeptide resistance gene cluster	ATGACCACCGGCACCGCCATGCAGCCTGATGGGGCTGCCCTCCCCGGCACGGGTTCCCCGCCGGCCGCCTCGAGCGGAGCGACCTTTGCGCGCTACGCGACCAACGCTGAACGGGAGCATGGCTTCGAGCCGCTGCGTATCGAGGGTCGCATCCCGGAGGGGCTGCGCGGCACGATGTACCGCAACGGCCCTGGTCTGCTCACCACGTTTAACCAGCCCTACGAGCACTCCTTCGAGGGCGACGGCGCCGTCAGCGCTGTCCGGCTCGATGGGCTCGAGCAGCGCGCGACCGGCGCCTACCATGTGGTCGAGAGCGAGGGGCTCCGGTTCGAGCGCGACGCAGGTCGGCCGATGTTCTCCTCGCGGGCGCCCTGGCGGACGCGCATGGGCAATGCGCTCCGACGTCGATTCAAGAACAATGCAAACACGAGCATCCTCGTCTGGCGCGATCGGCTCTTCGCGCTGGCGGACGGCGCCCGTCCCACCGAGCTCGACGCTGGGATGCTGACGACCGTCGGCGAAACGGATCTCGACGGGCTCATCGCGCAGACCTTCTCGGCCCATCCGCACGACGTGGTGGCCCGCTCCTCGATCTACAACTTCGGTGTTCGCTTCGGGCGCAAGACGCAGATCGACCTGTTTGAGCTGCCTTACAAGCACCGCCCGGCGAGGCGGCTCGGCCAGGTCGAGCTCGCCCATCCCGTCATGCTGCACGATTTCGTGGCCACCGAGCGCCACCTGGTCTTCCTGGTGTCGCCTGCGCGCCTCGTCCTCTGGCGCGCCGCGCTCATGCTCACGCCGGTATCGAAGCTGGTGCGCTGGTCCGAGCAGGACGGCACGGAGGTGATCGTCGTTCCGATCGACGCGCCGCGCTCCGTGACGCGCTTCCGCGTGGACCCTTTCTTTCAGTGGCATTTCGCGGGCGGCTTCGAGAGGGGAGGCGAGATCGCCGTCGATCTGGTGCGGTATCCGAGGCTCAATTCGTTGCACCAGACGGGCGAGCGCGCGGCTCGCTGCGGGACCTACCATCGGGCCATCATCGACCTGGCTCGCCGCAGCCTGACCTCGACCGAGGTGACCCCTGTGGGGTGCGAGTTTCCGCAGATCGATCCGCGCCGATCCGGGAGCGCTTTCCGCTACGCGTGGTGCGTGGCGGACGGCGCCGCGGGCGACTCCATCACGCGCATCGACACCGAGACAGGCAAGACGGTGGTGTACGACCTGGCCGCTTCGGAGCGCGCCTCGGAGCCGCTCTTCTGGCCGCGCGCGCCGGATTCCGGCGAGAGCGACGGATGGGTCCTCTCGCTGATCTACGACGCGAGCACGCATACGAGCCACGTGGCCGTGTTCGACGCCAACGGGTTGCAAGACGGCCCGGTGGCGCGGGTGCACTTCGACCATCACGTGCCTCCCACGTTTCACGGCAAGTGGGTCCCTTCACCGGCTTAG	MTTGTAMQPDGAALPGTGSPPAASSGATFARYATNAEREHGFEPLRIEGRIPEGLRGTMYRNGPGLLTTFNQPYEHSFEGDGAVSAVRLDGLEQRATGAYHVVESEGLRFERDAGRPMFSSRAPWRTRMGNALRRRFKNNANTSILVWRDRLFALADGARPTELDAGMLTTVGETDLDGLIAQTFSAHPHDVVARSSIYNFGVRFGRKTQIDLFELPYKHRPARRLGQVELAHPVMLHDFVATERHLVFLVSPARLVLWRAALMLTPVSKLVRWSEQDGTEVIVVPIDAPRSVTRFRVDPFFQWHFAGGFERGGEIAVDLVRYPRLNSLHQTGERAARCGTYHRAIIDLARRSLTSTEVTPVGCEFPQIDPRRSGSAFRYAWCVADGAAGDSITRIDTETGKTVVYDLAASERASEPLFWPRAPDSGESDGWVLSLIYDASTHTSHVAVFDANGLQDGPVARVHFDHHVPPTFHGKWVPSPA	MKSDFVFVDELVSGIRWDAKYATWDNFTGKPVDGYAANRIVGTRALCAALEKARENAASLGFGLLLWDGYRPQCAVDCFLRWSKQPEDGRTKQKHYPNIDRSEIIEKGYVAAKSGHSRGSAIDLTLYHLASGTLVPMGGDFDLMDSVSHHGAHGISQAEARNRQYLCSIMEASGFVSYACEWWHYSLKHEPYPNTYFDFLIA	238.61	gnl|BL_ORD_ID|2066|hsp_num:0	2243			285	435	vancomycin; teicoplanin
BGC0000380.1|Leupyrrin_29 # 63733 # 64854 # -1 # ID=1_29;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.661	BGC0000380.1|Leupyrrin_29 	63733	64854	-	Loose	500	25.7942	APH(3')-Va	29.03	3002649	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3')	ATGTACAAGGATCATCCTCTCGGTAATCTGGACGAAGGAGCCGTCCTTGGCGGGCCCTGGCCGGGGATCCAGCTCTTCTATCCGCTGGTCAAGTACTCGCCGGCCCTCGGAGCTTACGAGAGCATGGATCAGGCCAGGGCCCGCATGCGCAGGCACAGCCACGGCATCCAGGCCCATACGGTCGTGTTCGACCTGGAGGACGGCTGCCGGCAGAAGGCGATGAGCCGCGAGCTGCTGCGCCACGAGCTACCTCGTATCGCCCCCGAGCGCAAATTCCAGATAGCCGTCCGCATCAACCCGTTCCGCACCGAGGAGTACAACGAGGACCTCTCCCTTATCGAGGAGGTCGCCGATTGCATCGACGTCATCGTCCTGGCGAAGGCCGCCGAGGTCCACGGGGCGGCGGAGGTTCGCGACCTGTCCGCGTGGGTCGTAGGTCTCGGCAAGGATATCACCATCCAGCCGATCATCGAGCACCCCCGCGCCCTGAAGGCCGCGCCCGAGCTCATGGCCTTCCCGACCGTGAAGCACGTGGTGTTCGGCACCCACGATTTCGCGAGAGCCATGGCGATCCACCTCACCCCGAAGAACTGGATCGCCGAGCTGCGCACCTACCTCGACATCCTGCTGCTCGAAGCCCGCATCGCCGGCAAGGGCGTGATCGGCGGCGTCGAGGTGCTGATCAATCACGCCCCCATGCCCGAGGCGTGCGTCGAGCCCGGCGATGTGCGCAGCTGGATGGAGCTGCACGGCGACCACGATCTGCACGTGGTCTTCCAGCATGCGCTCGCGGAAGCGCAGATGGGCATGACCGGCAAGCCGGTCATCCACCCCAAGCACGTCCACGTCTGCAAGGTCGCGTTCACGCCGTCGCCGATGCAGATCCGCCGCAACGTCGAGATCCTGAAGGCGGCGCTCGAGGCCGACGCCCTGCTCGGCGGCGCCATCACCTTCGAGGGCGAGATGCTGGACCCGGCGATGTTCGGCAAGGCCCTGCAGGGCCTGCTGCGCGCCAACGCGCTGAAAGCGCTGGCGGACGCCGACAAGCAGTTCGCGCTCGACGTGATGAAGCGCCTTCCAGCCCATGTGCTCCGGGTAAACTGGCCCTACGGGACCATCTGA	MYKDHPLGNLDEGAVLGGPWPGIQLFYPLVKYSPALGAYESMDQARARMRRHSHGIQAHTVVFDLEDGCRQKAMSRELLRHELPRIAPERKFQIAVRINPFRTEEYNEDLSLIEEVADCIDVIVLAKAAEVHGAAEVRDLSAWVVGLGKDITIQPIIEHPRALKAAPELMAFPTVKHVVFGTHDFARAMAIHLTPKNWIAELRTYLDILLLEARIAGKGVIGGVEVLINHAPMPEACVEPGDVRSWMELHGDHDLHVVFQHALAEAQMGMTGKPVIHPKHVHVCKVAFTPSPMQIRRNVEILKAALEADALLGGAITFEGEMLDPAMFGKALQGLLRANALKALADADKQFALDVMKRLPAHVLRVNWPYGTI	MDDSTLRRKYPHHEWHAVNEGDSGAFVYQLTGGPEPQPELYAKIAPRAPENSAFDLSGEADRLEWLHRHGIPVPRVVERGADDTAAWLVTEAVPGVAAAEEWPEHQRFAVVEAMAELARALHELPVEDCPSDRRLDAAVAEARRNVAEGLVDLDDLQEERAGWTGDQLLAELDRTRPEKEDLVVCHGDLCPNNVLLDPGTCRVTGVIDVGRLGVADRHADIALAARELEIDEDPWFGPAYAERFLERYGAHRVDKEKLAFYQLLDEFF	139.18	gnl|BL_ORD_ID|30|hsp_num:0	38			45	231	neomycin; ribostamycin; paromomycin
BGC0000380.1|Leupyrrin_30 # 65353 # 66198 # 1 # ID=1_30;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.661	BGC0000380.1|Leupyrrin_30 	65353	66198	+	Loose	400	25.7942	QnrB80	36.59	3003192	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic target protection	quinolone resistance protein (qnr)	TTGCGGCCCGATCGATACGTCAAGTGCCAGGAGGCGGGGGCAGACATCAGCCTGGTCGATCTCGAGGATTCGGTCTCCGGCAACGACAAGCATGTAGCCCGTAAGGAGGCGGAGCGGTTCTTCACCGCGAAGGCTTCTGGCAGCGGTCTCCGTGCCGTCCGCATCAACGCGATCAGCCATCAGGAGGGTCTGCGCGATCTGCTCGCCATCCTCGATTACGCGGCGAAGCCGGACATCATCGCCATCCCGAAGGTGGAGTCTCCTCGCGACGTGGAGATCGCCGAGCTCGTCCTGCGGGATCAGTGCAGGGAGACGGGCTACCTCGCCATCGTGGAGACAGCGCGGGGGATCGAGAACGTCTTCGACATCGCGCGATCGTCCTCGCGGCTCAGAGCGCTCGTGTTCGGCTCGGCCGATTACTCCTTCAGCATCGGCTCGTCGATGTCGGACGGCGTTCTCTACCATGCTCGATCGAGGATCGTCACGGCGGCGCGGGCCGCAGGTATCCACGCGATCGATACGGCCTGCTTCGACATCCGGAACACGGCGCGGCTCGACGCCGAGGCGCGGATGTGCAGGGAGATGGGCTTCAGCGGCAAGGCGGCGATCCATCCCTCGCAGCTGCGCTGGATCAACGCCGCGTTCTCCCCCGACGACGAGACGCTGGAGAAGGCGCGACGCATCGTCGCGGCGAGCCGCGAGAGCAATCAAAATGTCTGTGTCGTCGACGGCATGATGGTCGGGATCCCGATCGTCGATGCGGCCCGGCGCATCCTCTCCGAGTTCGACGGCGGCGGCCGGGGCGAGGCTCCTCTGCGCGAGGGCCCTCGAGAGAGCGACGGGTAG	MRPDRYVKCQEAGADISLVDLEDSVSGNDKHVARKEAERFFTAKASGSGLRAVRINAISHQEGLRDLLAILDYAAKPDIIAIPKVESPRDVEIAELVLRDQCRETGYLAIVETARGIENVFDIARSSSRLRALVFGSADYSFSIGSSMSDGVLYHARSRIVTAARAAGIHAIDTACFDIRNTARLDAEARMCREMGFSGKAAIHPSQLRWINAAFSPDDETLEKARRIVAASRESNQNVCVVDGMMVGIPIVDAARRILSEFDGGGRGEAPLREGPRESDG	MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALDIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG	131.31	gnl|BL_ORD_ID|4921|hsp_num:0	5912			222	345	ciprofloxacin; levofloxacin; moxifloxacin; gatifloxacin; nalidixic acid; norfloxacin; sparfloxacin
BGC0000380.1|Leupyrrin_31 # 66306 # 66833 # 1 # ID=1_31;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=6bp;gc_cont=0.652	BGC0000380.1|Leupyrrin_31 	66306	66833	+	Loose	475	25.7942	Bla2	27.69	3004189	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	subclass B1 Bacillus anthracis Bla beta-lactamase	ATGGACGAACAGCGAAGCGGTTACAAGAGGGTAGGAGAGCAGCGGTACAGGGAGGTCATCGGCTTCGACTACGAGGACTTCGTGGTCGGCGACGTCTTCGAGCACCGGCCCGGGCGGATGGTGACAGAGGCCGACAACGTGTGGATGTCGACGCTCTGCATGAACCAGTCGCCTCTGCACATCGACGGCGCGTACGGCGAGCATACTCCATGGGGCAAGCCCCTCGTGTCGAGCCTGGTCACCTTCTCGATCGTGAATGGGATGAGCGTGCGGAGCACGAGCGGCCGCGCGCTCGCGAACCTCGGCTGGGACAGGGTGCGGCTCGTGAAGACGGTGTTCGTGGGGGAGACGCTCTACGCCGAGAGCACGATCCTCGCGAAGCGGCTCTCCGCGTCGCGCCCGGGGCAGGGGATCATCACGTGCGAGACGCGTGGCACCAAGGCGGACGGGGAGGTCTTCCTGACGTTCGAGCGGAGCTTCCTCGTCGCCACGCGCGAGCACAGCATGAACGATAAGGCGAGGTACTGA	MDEQRSGYKRVGEQRYREVIGFDYEDFVVGDVFEHRPGRMVTEADNVWMSTLCMNQSPLHIDGAYGEHTPWGKPLVSSLVTFSIVNGMSVRSTSGRALANLGWDRVRLVKTVFVGETLYAESTILAKRLSASRPGQGIITCETRGTKADGEVFLTFERSFLVATREHSMNDKARY	MKNTLLKLGVCVSLLGITPFVSTISSVQAERKVEHKVIKNETGTISISQLNKNVWVHTELGCFNGEAVPSNGLILNTSKGLVLVDSSWDDKLTKELIEMAEKKFKKSVTDVIITHAHADRIGGIKTLKERGIKAHSTTLTAELAKKNGYEEPLGDLQAITKLKFGNMKVETFYPGKGHTEDNIVVWLPQYNMLVGGCLVKSASAKDLGNITDAYVNEWSTSIENVLKRYENINFVVPGHGEVGDKGLLLHTLDLLK	68.36	gnl|BL_ORD_ID|2423|hsp_num:0	2836			210	402	
BGC0000380.1|Leupyrrin_32 # 66918 # 68339 # -1 # ID=1_32;partial=00;start_type=TTG;rbs_motif=GGG;rbs_spacer=6bp;gc_cont=0.672	BGC0000380.1|Leupyrrin_32 	66918	68339	-	Loose	900	28.4906	emrB	33.33	3000074	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	TTGCCATCCGCAGTCCAAGGCTATCGCTACAACGCCGACCCGATGGGGTTCATCGAAGAGTGCGCGGCGCGCTATGGCGACTGTTTCACCCTGCGCTTTCCGCTGCAGCCGGCGGCCGTGTATGTCAAGAGCCCGGAGGTGGTGAAGCAGATCTTTGCAGGATCCACGGACGACCTGAGAATGGGCGAGGCCGCTGCGCCCATCGACTTCCTCCTGGGCAGCAATTCGCTCATCCGGCTGGACGGCGCACGTCACACGCGCGATCGCAAGCTGCTGATGCCGTCGTTCCATGGCGAGCGGATGGTGGCGTATGCAGAGATGATGCGGGTGATCGCGGAGCGCGCCGTGGATGGCTGGGAGCTCGGCAAGCCGTTCTCCTTCTTGAAGGCCGCGCAGAACATCACGCTCAGCATCATGCTCGAGTGCATCTTCGGCGTCGGGCCCGGGGAGCTGCACGACCGGCTCCGCGCGTTGCTCCCGAAGTTCCTCCACGAGAGCTCGAAGCCGATGATATCGCTCCTGTGGGCGACCGTCCCGGGGAAGCTGCTGCGCGACGTGCTCGTCCGGGGGCTCGCGCCCGCGGCCCACGCGCTTGGCCCAGCGGGATCGGTCGTGCCGGCGGGGACCTGGGCGCGGAGCCTCCGGGAGATCGATGAGTTCTTGTATTCCCATATCGCCGCACAGCGCGCGCGCCGCTCTCCAGAGGCGAGCGACATCATATCGATGCTGATCGAGGTACGCGACGAGCAGGGCAACGCATTTTCCGACGCGGAGCTGCGCGACGAGATGATGACGATGCTCGTCGCGGGGTACGAGACGACGGCCATCACGCTCACGTGGGCGATGGCGAAGATCCTCGAGTACCCTCACGTGCTCGCCGCGATCCGCGAGGAGCTCGACCGAGTCATCGGGGACCGTCCGCCGTCGGGAGCGGCGATCGGTGAGCTCCGGTACCTGGACGCGACGATCAAGGAGGTGCTCCGGCTCTATCCGCCCTCGCCCGGAACCGCACGCAAGCTGCACGTGCCTGGTCGTTTCGGCGGGTATGATCTCCCCGCGGGCGTCGTGCTCTATCCTTCGATCTACCTGCTGCACCGCCGGCCGGACATCTGGCCCGACCCTTTGCGCTTCGATCCCTCGCGATTCCTCGACAAGAAGCCGAACCCGGCGGCCTACATCCCGTTCGGTGGCGGGCTGCGCACGTGCCTCGGCATGTCCTTCGCGCTGTTCGAGCTGAAGCTCGTGCTGGCTACGATACTCTCGCGCGCCTCGCTGCGCGCCGTCGAGGCGCCGCCGCTCCGGTACGTACCGCGAGGCATCCTCTTGCCCTTCGGGCCGTCGCACGACGTGCCGGTGGCCCTCGAGGCGCGTGAGCCGAAGAGGCCGCGGCGGAGCGCCCAGGCCTCGGTCCTATCGAATTGA	MPSAVQGYRYNADPMGFIEECAARYGDCFTLRFPLQPAAVYVKSPEVVKQIFAGSTDDLRMGEAAAPIDFLLGSNSLIRLDGARHTRDRKLLMPSFHGERMVAYAEMMRVIAERAVDGWELGKPFSFLKAAQNITLSIMLECIFGVGPGELHDRLRALLPKFLHESSKPMISLLWATVPGKLLRDVLVRGLAPAAHALGPAGSVVPAGTWARSLREIDEFLYSHIAAQRARRSPEASDIISMLIEVRDEQGNAFSDAELRDEMMTMLVAGYETTAITLTWAMAKILEYPHVLAAIREELDRVIGDRPPSGAAIGELRYLDATIKEVLRLYPPSPGTARKLHVPGRFGGYDLPAGVVLYPSIYLLHRRPDIWPDPLRFDPSRFLDKKPNPAAYIPFGGGLRTCLGMSFALFELKLVLATILSRASLRAVEAPPLRYVPRGILLPFGPSHDVPVALEAREPKRPRRSAQASVLSN	MQQQKPLEGAQLVIMTIALSLATFMQVLDSTIANVAIPTIAGNLGSSLSQGTWVITSFGVANAISIPLTGWLAKRVGEVKLFLWSTIAFAIASWACGVSSSLNMLIFFRVIQGIVAGPLIPLSQSLLLNNYPPAKRSIALALWSMTVIVAPICGPILGGYISDNYHWGWIFFINVPIGVAVVLMTLQTLRGRETRTERRRIDAVGLALLVIGIGSLQIMLDRGKELDWFSSQEIIILTVVAVVAICFLIVWELTDDNPIVDLSLFKSRNFTIGCLCISLAYMLYFGAIVLLPQLLQEVYGYTATWAGLASAPVGIIPVILSPIIGRFAHKLDMRRLVTFSFIMYAVCFYWRAYTFEPGMDFGASAWPQFIQGFAVACFFMPLTTITLSGLPPERLAAASSLSNFTRTLAGSIGTSITTTMWTNRESMHHAQLTESVNPFNPNAQAMYSQLEGLGMTQQQASGWIAQQITNQGLIISANEIFWMSAGIFLVLLGLVWFAKPPFGAGGGGGGAH	92.38	gnl|BL_ORD_ID|1706|hsp_num:0	1847			168	339	nalidixic acid
BGC0000380.1|Leupyrrin_33 # 68648 # 69400 # 1 # ID=1_33;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.722	BGC0000380.1|Leupyrrin_33 	68648	69400	+	Loose	500	26.9498	mphN	36.84	3004542	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	ATGCGCAAGGCGCGTGAGCGGGTCGGTAACGACCGAACGGCGATTGGCTTTCTCGGCGGCGCCGCGCCTCGGTCGTCGAGAGGGCGCACGAACTTGACGGGCTCGTCACAGGTGCCGCGTTCTGGAAACCTTCGCGCCAAGCGAGATCTCCAGAGGAGACACGCGCGCGAAACATTGGGATCGAGGTGGGGCCACGCGAACGCTCGGCGGTGCCACGGTTCCCACACAGCCGACCTCGAATCGACTCGCAACGTCCCTGAAGGCCTGTCGGGCTCCGCGGGCGCGTGGCGGGCGGGCGAGCCGACCGCGCGCTCCTCGGTCACCTCGTCCACCGCGCGCGAGCCGTTGACCGCCCCGCGCCCGCACTCCTCCGCGCGCCGTCTGCTTGACCGAGCCCACGCCGTCGAGCGCGATTTGATCCACGACCACCACCTCGTCGAGGTTGATCGTTCCCTTCGTACGGTGGATCGAGATGCGCCGGACGCGCGGCTATCGGTCGCCCGCAGCACGCGCCCGCCTGCCGCTTCGTCTGCAGCATGCGGAGGCGTGCCGCGCGTCGTTCGCCGCGCGGATCGCGACGGCGGGGCAGACCGCGATCGCCGCGCGGGCGGCGATCACGAGGACGCGTGGAGCTCGATCTCGCCCGCCGCGAGCGCCCGGAGGTCGGCCGCGCGCAGCGCCTTGACGCGCCGCTCGAAGTCGCGGCTGTCGTCCTCGGTGAGCTTCGCCCCGCCGAAGCGGGCGCGCAGGTAG	MRKARERVGNDRTAIGFLGGAAPRSSRGRTNLTGSSQVPRSGNLRAKRDLQRRHARETLGSRWGHANARRCHGSHTADLESTRNVPEGLSGSAGAWRAGEPTARSSVTSSTAREPLTAPRPHSSARRLLDRAHAVERDLIHDHHLVEVDRSLRTVDRDAPDARLSVARSTRPPAASSAACGGVPRVVRRADRDGGADRDRRAGGDHEDAWSSISPAASARRSAARSALTRRSKSRLSSSVSFAPPKRARR	MNEFKRLAKNKGLDVLENSIVVNESGVDFQVAYAKDTLGSKWILRIPRRLDSMRSALKEKMALEIMEEHVSFQVPNWSIFDDELIAYKQLDGVPVATIDVEQQDYIWSFDKENTPQSYYQSLGKVLAELHTLPHRHFKEIGIKTLYARDLKSSMKIRMEKVRQKYHVNSELWERWQEWLANDSLWPSHVGVSHGDLHPGHILINKNFEVSGLIDWTEISIADTSVDFLSHLLLFGKDGLTKLLDAYDNAGGRTWSRMDEHIIELLTTSAITVAEFAEISDLQDMRETAAHMLAQNV	84.46	gnl|BL_ORD_ID|2689|hsp_num:0	3218			27	126	erythromycin
BGC0000380.1|Leupyrrin_34 # 69262 # 71436 # -1 # ID=1_34;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.729	BGC0000380.1|Leupyrrin_34 	69262	71436	-	Loose	1250	31.187	mecC	26.32	3001209	protein homolog model	n/a	n/a	penam	antibiotic target replacement	methicillin resistant PBP2	ATGAGATTCGGGATGGTGCATCGGATCATGACCGACGCGCTCGCGGCGCTCGGCGTCATCGCCCTCGTCGCGAGCGGCCAGTTCAACCGCTATGTGAGCTGGGCCATCCTCATCGGCCTCGCGCTCGCGCTCGTCGTGCGCGAGTCCTGGCAGCGGCACCCGGCGCTCCGCCACCTCGACACGGGCGTCCTCCTGGTCGTCATCGCCGTCCAGGTGGTCCGCATCGTCCTCACCGACGCGAGCGTCCTCGACGTGCTCGTGGAGTTCGCCGCCGCGCTGCAGATCATCCGGCTCGCGACGCGCAAGGGGGCGGCGCACGACCAGCAGGTCATCGTGCTGGCGCTGCTGCACCTCATCGCCGGGACCGTCCTCGGCGGCGGCCTCGGCTACGGGCTGTGCTTCATCGGCGTGCTCGTCGTCGCGCCAGGCGCGCTCGTGCTCAGCCACCTGCGGCGCGAGGTCGAGGGCAACTACCGGCAGGGGGCGCGCGACCGGACGGGGCTGCCTGTCGACGTGCCGCGCATCCTGCGCTCACGGCGGGTGGTCGGGCGCTCGTTCCTGGCCGTCACCTGCCTGCTGTCGATCCCGATCTTCGTCTTCACCGCGGCCCTCTTCGTCATCTTCCCGCGCGTCGGCCTCTCGCTGCTCCTGCTCAACCGCGGCCACACGGGGCGGATGATCGGCTTCTCGGGCAAGGTCGACCTGGGCGCGGTCGGCGTGCTGCGCAGCGATCCCAAGCTGGCGATGCGGGTCGAGATCCCCGACCTGCCGGAGCCGCCGCCCCCGCGCCTCACCATGCACCTGCGCGGCACCGCCCTCGACGCGTACGACGGCCGCACCTGGACCCAGAGCGAGAACTTCAAGCGCCCGACCGAGAGCGACGCGGGGCTCGTGCCGATCGAGCGGTACCCGGACCCGTCGGTCGACCCGGTGATGCGGATCGATCTCGAGCCGATCGATCCGCCCGTGATCTTCATCCCGCCGAACGCGACGGGGCTCCGGTTCAAGAACCGCGGGCAGCTCGGGGTCGAGGCGAGCACGATGGCCCACCGGGGGCCGGAGGGGGAATTCAGGTACCAGCCCCTGGACGACCGCGGGCTGGTCTACGACGTCTTCCTGTCGCGGAAGCGGTCGCCGACGTTCCAGCGCCTCTCGGCGGCCGACCGGCGGCGCTACCTGGAGCTCCCGAGGGACCTGCCGACGCGCGTCGCCGAGCTCGCGCAGACCTGGACGCGCGGCGTGGATCGCCCGGCGGACCGGGCGCGGGCCATCCAGGAGCACCTGCGCACGGAGTACCGGTACGACCTCGCGTCTCCGTCAGGCGCGGATCCGCACCCGCTCGATCACTTCCTGTTCGAGTCGAAGCGCGGGCACTGCGAGTTCTACTCGACGGCGATGGCCATCCTGCTGCGCGCGGTCGACGTCCCGACGCGCAACGTGACCGGCTTCGTCGGCGGCACCTACAACCGCTTCGGCCGGTTCTATGCGGTGCGCCAGGGCGACGCCCACTCGTGGGTCGAGGTCTACCTCGACGGCGAGGGGTGGATGACGTTCGACCCGACGCCGCCGGCCGACGCGGCGCCGAAGAGCGAGCTGGTCGGGGTCTGGGCGTACCTCCGCGACTTCATCGAGGCGACGAGCCAGCGCTGGGACAGGCACATCGTCGGCTACGACCTGAACCAGCAGGTGAGCCTGCTCCAGACGCTCACGTCGCGCTACCGGCGGTCCGGCTCGAGCGGCGACGTCGCGCTGTCGCGCCCGCGGCTCCTCGCGGTCGCCGCCGTCGCGCTCGCGCTCGGCGGCGGCCTGCTCTACTGGCGCTTCCGCCGCTCGCGCCGCGGGCGCGAGGAGAGCCGCGCGGGCGCCGGGCGCACCCCGAGCGCGCTCCTGGCGACCGCGCTGTACGAGAGCCTGGAGTCCGCGATGCTCGCGCAGGGCGTGCCGCGCCCCCCCAGCATGCCGCCGCTGCGCCACGCCGAGGCGCTGGCGCTCGCGGCGCACCCGCTGGCGCGCGAGATCCTGACGCTCACGCAGGTCTACCTGCGCGCCCGCTTCGGCGGGGCGAAGCTCACCGAGGACGACAGCCGCGACTTCGAGCGGCGCGTCAAGGCGCTGCGCGCGGCCGACCTCCGGGCGCTCGCGGCGGGCGAGATCGAGCTCCACGCGTCCTCGTGA	MRFGMVHRIMTDALAALGVIALVASGQFNRYVSWAILIGLALALVVRESWQRHPALRHLDTGVLLVVIAVQVVRIVLTDASVLDVLVEFAAALQIIRLATRKGAAHDQQVIVLALLHLIAGTVLGGGLGYGLCFIGVLVVAPGALVLSHLRREVEGNYRQGARDRTGLPVDVPRILRSRRVVGRSFLAVTCLLSIPIFVFTAALFVIFPRVGLSLLLLNRGHTGRMIGFSGKVDLGAVGVLRSDPKLAMRVEIPDLPEPPPPRLTMHLRGTALDAYDGRTWTQSENFKRPTESDAGLVPIERYPDPSVDPVMRIDLEPIDPPVIFIPPNATGLRFKNRGQLGVEASTMAHRGPEGEFRYQPLDDRGLVYDVFLSRKRSPTFQRLSAADRRRYLELPRDLPTRVAELAQTWTRGVDRPADRARAIQEHLRTEYRYDLASPSGADPHPLDHFLFESKRGHCEFYSTAMAILLRAVDVPTRNVTGFVGGTYNRFGRFYAVRQGDAHSWVEVYLDGEGWMTFDPTPPADAAPKSELVGVWAYLRDFIEATSQRWDRHIVGYDLNQQVSLLQTLTSRYRRSGSSGDVALSRPRLLAVAAVALALGGGLLYWRFRRSRRGREESRAGAGRTPSALLATALYESLESAMLAQGVPRPPSMPPLRHAEALALAAHPLAREILTLTQVYLRARFGGAKLTEDDSRDFERRVKALRAADLRALAAGEIELHASS	MKKIYISVLVLLLIMIIITWLFKDDDIEKTISSIEKGNYNEVYKNSSEKSKLAYGEEEIVDRNKKIYKDLSVNNLKITNHEIKKTGKDKKQVDVKYNIYTKYGTIRRNTQLNFIYEDKHWKLDWRPDVIVPGLKNGQKINIETLKSERGKIKDRNGIELAKTGNTYEIGIVPNKTPKEKYDDIARDLQIDTKAITNKVNQKWVQPDSFVPIKKINKQDEYIDKLIKSYNLQINTIKSRVYPLNEATVHLLGYVGPINSDELKSKQFRNYSKNTVIGKKGLERLYDKQLQNTDGFKVSIANTYDNKPLDTLLEKKAENGKDLHLTIDARVQESIYKHMKNDDGSGTALQPKTGEILALVSTPSYDVYPFMNGLSNNDYRKLTNNKKEPLLNKFQITTSPGSTQKILTSIIALKENKLDKNTNFDIYGKGWQKDASWGNYNITRFKVVDGNIDLKQAIESSDNIFFARIALALGAKKFEQGMQDLGIGENIPSDYPFYKAQISNSNLKNEILLADSGYGQGEILVNPIQILSIYSALENNGNIQNPHVLRKTKSQIWKKDIIPKKDIDILTNGMERVVNKTHRDDIYKNYARIIGKSGTAELKMNQGETGRQIGWFVSYNKNNPNMLMAINVKDVQNKGMASYNATISGKVYDDLYDNGKTQFDIDQ	108.87	gnl|BL_ORD_ID|742|hsp_num:0	810			1770	1977	methicillin
BGC0000380.1|Leupyrrin_35 # 71433 # 72665 # -1 # ID=1_35;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=7bp;gc_cont=0.732	BGC0000380.1|Leupyrrin_35 	71433	72665	-	Loose	1900	26.9498	MuxC	30.23	3004075	protein homolog model	n/a	n/a	macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGGGACAGAGGACCGGGAGCGGGGATCTCTCAGCGGCAGCTCCCGCGGCGCCGAGCGCGCCGACACAGCGACGCGCAGCGCCATCCGTCCGAGCAGGCCGAGGCGCGACAGGCCTCCGGTCGAGCAGCGCCCGCTGCGGCCCTCGCGCGGCGAGAAGGCGTCGCCGTGGACCCGGTTCCTCTTCGCCCTGAGGCCGCCCCGGAAGCTCAAGTTCACCCGGGAGGGGAAGTACTACCTCGGGATCACGCTGGGCGTCGGCTTCGCGGCGATCAACACGGGCAACAACCTGCTCTACCTGCTGCTCGGGATGCTGCTGTCGCTGATCGTCGTCTCCGGCGTGATGAGCGACCTGTCGCTCCGACACCTCACCGTGACCCGGCGGCTCCCGGCCCGCGCGCAGGTGGGCCGGGCGCACCTCGTCGAGATCGAGGTCTACAACCACAAGAAGCGCGTGCCGTCGTACGCGATCGAGGTCGAGGACCTGCGCGCGGGCCAGCCGGCCGATAAGCGCTGCTTCTTCCTGAAGATCAGCCCCTCGAGCGCGCAGGTGGCCGCCTACCGCCGGACGCCGGCGAAGCGCGGCCGCGACCGGCACACCGGCTTCCGCATCGCGACCCGCTTCCCCTTCGGGCTGTTCGAGAAGTCGCGCGAGGTCGAGGCCGAGGGCGATCTCATCATCTACCCCGCGGTCGACCCGGTCCGGCTCCCGGCCGAGGACGCCGGGCGGCGCGAGGGCGGCGCGAGCCTGAACGGGCGCGGGGGCGGCGACGAGACCTTCGGGCTCCGGCCGATGCGCGAGGGGGACGATCCGCGCGACATCTACTGGAGGAAGAGCACGATGCGCGACCAGATGGTGCTGCGCGAGCGGACCCGCGAGACGCGGCCCGACGTGCAGATCGTCGTCGACGCGGTGCGCCCCGCCGGGGAAGGCGACGGGTTCGCGCAGCTGTTCGAGCGCCGGATCCGCGAGGCGGCCTCGCGCGCCGTCGCCCACATCAAGCGCGGCGACGCCGTGGTCGTCGCGACGACGCTGGGCGAGCGGGTGCGCGGCGATCGCAACATCGGCTCCGACGCGATCCTCAGGTTCCTCGCGCTGCTCGACGCGGTGGAGGAGAGCCGGATGTCGGAGCTCAGGGCCGAGCGCGCCGCCCGGGCGTCCCAGCGCCAGGGCTCGAGCCCGGGCCCCAGCAGCGGCGAGCGCCGCACAAGCACCCCGAGGACCACCTCATGA	MGTEDRERGSLSGSSRGAERADTATRSAIRPSRPRRDRPPVEQRPLRPSRGEKASPWTRFLFALRPPRKLKFTREGKYYLGITLGVGFAAINTGNNLLYLLLGMLLSLIVVSGVMSDLSLRHLTVTRRLPARAQVGRAHLVEIEVYNHKKRVPSYAIEVEDLRAGQPADKRCFFLKISPSSAQVAAYRRTPAKRGRDRHTGFRIATRFPFGLFEKSREVEAEGDLIIYPAVDPVRLPAEDAGRREGGASLNGRGGGDETFGLRPMREGDDPRDIYWRKSTMRDQMVLRERTRETRPDVQIVVDAVRPAGEGDGFAQLFERRIREAASRAVAHIKRGDAVVVATTLGERVRGDRNIGSDAILRFLALLDAVEESRMSELRAERAARASQRQGSSPGPSSGERRTSTPRTTS	MSLSTPFIRRPVATTLLTLALLLAGTLSFGLLPVAPLPNVDFPAIVVSASLPGASPETMASSVATPLERSLGRIAGISEMTSSSSLGSTTVVLVFDLEKDIDGAAREVQAAINGAMSLLPSGMPNNPSYRKANPSDMPIMVLTLTSETQSRGEMYDLASTVLAPKLSQVQGVGQVSIGGSSLPAVRVDLNPDAMSQYGLSLDSVRTAIAAANSNGPKGAVEKDDKHWQVDANDQLRKAREYEPLVIHYNADNGAAVRLGDVAKVSDSVEDVRNAGFSDDLPAVLLIVTRQPGANIIEATDAIHAQLPVLQELLGPQVKLNVMDDRSPSIRASLEEAELTLLISVALVILVVFLFLRNGRATLIPSLAVPVSLIGTFAVMYLCDFSLNNLSLMALIIATGFVVDDAIVVVENIARRIEEGDPPIQAAITGARQVGFTVLSMTLSLVAVFIPLLLMGGLTGRLFREFAVTLSAAILVSLVVSLTLTPMLCARLLRPLKRPEGASLARRSDRFFAAFMLRYRASLGWALEHSRLMVVIMLACIAMNLWLFVVVPKGFLPQQDSGRLRGYAVADQSISFQSLSAKMGEYRKILSSDPAVENVVGFIGGGRWQSSNTGSFFVTLKPIGERDPVEKVLTRLRERIAKVPGAALYLNAGQDVRLGGRDSNAQYEFTLRSDDLTLLREWAPKVEAAMRKLPQLVDVNSDSQDKGVQTRLVIDRDRAATLGINVEMVDAVLNDSFGQRQVSTIFNPLNQYRVVMEVDQQYQQSPEILRQVQVIGNDGQRVPLSAFSHYEPSRAPLEVNHQGQFAATTLSFNLAPGAQIGPTREAIMQALEPLHIPVDVQTSFEGNAGAVQDTQNQMPWLILLALLAVYIVLGILYESYVHPLTILSTLPSAGVGALLALILCRSELSLIALIGIILLIGIVKKNAIMMIDFALEAERNHGLSPREAILEACMMRFRPIMMTTLAALLGALPLIFGIGGDAALRRPLGITIVGGLIGSQLLTLYTTPVVYLYLDRLRHWVNQKRGVRTDGALETPL	39.58	gnl|BL_ORD_ID|2367|hsp_num:0	2720			2544	2673	erythromycin; tetracycline; novobiocin; aztreonam; kitasamycin; rokitamycin
BGC0000380.1|Leupyrrin_36 # 72676 # 73596 # -1 # ID=1_36;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.721	BGC0000380.1|Leupyrrin_36 	72676	73596	-	Loose	525	25.409	AFM-1	40.91	3006890	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	AFM beta-lactamase	TTGAAGCTTCGCTCTGCCGTGGAGCAGGCCCTCGAAGGCAAGCCAGAGGCGGTCGAGCTGGCGCTCATCGCGCTGCTCGCCCGGGGCCATGTCCTCATCGAGGACGTGCCGGGCGTCGGCAAGACGACGCTTGCCCGAGCGCTGGCGAAGGCCGTGGGGGGCGAGCTCCGTCGCGTTCAGTTCACCAGCGATCTCCTGCCGAGCGACGTCCTCGGGGTGAGCGTCTTCGACCAGCGCCTCGGCCAGTTCGTCTTCCGCCAGGGGCCGATCTTCGCGAACGTCCTGCTCGCCGACGAGATCAACCGGGCGAGCCCGCGGACGCAGTCGGCGCTGCTGGAGGCGATGAACGAGGGGCAGGTGTCCATCGAGGGGACGGCGACGCCGCTGCCGGAGCCGTTCTTCGTGCTCGCGACCCAGAACCCCCAGGACTTCGCCGGCACATTCCCGCTGCCGGAGTCGCAGCTCGACCGGTTCATGGTGCGGATCCGGATCGGGTACCCGCCGCCGCAGGTGGAAATGCGGCTGCTCCTCCAGGGCGGCGAGCCCGATCGCGCGCGGAACGTGCCGCAGGTCATCGATCCCGCCCAGCTCGTGGCGCTGCAGCGCGAGGTCGACCGCGTCGAGCTCGACTCGTCGCTGGCGACCTACCTTCAGGCGGTGCTCGCGGCGACGCGCTCGAGCCCGACCCTCTCGCTGGGCGCGTCGCCGCGCGCCGGCATGAACCTGGCGCGCGCAGCCCGGGGGCGCGCCGTGCTCCACGGGCGCTCGTACTGTATCGCGGACGACATCCATGACCTCGCGGTCGCCGTGCTGGCGCACCGGGTCCGGCTCTCGGCCCACGCGGAGGGCTACATGCCGACCCGCGACGAGTGCGAGGCGGCCGTGCGCGACCTCGTGGCGCGGGTGCCGGTCCCGCTCTGA	MKLRSAVEQALEGKPEAVELALIALLARGHVLIEDVPGVGKTTLARALAKAVGGELRRVQFTSDLLPSDVLGVSVFDQRLGQFVFRQGPIFANVLLADEINRASPRTQSALLEAMNEGQVSIEGTATPLPEPFFVLATQNPQDFAGTFPLPESQLDRFMVRIRIGYPPPQVEMRLLLQGGEPDRARNVPQVIDPAQLVALQREVDRVELDSSLATYLQAVLAATRSSPTLSLGASPRAGMNLARAARGRAVLHGRSYCIADDIHDLAVAVLAHRVRLSAHAEGYMPTRDECEAAVRDLVARVPVPL	MITKSNIARIGLPLALAMALPGCIPGEIRPSIGEQVDKGDQRFGDLVFRQLAPNVWQHTSFMDVPGFGAVSSNGLIVKDGERVLLVDTAWTDDQTSQILNWIKQEINLPVALAVVTHAHQDKMGGMGALHAEAIPTYANALSNQLAPQEGMTAAQHSLTFAANGWVDPATAPNFGPLRVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTERYAASARAFGAAFPKANTIAMSHSAPDSRAAITHTARMADKLR	114.61	gnl|BL_ORD_ID|3287|hsp_num:0	4356			45	150	
BGC0000380.1|Leupyrrin_38 # 75148 # 75888 # 1 # ID=1_38;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.721	BGC0000380.1|Leupyrrin_38 	75148	75888	+	Loose	500	29.6462	NDM-10	40.62	3002360	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	NDM beta-lactamase	ATGCCCGGCGCCGGCGCGGAGCTCGCCCGGCCGGGGGCAGCGCCGGCCGGCGAGAAGCCCACCGCGAAGAGCGACGCGCTGACCGACCTCGCGCTGACGATGCCGATCTTCGTCCTCTATCACCTCGGCGTCGCCTTCCTCCCCATCCGCAACGCGGCGGATCCGGTCACCGCCGAGCTCCGCGCCCTCGCCAAGCACAGCCTCCCGCTCTACGCGGGCCTCACGTTCGCCGTCGGCGCCGTGTTCGTCCTGGTCCTCTCCGTCCTCGGCCGAGGCCACGCCCTCCAGACGAGGCGCTTCGCGCTGCTCGCCACCGAGGGCGCGCTCTACGCCATCCTGATGCGCTTCGCGGGCGCTTACGTGGTCGGCTCCCTCCGGCTCGGCCCGCCCGCGGCGACCAACGACATCTTCACCGGGGTCGTGATGTCGCTCGGCGCCGGCTTCTACGAGGAGATCGCCTTCCGCGCCGGCCTCTACGGGCTGGGCGCGCTCGCGATCAAGCTCTTCTTCGGCCGGGGGGTCCAGGGGATGGTGCTGCTGGTCGGCTGGGCGTTCGTGGCCGCCGCCATCTTCTCCGGCTGGCACTACGTCGGCGCGATGGGCGACCCCTGGAACCTGCCCTCCTTCGTGTTCCGGATGGTGTGCGGGCTCGTGCTCACGGGGATCTACGTCTTCCGCGGCTTCGCGCCGGCCGTCTGGACGCACGCGCTCTACGACGTCTGGGTCCTCGTGCTCCGCTGA	MPGAGAELARPGAAPAGEKPTAKSDALTDLALTMPIFVLYHLGVAFLPIRNAADPVTAELRALAKHSLPLYAGLTFAVGAVFVLVLSVLGRGHALQTRRFALLATEGALYAILMRFAGAYVVGSLRLGPPAATNDIFTGVVMSLGAGFYEEIAFRAGLYGLGALAIKLFFGRGVQGMVLLVGWAFVAAAIFSGWHYVGAMGDPWNLPSFVFRMVCGLVLTGIYVFRGFAPAVWTHALYDVWVLVLR	MELPNIMHPVAKLSTALAAALMLSGCMPGEISPTIDQQMETGDQRFGDLVFRQLAPNVWQHTSYLDMPSFGAVTSNGLIVRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVALAVVTHAHQDKMGGMDALHAAGIATYANALSNQLAPQEGMVAAQHSLTFAANGWVEPATAPNFGPLKVFYPGPGHTSDNITVGIDRTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAFPKASMIVMSHSAPDSRAAITHTARMADKLR	91.11	gnl|BL_ORD_ID|60|hsp_num:0	70			96	192	
BGC0000380.1|Leupyrrin_39 # 75974 # 77110 # 1 # ID=1_39;partial=00;start_type=GTG;rbs_motif=GGGGGG;rbs_spacer=3bp;gc_cont=0.748	BGC0000380.1|Leupyrrin_39 	75974	77110	+	Loose	800	26.9498	OprN	41.86	3000805	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGTCCCTCGCACAGCAGCTCTCCGCCCTCCCTGCTCCTCTCCTGAAGCGCCTGCACGACAGGGGCTTCGACGGGTCGCGCCTTTCGCGCTGGGCGGCGACCATCGGCGTGGAGCGGGACGCGCGCAACCGGCTGCCCGGCCGGGTCGAGCCCCCCACGCCGGACGACATCACGGCGGCGCCTGTCGAGGGCACCGCCGAGCACGGGCGCTACCGCGAGCGCGGGCTCGCGGCGCTGGCAGGGGGCGAGGTGGCCCTCTGCGTCCTCGCCGGCGGCATGGCGACCCGGATGGGCGGCGTGGTCAAGGCGCTGGTGGAGGCGCTCCCGGGCCGGACCTTCCTCGACCTCCGGCTGGGCGAGAACGCGCACCTCGAGCGGCTGGCGAACCGCGCCGGCGTCCACGTGCCGCTCTGGCTCATGACGAGCGAGGCCACCGAGCGGCCCATCCGCGACGCCCTCGGCCCGCGCCTCGACGGCGCGCGCTGCGCCACCTTCGAGCAGAACGTCTCGCTGCGCCTGGCGCCCGAGGGCGCGCTGTTCCTCGACGAGGAGGGCGAGCCGAGCGTCTACGCCACCGGCCACGGCGACCTGCCCGACGCGCTCCGCCGGAGCGGCCTGCTCGCCCGCTTCCTCGAGCGCGGCGGCAAGACGGTCTGGATCGCCAACCTCGACAACCTCGGCGCGACCGTCGACCCGGCCATCCTCGGCTGGCACCTCGCCCACGGCGACCCCCTCACGGTCGAGGTCGTCGACAAGGTCGGCGCGGACCGGGGCGGCGGGCCCGTCCGGTGGAACGGCAAGCGCATCATCACCGAGGAGCTCCGCCTCCCCCACGGCTTCGATCCGGCCGCCGTGCCGGTCTTCAACACGAACACGTTCATCGTCGGCGCCGCGGCGCTCGACGCGCTCGCGATGGAGTGGACCTACGTCGAGGTCGAGAAGAAGATCGGCGACCGGAGGGCGATCCAGTTCGAGCGGCTCCTCGGCGAGATCACGGCGGCGCTCGAGCCCCGGTTCCTGCGCGTGCCGCGCGAGGGGGTCGCCTCGCGCTTCCTCCCGGTCAAGGACGTACCGGAGCTCGAGCGGCGTCGCCCCGAGATCGAGGCGATCGCGCGGGCGCGCGGCATGCTCGGCTGA	MSLAQQLSALPAPLLKRLHDRGFDGSRLSRWAATIGVERDARNRLPGRVEPPTPDDITAAPVEGTAEHGRYRERGLAALAGGEVALCVLAGGMATRMGGVVKALVEALPGRTFLDLRLGENAHLERLANRAGVHVPLWLMTSEATERPIRDALGPRLDGARCATFEQNVSLRLAPEGALFLDEEGEPSVYATGHGDLPDALRRSGLLARFLERGGKTVWIANLDNLGATVDPAILGWHLAHGDPLTVEVVDKVGADRGGGPVRWNGKRIITEELRLPHGFDPAAVPVFNTNTFIVGAAALDALAMEWTYVEVEKKIGDRRAIQFERLLGEITAALEPRFLRVPREGVASRFLPVKDVPELERRRPEIEAIARARGMLG	MIHAQSIRSGLASALGLFSLLALSACTVGPDYRTPDTAAAKIDATASKPYDRSRFESLWWKQFDDPTLNQLVEQSLSGNRDLRVAFARLRAARALRDDVANDRFPVVTSRASADIGKGQQPGVTEDRVNSERYDLGLDSAWELDLFGRIRRQLESSDALSEAAEADLQQLQVSLIAELVDAYGQLRGAQLREKIALSNLENQKESRQLTEQLRDAGVGAELDVLRADARLAATAASVPQLQAEAERARHRIATLLGQRPEELTVDLSPRDLPAITKALPIGDPGELLRRRPDIRAAERRLAASTADVGVATADLFPRVSLSGFLGFTAGRGSQIGSSAARAWSVGPSISWAAFDLGSVRARLRGAKADADAALASYEQQVLLALEESANAFSDYGKRQERLVSLVRQSEASRAAAQQAAIRYREGTTDFLVLLDAEREQLSAEDAQAQAEVELYRGIVAIYRSLGGGWQPSA	80.08	gnl|BL_ORD_ID|293|hsp_num:0	172			780	894	ciprofloxacin; trimethoprim; chloramphenicol; norfloxacin
BGC0000380.1|Leupyrrin_41 # 78010 # 78951 # 1 # ID=1_41;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.723	BGC0000380.1|Leupyrrin_41 	78010	78951	+	Loose	3000	26.1794	abcA	34.55	3003942	protein homolog model	n/a	n/a	cephalosporin; penam; peptide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGCGGAGCAACCCCCCGCGCAGCGCCGCCCGCCCCGCGTCGCGCTCGTCGTCAAGCGCTCTGCCTGGAGGATCTACCGCGAGGAGCGGAAGGACCCGCGCATCACGCAGCTCATCGAGGCTGGCGACGCCGCCATCGCGCGCCTCAAGGCGTCGCACGATGCGCACGAGCAGACCGTGCGCGAGGTCACGGCGGCGCTCGACGATCTCGGCGTGCAGGTCGACGTCATCGCCGGCACGGCGGAGTCCTTCGACGCGGGCGAGCTCGACCTCGTGATCACGGTCGGCGGCGACGGGACGCTCCTCAGCGCTTCCCACAACGTCGGCGACGTGCCCATCCTCGGCATCAACAGCGCGCCGGGCCACTCCGTCGGCTTCTTCTGCGGCGCGACCAGCGGCGAGGCGGCCGACGCGATCGCGAAGGCGCTGCGCGGCTCGCTCCGTCGCACCGTGCTCACCCGCATGCAGGTCACGGTGAACGACAAGGTGGCGACGGCGCGCGTCCTGAACGACGCGCTCTTCTGCCACGTCTCCCCCGCGGCCACGTCGCGCTACATCATCCGCCTCGGCCGGGCCGAGGAGGAGCAGAAGTCGAGCGGCTTCTGGATCGGCCCCGCTGCCGGCTCGACGGCCGCGCAGCGCTCGGCCGGCGGGCGCGTCCTGCCCCTCACCTCGAAGCGCCTCCAGCTCGTCGTCCGCGAGCCGTACACGCCCCACGGCGAGGAGTACCGCTTCCGCCACGCGCTGATCCAGCCGGGCTCCTCGCTGGTCGTGCGGAGCAAGACGCACGACGCGAAGCTCTTCTTCGACGGGCCGATCCACGCGGTGAGCGTCGGCTTCGGCGACGTGATGGAGTTCACGCAGGCGCCTCAGTCGCTGACGATCCTGGGCCTCTCCGCCAAGAGGAAGTGGGGCGCGGGCTCGGCGGTCAGCCGCCGCTAG	MAEQPPAQRRPPRVALVVKRSAWRIYREERKDPRITQLIEAGDAAIARLKASHDAHEQTVREVTAALDDLGVQVDVIAGTAESFDAGELDLVITVGGDGTLLSASHNVGDVPILGINSAPGHSVGFFCGATSGEAADAIAKALRGSLRRTVLTRMQVTVNDKVATARVLNDALFCHVSPAATSRYIIRLGRAEEEQKSSGFWIGPAAGSTAAQRSAGGRVLPLTSKRLQLVVREPYTPHGEEYRFRHALIQPGSSLVVRSKTHDAKLFFDGPIHAVSVGFGDVMEFTQAPQSLTILGLSAKRKWGAGSAVSRR	MNESHEAGKNSSTNVEEREEEVLRLARQFTEQSSYSTAGQTPFAAEAGSALDPNGERFNARAWCKAMLQMHIGDKEAHPLRTLGVAFSNLNVHGFGSDTDYQKSVGNVWLKTLSLARIAFGQKQRKVDILQNLEGLVEAGEMLVVLGPPGSGCSTFLKTIAGETYGFHVDKNSNINFQGIAKQMAHEFRGEAIYTAEVDVHFPKLTVGDTLYFAARARTPRHIPGGVNATQYAGHMRDVIMAMFGISHTKNTIVGNDFIRGVSGGERKRVSIAEACLSNAPLQCWDNSTRGLDSANAIEFCKTLRMQADINGTTACVSLYQAPQAAYDYFDKVLVLYEGREIYFGPTSMAKHYFLQMGFVCPDRQTDADFLTSMTSHLERVVQPGYEDRVPRTPDEFAARWKASPQRAQLMQHIKSYNAKFALDGEYLDKFKQSRRAQQAKAQRVSSPYTLSYVQQVKLCLWRGYQRLKADPSVTISSLFGNTIISLVIASIFYNLKADTSTFFQRGALLFFAVLMNALGCGLEMLTLYAQRGIIEKHSRYALYHPSAEAFSSMIMDLPYKILNAITSNIVLYFMTNLRREPGAFFFFVFTSFILTLTMSMFFRSMASLSRSLVQVLPFSAVLLLGLSMYTGFAIPTGYMLGWARWIAYINPISYGFESLMINEFHNRDFPCMDYVPSGPGYTDVGLNNRVCSTVRSVPGQAFVNGNAYIESAYSYTASHKWRNIGVIFAYMFLLGAVYLVATDFITEKKPKGEILVFPRGHKALKKGKSDEDLEGGGGRSATVEKIGSDGLAMIERQTAIFQWKDVCFDIKIGKENCRILDHVDGWVKPGILTALMGVSGAGKTTLLDVLATRTTMGIISGEMLVDGQPRDESFQRKTGYAQQQDLHLSTATVREALEFSALLRQSAHVPRQEKIDYVTEVIKLLDMTEYADAVIGVPGEGLNVEQRKRLTIGVELAARPQLLLFLDEPTSGLDSQTSWAILDLLDKLKKNGQAILCTIHQPSAMLFQRFDRLLFLQAGGRTVYFGEIGQNSQILIDYFVRNGAPPCPPDANPAEWMLDVIGAAPGSHTSINWFETWRRSPEYARVQEHLAELKHERRHQTNLFRTTSGQKREDKDSYREFAAPFWAQLYQVQVRVFQQIWRSPTYIYSKTALCVLSALFVGFSLFHTPNTIQGLQNQMFGIFMLLTLFGQLIQQIMPHFVAQRALYEVRDRPAKTYSWKAFLIANIVVELPWNSLMSVLMFLCWYYPIGLYRNAEPTDAVHLRGTQMWLMIWTFLLFSSTFAHFMIAAFDAAENAGNLGNLLFLLCLLFCGVLATPDQLPRFWIFMYRVSPFTYLVSGMLSVGISNTNVTCADNEYLRFDPVNGTCGEYMGSYMSNLGGYLADEMATANCSFCPIKETNVFLGRVSSSYSDIWRNFGLMWVFIVFNIFAACSLYWWVRVPRDKKPVAKAE	21.56	gnl|BL_ORD_ID|2167|hsp_num:0	2416			1308	1473	methicillin; daptomycin; cefotaxime; moenomycin A1
BGC0000380.1|Leupyrrin_43 # 79845 # 80174 # 1 # ID=1_43;partial=01;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.712	BGC0000380.1|Leupyrrin_43 	79845	80174	+	Loose	1000	23.8682	MCR-1.31	25.24	3007245	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	ATGACGCTCGCCGTCCGACTCCTCCGCGCGCTGTTCGCGTTCTCGGTCATCCTGACGAGCTACCTCATCCAGCTGGGGCTCGCGCGGGTGTTCGCGAGGCGCCTCGGGAGCGGCGCCGCCGCGCGTGAGCTGCCCGGCTGGCTCGTCGAGCGCCGGGCCCGCGTCGATCAGAAGAACGCCCGCCGCCTGCTGCGCGCCATGCTCAAGCTGCGGGGCGTCTTCATCAAGCTCGGCCAGGTGCTGTCGATCATGGGCGGCTTCCTGCCGCGGGCCTACGGCAAGGAGCTCGAGCAGCTCCAGGACCAGGTGCCGCCCCACCCCTTCAGCGAT	MTLAVRLLRALFAFSVILTSYLIQLGLARVFARRLGSGAAARELPGWLVERRARVDQKNARRLLRAMLKLRGVFIKLGQVLSIMGGFLPRAYGKELEQLQDQVPPHPFSD	MMQHTSVWYRRSVSPFVLVASVAVFLTATANLTFFDKISQTYPIADNLGFVLTIAVVLFGAMLLITTLLSSYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNALQTDQAETKDLLNAVFIMRIIGLGVLPSLLVAFVKVDYPTWGKGLMRRLGLIVASLALILLPVVAFSSHYASFFRVHKPLRSYVNPIMPIYSVGKLASIEYKKASAPKDTIYHAKDAVQATKPDMRKPRLVVFVVGETARADHVSFNGYERDTFPQLAKIDGVTNFSNVTSCGTSTAYSVPCMFSYLGADEYDVDTAKYQENVLDTLDRLGVSILWRDNNSDSKGVMDKLPKAQFADYKSATNNAICNTNPYNECRDVGMLVGLDDFVAANNGKDMLIMLHQMGNHGPAYFKRYDEKFAKFTPVCEGNELAKCEHQSLINAYDNALLATDDFIAQSIQWLQTHSNAYDVSMLYVSDHGESLGENGVYLHGMPNAFAPKEQRSVPAFFWTDKQTGITPMATDTVLTHDAITPTLLKLFDVTADKVKDRTAFIR	20.33	gnl|BL_ORD_ID|4865|hsp_num:0	5850			153	441	colistin A; colistin B
BGC0000380.1|Leupyrrin_15 # 19342 # 20541 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=13bp;gc_cont=0.670	BGC0000380.1|Leupyrrin_15 	19342	20541	+	Loose	660	31.187	MexS	24.03	3000813	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGAGATCATGACGAGGTCGTTGGCGGCCGCCGGGGCTTCTTCCCGCGGCTATGAGACGGATGCATGGGTGATCTACGCCGGCGGGCCGCGCGACACGTCGCACGCCGAGCTCGTGCGCGAGCGCATCGAGATCGACCCGCTGGGCCCTGGCGAGGTCCTGGTCGAGCCGCTCTACGGGTGCTGGGAGGGCAACATGGGGCACGCGATCGAGCGCAGCCCCGTCGATATCTGCCGGATGCGCCGCGAGAAGCGGGTCGTGCTCGGGAACGCCGGCGTGGTCAGGGTCGTCGAGCTGGGCCCGGAGGTGAAGGGGGTCGCCCCCGGCGATGTGGCCATGCTGTTCGCGAGCGGAGAGCAGGACCGCGTCGGCTACATGAAGAAGGCCCTGGGCTTCGACGCCGCGGGGCAGGCCGGCATGCTGGCCAAGCGGACGAAGCTCCGGGAAGATCAGCTCATCGTGCTGCCGCCGAACAACGGCTTCTCCCTGCCCCAGTGGGCGGCCTTCTCCGTGCGCTACGTGACCGCGTGGTCGAACTGGGAGCTCGCCTACGGCGTCTTTCGGCTGCAGATGACCGCCGAGGATTGCCCGCGACCGTACGTCTGGGGCTGGGGCGGCGGCACCACCCTGGCGGAGCTCGATCTGGCCCAGCGATTCGGCTGCGACGCCGTGATGATCTCGGGCACCGACGTGAACATCGACCTCATCAAGAAGTGCGGGATCGAGATGATCGATCGCCGCGAGTACCCCAACCTCCTGCTCGACCAGGAGCGGTTCGACGCCGACGCCACGTACCGCGAGTCGCACAACCGCTCGAAGCGGGAGTTCGTTCAGCGCGTGACCGAGCGCACGAACGGCGAGCTTGTCCATATCTTCCTCGATTACCTCGGGCCCCCCGTCTACCAGCTCACGCTCCGCCTGCTGGCGAGGCAGGGGGTGATCGCGACCGCCGGATGGAAGGAGGGTAGAGACGTCTCCCACTCGCGCTCCCAGGAGTGCATCATGCGGCACCAGCACATCTACACCCATTACGCGCGGCGCTCGCAGGCGGAGGCCGCGATCAGCTACGCTATCAAGACCGGGTGGATGCCGCAGGTGGACGAGCGCGTGTACTCGTTCGACGAGATCCCGGAGCTCGGGCAGCGATACCTCCAGGGAGACACGCATTATTTTAGCTGCTACTCCATCAACCCTACGTGA	MEIMTRSLAAAGASSRGYETDAWVIYAGGPRDTSHAELVRERIEIDPLGPGEVLVEPLYGCWEGNMGHAIERSPVDICRMRREKRVVLGNAGVVRVVELGPEVKGVAPGDVAMLFASGEQDRVGYMKKALGFDAAGQAGMLAKRTKLREDQLIVLPPNNGFSLPQWAAFSVRYVTAWSNWELAYGVFRLQMTAEDCPRPYVWGWGGGTTLAELDLAQRFGCDAVMISGTDVNIDLIKKCGIEMIDRREYPNLLLDQERFDADATYRESHNRSKREFVQRVTERTNGELVHIFLDYLGPPVYQLTLRLLARQGVIATAGWKEGRDVSHSRSQECIMRHQHIYTHYARRSQAEAAISYAIKTGWMPQVDERVYSFDEIPELGQRYLQGDTHYFSCYSINPT	MSRVIRFHQFGPPEVLKCEELPTPAPAAGEVLVRVQAIGVSWKDVLWRQNLAPEQAALPSGLGFELAGEVLAVGAGVGDLPLGSRVASFPAHTPDHYPAYGDVVLMPRAALAVYPEVLTPVEASVYYTGLLVAYFGLVDLAGLKAGQTVLITEAARMYGPVSIQLAKALGARVIASTKSAEEREFLREQGADKVVVTDEQDLVLEVERFTEGKGVNVILDELGGPQMTLLGDVSATRGKLVLYGCNGGNESAFPACAAFKKHLQFYRHCLMDFTGHPEMGLERNDESVSKALAHIEQLTRDRLLKPVVDRVFEFDQVVEAHRYMETCPKRGRVVIHVAD	117.70	gnl|BL_ORD_ID|1039|hsp_num:0	1041			594	975	ciprofloxacin; trimethoprim; chloramphenicol
